Total synthesis of (-)-mucocin and studies toward the asymmetric total synthesis of brianthein A by Zhang, Yan
 
TOTAL SYNTHESIS OF (-)-MUCOCIN 
AND 
STUDIES TOWARD THE ASYMMETRIC TOTAL SYNTHESIS OF BRIANTHEIN A 
 
 
 
 
 
Yan Zhang 
 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel 
Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in 
the Department of Chemistry 
 
 
 
 
 
Chapel Hill 
2007 
 
 
 
 
 
 
 
 
 
Approved by:    
 
Advisor:  Professor Michael T. Crimmins 
 
Reader:  Professor Jeffrey S. Johnson 
 
Reader:  Professor Maurice S. Brookhart 
 ii
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2007 
Yan Zhang 
 
 
 
 iii
ABSTRACT 
 
Yan Zhang 
 
Total Synthesis of (-)-Mucocin and  
Studies Toward the Asymmetric Total Synthesis of Brianthein A 
(Under the direction of Professor Michael T. Crimmins) 
 
 A highly convergent asymmetric total synthesis of antitumor acetogenin 
natural product (-)-mucocin is described. This approach combined asymmetric 
glycolate aldol additions with ring-closing metatheses to construct cyclic ethers. In 
addition, a relay ring-closing metathesis strategy was successfully applied to the 
regioselective formation of an intermediate dihydrofuran. Finally, the two complex 
alkene fragments were coupled via a selective cross metathesis reaction. 
During efforts toward the asymmetric total synthesis of bioactive natural 
product brianthein A, a novel asymmetric aldol addition-thioimide transesterification-
dianionic Claisen rearrangement strategy was developed. This strategy showcased 
the utility and versatility of the thiazolidinethione-mediated propionate aldol 
methodology previously developed in the Crimmins laboratories, and allowed rapid 
access to several complex intermediates containing all-carbon quaternary stereo-
centers in high yield and diastereoselectivity. Furthermore, synthesis of the highly 
functionalized trans-fused 6,10-bicyclic core of brianthein A was accomplished. By 
utilizing ring-closing metathesis as the key cyclization strategy, along with 
introducing an appropriate conformational constraint to the cyclization substrate, 
formation of the challenging ten-membered carbocycle was successful. 
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CHAPTER 1 
TOTAL SYNTHESIS OF (-)-MUCOCIN 
1.1 Background 
1.1.1 Isolation and Biological Activities of (-)-Mucocin 
In 1995 mucocin (1), a novel member of the anonnaceous acetogenin family, 
was isolated from the leaves of Rollinia mucosa by McLaughlin and co-workers.1 The 
annonaceous acetogenins are a series of antimitotic and cytotoxic polyethers, 
containing either adjacent or nonadjacent tetrahydrofuran (THF) rings. Mucocin was 
the first member of this family reported to bear a tetrahydropyran (THP) ring along 
with a THF ring. Extensive spectroscopic analysis (MS, 1H, 13C and 2D NMR) further 
revealed that mucocin is highly oxygenated, and contains a total of nine 
stereocenters. The absolute stereochemistry of 1 was eventually elucidated using 
Mosher’s methodology. 
O
O
C10H21 H H
OH
HO
H H
OH
HO
O
O
Me
14
1215
16
19
2024
23
 
Figure 1. (-)-Mucocin (1) 
Biologically, (-)-mucocin is quite active in the brine shrimp toxicity (BST) 
assay (IC50 = 1.3 µg/mL). It also demonstrates remarkable selective inhibitory effects 
against A-549 (lung cancer, ED50 = 1.0 x 10-6 µg/mL) and PACA-2 (pancreatic 
cancer, ED50 = 4.7 x 10-7 µg/mL) in a panel of six human solid tumor cell lines, with 
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potency up to 10,000 times that of the known antitumor agent adriamycin.2 The 
mode of action is believed to involve the inhibition of both the mitochondrial complex 
I (NADH-ubiquinone oxidoreductase) and the plasma membrane NADH oxidase. As 
a result of this blockage, the ATP level of the tumor cells decreases and apoptosis is 
induced in the malignant cells.3,4 
The potent antitumor activity and the unique structure of mucocin have 
consequently stimulated several synthetic endeavors, as five research groups have 
published their total syntheses of mucocin.5,6,7,8,9 
1.1.2 Previous Total Syntheses of (-)-Mucocin 
1.1.2.1 Keinan’s Total Synthesis of (-)-Mucocin 
 The first total synthesis of (-)-mucocin was reported by Keinan and co-
workers in 1998.5 Upon division of the molecule into two key fragments 2 and 3, 
Keinan proposed that both the THP and THF rings of bicyclic fragment 2 would be 
simultaneously constructed via a acid-mediated double regio- and stereoselective 
epoxide opening of linear intermediate 4 (Scheme 1). The underlying rationalization 
for the five-membered THF ring formation was based on the well-defined Baldwin’s 
rules, which predicted that 5-exo cyclization would be more favorable than 6-endo 
ring-closure. In contrast, the cyclization of the six-membered THP ring was expected 
to be facilitated by stabilization of the developing positive charge on the epoxide with 
the nearby olefin. Tetraol 4, in turn, was envisioned to ultimately arise from 
trans,trans,trans-1,5,9-cyclododecatriene (5), and all the stereocenters would be 
introduced by subsequent asymmetric epoxidation and asymmetric dihydroxylation 
reactions. 
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Scheme 1. Retrosynthetic Analysis of Keinan’s Total Synthesis of (-)-Mucocin 
 The synthesis began by selective dihydroxylation of one of the three olefins of 
triene 5, followed by oxidative cleavage to provide dialdehyde 6 (Scheme 2). Both 
aldehydes were converted to α,β-unsaturated esters under Horner-Wardsworth-
Emmons olefination conditions, followed by DIBAL reduction to afford bis-allylic 
alcohol 7. Standard Sharpless asymmetric epoxidation conditions were 
subsequently applied to deliver bis-epoxide 8 in high enantioselectivity (98% ee). 
Mono-silylation of the diol, followed by an oxidation-olefination sequence of the 
remaining free alcohol gave Z,E,E triene 9. The inherent difference in reactivity 
between Z and E olefins toward Sharpless asymmetric dihydroxylation conditions 
allowed the two E-olefins to be dihydroxylated, while keeping the Z double bond 
intact. With all the stereocenters established, the resulting tetraol 4 was subjected to 
the key epoxide opening reaction. It was found that treatment of 4 with a catalytic 
amount of triflic acid for one hour offered the desired bicyclic intermediate 10 in 72% 
yield. After an additional eight steps, alkyne 2 was obtained, setting the stage for the 
subsequent coupling with vinyl iodide 3 using Sonogashira protocol. Selective 
hydrogenation of the resulting polyenyne 11 with Wilkinson’s catalyst followed by 
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global deprotection completed the first total synthesis of (-)-mucocin with 20 steps in 
the longest linear sequence. 
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Scheme 2. Keinan’s Total Synthesis of (-)-Mucocin 
1.1.2.2 Koert’s Total Synthesis of (-)-Mucocin 
 In 1999, Koert and co-workers reported a more convergent total synthesis of 
(-)-mucocin by breaking down the molecule into three key fragments.6 As illustrated 
in Scheme 3, following a Wittig olefination to connect THF fragment 14 and 
butenolide 15, the coupling product would be converted to aldehyde 13. This would 
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set the stage for a subsequent stereoselective addition of the carbon nucleophile 
derived from THP fragment 12 to complete the total synthesis. Similar to the strategy 
exploited by Keinan, the THP fragment was envisioned to be accessed via an 
epoxide opening of 16, while five-membered cyclic ether 14 would instead be 
accessed from linear intermediate 17 via an intramolecular Williamson ether strategy. 
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Scheme 3. Retrosynthetic Analysis of Koert’s Total Synthesis of (-)-Mucocin 
The synthesis of THP fragment 12 started with a four step conversion of 
commercially available (E)-dihydromuconic acid (18) to alkene 19 (Scheme 4). 
Asymmetric dihydroxylation followed by protection of the resulting diol as acetonide 
20 allowed for the subsequent alkylation-reduction sequence to yield allylic alcohol 
21. Upon exposure to Sharpless epoxidation conditions and further manipulation of 
the alcohol functional group, epoxide 16 was obtained in preparation for the key 
cyclization. Iso-propyl alcohol as co-solvent proved to be critical for the acid-
catalyzed epoxide opening, giving the six-membered cyclization product 22 in 89% 
yield. A four step sequence was then initiated to give rise to iodide 12.  
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Scheme 4. Koert’s Synthesis of THP Fragment 12 
To prepare the THF fragment, functionalized diorganozinc species 24 was 
added to aldehyde 23 in a stereoselective fashion, followed by tosylation of the 
resulting alcohol 25 to produce the Williamson etherization substrate 17 (Scheme 5). 
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Scheme 5. Koert's Total Synthesis of (-)-Mucocin 
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Both TIPS groups of 17 were removed upon treatment with TBAF, and a 
concomitant cyclization occurred to provide the trans-2,5-disubstituted THF 
derivative 26 in 95% yield. The primary alcohol of 26 was then protected as its silyl 
ether, followed by conversion of the pivaloyl protected alcohol to phosphonium salt 
14. Wittig olefination between 14 and butenolide aldehyde 15 formed diene 27 in 
60% yield, which was further manipulated to provide aldehyde 13. Finally, the alkyl 
magnesium species derived from iodide 12 underwent stereoselective addition to 
aldehyde 13, furnishing the natural product upon global deprotection. 
1.1.2.3 Takahashi’s Total Synthesis of (-)-Mucocin 
 Takahashi’s strategy towards the total synthesis of (-)-mucocin was proposed 
to rely on a convergent palladium-catalyzed coupling between alkyne 28 and vinyl 
iodide 29 (Scheme 6).7 The central core of 28 would be further disconnected to THP 
aldehyde 30 and ethynyl THF 31. Unlike Keinan or Koert, Takahashi’s unique 
approach would access all three key fragments from commercially available cyclic 
carbohydrates as starting materials. 
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OC10H21
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O
H
O
MOMO
TBSO OTBS
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+
HH
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H H
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30 31  
Scheme 6. Retrosynthetic Analysis of Takahashi’s Total Synthesis of (-)-Mucocin 
 The preparation of THP fragment 30 started from methyl α-D-
galactopyranoside (32). All four alcohols were protected as benzyl ethers, and a two-
 8
step sequence converted the resulting lactal to lactone 33 (Scheme 7). The key C-
glycosidation took place by adding decylmagnesium bromide to lactone 33, and 
stereoselective reduction of the resultant hemiacetal with triethylsilane in the 
presence of BF3•OEt2 provided pyran 34. Following hydrogenolysis to remove all the 
benzyl protecting groups and selective protection of the primary alcohol as a TBDPS 
ether, the resulting triol was subjected to regioselective deoxygenation following 
Ando’s protocol, with acylation occurring in the same pot to give allylic acetate 35. 
Finally, a series of five more steps were required to complete THP fragment 30. 
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Scheme 7. Takahashi’s Preparation of THP Fragment 30 
 2,5-Anhydro-D-mannitol (36) was utilized as the starting point for the 
synthesis of THF fragment 31 (Scheme 8). Successive treatment of 36 with trityl 
chloride and TBSCl in a one-pot manner gave fully protected THF intermediate 37. 
Selective mono-detritylation followed by Swern oxidation proceeded smoothly to give 
aldehyde 38. Stereoselective ethynylation of aldehyde 38 proved most efficient in 
the presence of zinc chloride (93:7 dr) and the THF fragment 31 was eventually 
obtained upon protection of the resulting alcohol as the MOM ether. In spite of 
extensive experimentation, the addition of alkyne 31 to aldehyde 30 failed to give 
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good selectivity for the desired diastereomer. As a result, a hydrogenation-oxidation-
reduction sequence was implemented to provide the required stereocenter of alcohol 
40. Upon deoxygenation and side chain elaboration, alkyne 28 was delivered to 
couple with iodide 29 under Sonogashira conditions. The resulting enyne 41 
underwent selective hydrogenation and global deprotection to complete the total 
synthesis. 
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Scheme 8. Takahashi’s Total Synthesis of (-)-Mucocin 
1.1.2.4 Evans’ Total Synthesis of (-)-Mucocin 
 In 2003, Evans group reported an elegant convergent synthesis of (-)-
mucocin, showcasing the utility of a temporary silicon-tethered ring-closing 
metathesis (RCM) strategy (Scheme 9).8  In contrast to previous total syntheses, the 
C4 stereocenter was planned to be installed via the enantioselective addition of 
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alkyne 44 to aldehyde 45. A bismuth tribromide-mediated reductive etherification 
would be exploited to form THP fragment 43, and an oxidative cyclization would be 
key to the construction of THF fragment 44. Both 43 and 44 would be eventually 
derived from a common synthetic intermediate 46.  
OC10H21
TBSO
O
+ O
O
O
Me
H
O
O
TIPSO
Me
O O
Si
i -Pr i -Pr
O
PMPO
C10H21
TBSO
OH
O
OH
+O
H HHH
HH HH
(-)-mucocin (1)
4
42
43 44 45
46  
Scheme 9. Retrosynthetic Analysis of Evans’ Total Synthesis of (-)-Mucocin 
 The synthesis of THP fragment 43 was accomplished in merely six steps from 
46, starting with a Mitsunobu inversion of the allylic alcohol to afford ether 47 
(Scheme 10). Regiospecific opening of the epoxide with homoenolate equivalent 48, 
followed by in situ protection of the resultant secondary alcohol gave bis-TBS ether 
49. Subsequent Sharpless asymmetric dihydroxylation chemoselectively occurred at 
the electron-rich internal double bond of triene, furnishing enone 50, into which the 
alkyl side chain was introduced via conjugate addition to provide ketone 51. 
Reductive etherification upon treatment of 51 with BiBr3 and t-Bu2MeSiH, followed by 
protection of the secondary alcohol in the same pot gave rise to six-membered cyclic 
ether 52 in 93% yield and higher than 19:1 diastereoselectivity. Finally, the PMP 
protecting group was removed with CAN reagent to afford alkene 43. 
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Scheme 10. Evans’ Synthesis of THP Fragment 43 
 The construction of the THF fragment also initiated from epoxide 47 (Scheme 
11). Regiospecific ring opening provided alcohol 53, which was subjected to a cobalt 
(II)-catalyzed oxidative cyclization to deliver five-membered cyclic ether 54 in 83% 
yield and higher than 19:1 diastereoselectivity. The alkynyl side chain was then 
installed via a tosylation-alkylation sequence that set the stage for coupling with the 
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H H
HO
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2. TsNH-NH2
NaOAc, 95%
1
 
Scheme 11. Evans’ Total Synthesis of (-)-Mucocin  
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butenolide fragment. Enantioselective addition of the alkynyl zinc reagent derived 
from 44 to aldehyde 45 afforded the propargylic alcohol with excellent 
stereoselectivity (20:1), which was protected as its TIPS ether, and selectively 
deprotected the PMP group to give allylic alcohol 55. Alkene 43 and 55 were then 
linked with a diisopropyl silicon tether, and a subsequent RCM reaction generated 
seven-membered ring 42 in 83% yield to complete the construction of the carbon 
skeleton of mucocin. Fluoride-mediated silyl deprotection and selective 
hydrogenation concluded the total synthesis of (-)-mucocin with only 12 steps in its 
longest linear sequence. 
1.1.2.5 Mootoo’s Total Synthesis of (-)-Mucocin 
 Mootoo and co-workers published the fifth total synthesis of (-)-mucocin in 
2005, utilizing a convergent cross metathesis strategy to couple alkene 58 and 59 
(Scheme 12).9 A Julia olefination would be subsequently applied to stitch butenolide 
fragment 57 to the rest of the molecule. Common intermediate 60 was envisioned to 
yield both 58 and 59 via different cyclization strategies. 
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Scheme 12. Retrosynthetic Analysis of Mootoo’s Total Synthesis of (-)-Mucocin 
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 Addition of the lithiated dithiane 61 to aldehyde 60 (available in five steps 
from 3-hydroxy-1,4-pentadiene) gave an inseparable 1:1 mixture of alcohols 62 
(Scheme 13). Treatment of 62 with mercuric perchlorate resulted in hydrolysis of 
both the dithiane and acetal, as well as concomitant formation of a mixture of bicyclic 
acetals. The desired diastereomer 63 was isolated in 32% over the two steps, and 
subjected to stereoselective reduction with triethylsilane to provide THP fragment 58. 
60
S S
C10H21
O
O
HO
C10H21
SS Hg(ClO4)2
32%
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O
O
BF3·OEt2
n-BuLi
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C9H19
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80%
O
HO
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HH
63 58
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Scheme 13. Mootoo’s Synthesis of THP Fragment 58 
 Wittig olefination of 60 followed by pivalylation provided diene 64, which was 
treated with IDCP to undergo intramolecular iodocyclization (Scheme 14). Radical 
reduction of the resulting iodide 65 and protection of the alcohol as an acetate  
60
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Scheme 14. Mootoo’s Total Synthesis of (-)-Mucocin 
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furnished the trans-2,5-disubstituted THF fragment 59. Exposure of a 1:3 mixture of 
the two coupling partners, 58 and 59, to Grubbs second generation catalyst provided 
the cross product 56 in 51% yield, which was manipulated in six steps to arrive at 
sulfone 66. Julia olefination was then performed between sulfone 66 and aldehyde 
57 to give diene 67, which was subjected to selective hydrogenation and global 
deprotection to complete the total synthesis of (-)-mucocin. 
1.1.3 Crimmins’ Ring-Closing Metathesis Approach to Small and Medium 
Cyclic Ethers 
 
One of the major research areas in the Crimmins laboratory over the past 
decade has been the development of novel strategies for the efficient and 
stereoselective synthesis of highly functionalized small and medium size cyclic 
ethers. These strategies are based on a ring-closing metathesis reaction that 
mediate the cyclization of alkyl ether backbones terminating in two alkene 
functionalities. Such an approach was made possible due to the tremendous 
advancement in organometallic catalysts since the initial breakthrough study of 
Schrock’s molybdenium catalyst 68 in 1990.10 Despite its high reactivity towards a 
broad range of substrates, 68 suffered from several drawbacks including poor 
functional group tolerance and high air and moisture sensitivity. In contrast, the 
ruthenium-based alkylidene complexes (G111 and G212) developed by Grubbs and 
co-workers in the mid to late 1990s, could tolerate a wide variety of functional groups 
with high reactivity as well as thermal stability. More recently, Hoveyda and co-
workers described the development of “reusable” ether-tethered ruthenium catalysts 
(Hoveyda-G113 and Hoveyda-G214). Through the development of these important 
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metathesis catalysts, it is now possible to routinely prepare ring ethers containing 
five to nine atoms with very high efficiency.15 
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RuCl
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O
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RuCl
Cl
PCy3
OH3C
CH3
Hoveyda-G1 Hoveyda-G2
Figure 2. Olefin Metathesis Catalysts 
 The production of the precursor diene fragments for the RCM reaction 
primarily relies on the chiral auxiliary-mediated glycolate alkylation and glycolate 
aldol reactions developed in the Crimmins laboratory. A highly efficient, diastereo-
selective glycolate alkylation reaction using N-glycolyloxazolidinones was reported in 
2000.16 Enolization of the substrate using sodium hexamethyldisilazide followed by 
addition of an appropriate electrophile (typically allyl iodides) leads to the alkylation 
product in good yield and excellent diastereoselectivity. As shown in the total 
synthesis of ophirin B (72),17 for example, this alkylation/RCM approach readily 
generated diene ether 70 from glycolate 69 in 93% yield (Scheme 15). RCM with the 
Grubbs second generation catalyst cleanly provided the nine-membered ring 71, 
ON
O
BnO
i-PrMe
OO
BnO
NaN(SiMe3)2
I
Me
THF, -78 to -40 oC
93%
Xc
O
BnO
Me
O
BnO
Me
1. LiBH4, MeOH
2. G2, C6H6
82%
O
Me
OBn
H
H
Me
BnO
OH
69 70
O
Me
Me
H
H
H
H
OAc
Me
AcO
MeMe
OAc
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Scheme 15. Total Synthesis of Ophirin B: Alkylation/RCM Approach (Crimmins/Brown) 
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which was carried forward to the natural product. 
 An alternative approach towards generating the diene ethers relies on 
glycolate aldol additions. The Crimmins laboratory has developed methods using the 
titanium enolates of N-glycolyloxazolidinones and N-glycolyloxazolidinethiones to 
obtain either syn18,19 or anti20 adducts with high selectivity and good yields. More 
recently, our laboratory has developed an improved procedure21 that leads to a 
significant increase in the yields of syn aldol reactions using complex oxazolidinone 
glycolate substrates. As shown in Scheme 16, it is possible to access the RCM 
substrates of different sizes and substitution patterns by merely varying the aldehyde 
partners. For example, glycolate aldol adduct A1 can readily undergo protecting 
group manipulation and auxiliary removal to generate diene A2, which can be 
converted to cyclic ring ether A3 via RCM (Route A). Alternatively, RCM substrate 
polyolefin B2 can be accessed from glycolate aldol adduct B1 by elaborating its 
auxiliary-bearing carbonyl group into an olefin, providing cyclic ether B3 upon 
subsequent RCM (Route B).  
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Scheme 16. Asymmetric Glycolate Aldol/RCM Approach to Small and Medium Size Ethers 
Scheme 17 illustrates the use of this approach in the total synthesis of (+)-
gigantecin (77)22. Syn selective glycolate aldol reaction with glycolylimide 73 and n-
 17
tridecanal directly generated the 1,2-syn aldol adduct 74 in 74% yield with 15:1 dr. 
Following the representative Route B shown in Scheme 16, diene 75 was prepared 
and readily subjected to G2 catalyst to provide the five-membered cyclic ether 76 in 
99% yield, which was further elaborated to afford the natural product. 
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Scheme 17. Total Synthesis of (+)-Gigantecin: Glycolate Aldol/RCM Approach (Crimmins/She) 
1.2 Total Synthesis of (-)-Mucocin 
 The general utility of the asymmetric glycolate aldol/RCM methodology gave 
us access to other biologically active natural products that contain small and medium 
cyclic ethers, and led us to the development of the total synthesis of (-)-mucocin.  
1.2.1. Previous Synthetic Efforts in the Crimmins Group Toward (-)-Mucocin 
In late 1990s, Crimmins’ original synthetic plan towards mucocin involved a 
temporary silicon tether-RCM strategy to couple the THP and THF fragments, 
followed by a Sonogashira coupling with the butenolide fragment to furnish the 
natural product (Figure 3).  
Pd(0) catalyzed
coupling
O
O
C10H21 H H
OH
HO
H H
OH
HO
O
O
Mesilicon
tether-RCM  
Figure 3. Initial Retrosynthetic Analysis for the Total Synthesis of (-)-Mucocin (Crimmins/Diaz) 
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Dr. Frank Diaz, a former graduate student in the Crimmins laboratory, initiated 
this project, and prepared both THP alkene 78 and THF alkene 79 (Scheme 18).23 
Various silyl species and reaction conditions were investigated toward the formation 
of an appropriate silicon linkage. However, no diphenyl or diisopropyl tether was 
able to be obtained, presumably due to the steric demand of the allylic alcohol on 
each fragment. Dr. Diaz eventually prepared dimethylsilyl tethered polyene 80, 
although in only modest yields. Unfortunately, 80 proved to be incompatible with the 
subsequent RCM conditions, resulting in full recovery of starting material at room 
temperature or decomposition at 40 oC. With little success of the silicon tether-RCM 
strategy, other coupling strategies were explored. 
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Scheme 18. Investigation on the silicon tether-RCM strategy (Crimmins/Diaz) 
1.2.2 Retrosynthetic Analysis – Cross Metathesis Strategy 
        Mucocin was envisioned to derive from the convergent assembly of three key 
subunits (Scheme 19). The advanced acetylene 81 would be coupled to known 
butenolide 8222 via a Pd(0) catalyzed Sonogashira reaction. A selective cross-
metathesis reaction was selected to couple C18-C34 fragment 78 and C7-C17 
fragment 83. Both fragments 78 and 83 would be accessible by applying the 
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asymmetric glycolate aldol-ring-closing metathesis strategy developed in the 
Crimmins laboratory. 
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Scheme 19. Retrosynthetic Analysis of (-)-Mucocin 
1.2.3 Synthesis of C18-C34 Fragment 
The synthesis of C18-C34 fragment 78 began with the protection of the 
known compound (2R,3R)-1-oxiranylundecan-1-ol (84) 24  as its THP ether 85, 
followed by epoxide opening25 to afford the homologated allylic alcohol 86 in 87% 
yield (Scheme 20). The resulting secondary alcohol was protected as a benzyl ether, 
and the THP was removed under acidic conditions to deliver alcohol 87 in 86% yield 
over the two steps. Alkylation of the sodium alkoxide of alcohol 87 with sodium 
bromoacetate gave glycolic acid 88 in 86% yield, which was converted to its mixed 
pivalic anhydride and treated with (R)-3-lithio-4-benzyloxazolidin-2-one to generate 
the N-glycolyloxazolidinone 89 in 80% yield. We exploited the recently developed 
aldol reaction protocol21 in which the chlorotitanium enolate of glycolate 89 was 
formed by treatment with TiCl4 (1.0 equiv), i-Pr2NEt (2.5 equiv), and N-methyl-2-
pyrrolidinone (1.0 equiv). Addition of acrolein to the enolate solution gave the 
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desired syn aldol adduct 90 in good yield and diastereoselectivity (77%, 11:1 dr). 
Other aldol protocols gave significantly lower yields and diastereoselectivity.       
Alcohol 90 was protected as its MOM ether 91 in 90% yield, followed by reductive 
removal of the chiral auxiliary with lithium borohydride to afford alcohol 92 in 87% 
yield. A subsequent Dess-Martin oxidation-Wittig olefination sequence delivered 
triene 93 in 81% yield over the two steps. Exposure of triene 93 to Grubbs second  
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Scheme 20. Synthesis of C18-C34 Fragment 
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generation catalyst, however, gave a disappointing 2:1 mixture of the desired six-
membered ring 94 and undesired seven-membered ring 95. 
We believed that the formation of both cyclic products was due to 
indiscriminate insertion of the catalyst into all three alkenes of triene 93 (Figure 4). In 
particular, catalyst insertion to the C22 olefin would allow the formation of both six 
and seven-membered rings. Cyclization of the intermediate with the C21 ruthenium 
carbene species would predominantly give the six-membered cyclic ether 94 since 
the formation of a cyclobutene would be very unfavorable in a RCM reaction. For the 
same reason, seven-membered ring product 95 would dominate as a result of 
ruthenium insertion to C18. 
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Figure 4. Rationalization for the Unselective Triene RCM 
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Based on this rationale, we reasoned that increasing the steric bulk of the 
protecting group on C19 allylic alcohol of triene 93 should selectively deactivate the 
adjacent C18 olefin, leading to a more selective formation of the desired six-
membered ring. Therefore, we prepared several triene analogues with different 
protecting groups and investigated several reaction conditions. As illustrated in 
Table 1, with the bulkier TES protecting group, the regioselectivity of RCM increased 
to 11:1 with G2 (entry 5) and >20:1 with G1 (entry 4), in favor of the desired six-
membered ring. Further increasing the size of the protecting group to TBS did not 
further increase the regioselectivity (entry 6,7). 
Table 1. Effects of Protecting Groups on the Regioselectivity of Triene RCM 
O
OR'
O
BnO
C10H21
OR
H
O
BnO
C10H21
OR'
H
G1 or G2
+
A B
H
H
BnO
C10H21
 
Entry R R' 
 
Cat. Reaction 
Condition 
Selectivity 
(A : B) 
Conversiona
1 MOM MOM G1 CH2Cl2, 40 oC 4.4 : 1b 30% 
2 MOM MOM G2 CH2Cl2, 40 oC    2 : 1b 100% 
3 MOM MOM G1 C6H6, 80 oC 2.5 : 1b 60% 
4c TES H G1 CH2Cl2, 40 oC 
then deprotection 
 >20 : 1d 50% 
5c TES H G2 CH2Cl2, 40 oC  
then deprotection
   11 : 1e 80% 
6 TBS TBS G1 CH2Cl2, 40 oC  >20 : 1d 67% 
7 TBS TBS G2 CH2Cl2, 40 oC   8 : 1d 100% 
a. Conversion was determined by NMR of crude RCM reaction mixture. b. Ratio was determined by NMR of crude RCM 
reaction mixture. c. The TES deprotection was achieved by acidic treatment of the RCM reaction mixture. d. Only one product 
spot was observed by TLC. e. Isolated ratio was determined after column chromatography. 
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After consideration of both regioselectivity and conversion issues, the TES 
group was selected to protect the secondary alcohol of aldol adduct 90 in 98% yield 
(Scheme 21). A three-step sequence of auxiliary removal-Swern oxidation-Wittig 
olefination delivered triene 98 in 80% overall yield. Triene 98 was subsequently 
exposed to the Grubbs second generation catalyst, followed by in situ acid mediated 
TES deprotection to generate the dihydropyran 78 regioselectively in good yield, 
with less than 5% of the corresponding seven-membered metathesis product. 
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O
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Scheme 21. Synthesis of C18-C34 Fragment 
1.2.4 Synthesis of C7-C17 Fragment 
Preparation of the C7-C17 fragment 83 began by selectively protecting the 
terminal alkyne of 5-hexyn-1-ol (99) with a TIPS group (Scheme 22). 26  It was 
anticipated that the hindrance brought by the introduction of the sterically demanding 
TIPS group should prevent the undesired coordination between the adjacent alkyne 
and ruthenium carbene catalyst in the course of the ensuing metathesis reactions. 
Swern oxidation of the resultant primary alcohol 100 and subsequent Grignard 
addition of vinylmagnesium bromide delivered allylic alcohol 101 in 66% yield over 
three steps. Allylic alcohol 101 was then exposed to standard Sharpless kinetic 
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resolution conditions27. The reaction was quenched at 52% conversion to provide 
alcohol 102 in 92% ee. Alkylation of the secondary alcohol with sodium 
bromoacetate and coupling of the resultant acid 103 with (R)-3-lithio-4-benzyl-2-
oxazolidinone gave glycolate 104 in 77% yield. The NMP-promoted asymmetric 
aldol reaction was again utilized. Exposure of glycolate 104 to these conditions with 
acrolein provided the corresponding aldol adducts in 82% combined yield (93% 
based on recovered starting material), as an inseparable 4:1 mixture favoring the 
desired Evans syn adduct 105. Silylation of the mixture as TES ethers followed by 
reductive auxiliary cleavage afforded the desired primary alcohol 106 in excellent 
yield, separable from the other diastereomer. 
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Scheme 22. Synthesis of C7-C17 Fragment 
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With the desired stereocenters established, we next focused our efforts on 
the regioselective formation of the five-membered ring. Previous studies conducted 
by Dr. Jin She in the Crimmins laboratory have shown that the RCM reaction of 
simple trienes 107 with ruthenium alkylidene catalysts gives poor regioselectivity for 
five-membered rings over six-membered cyclic ethers (Scheme 23).28 The lack of 
selectivity is thought to be a result of indiscriminate insertion of the ruthenium 
carbene into all three alkenes of triene 107, followed by fast ring-closure to generate 
both cyclic isomers. To circumvent this problem, Hoye’s “activation” strategy was 
utilized, wherein RCM substrate 108 was modified to contain an allyloxymethyl side 
chain.29 It is believed that the ruthenium carbene complex preferentially inserts in the 
terminal alkene of the allyloxymethyl group for both steric and electronic reasons, 
generating 2,5-dihydrofuran as a byproduct and leaving the metal carbene in the 
desired position to construct the five-membered cyclic ether selectively. 
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Scheme 23. Regioselective Polyene Metathesis (Crimmins/She) 
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This successful strategy was applied to the synthesis of fragment 83 (Scheme 
24). Alcohol 106 was subjected to Swern oxidation, followed by Wittig olefination 
with Ph3P=CHCO2Me in the same pot without any evidence of epimerization of the 
α-substituted aldehyde. The resultant α,β-unsaturated ester 109 underwent selective 
1,2-reduction with i-Bu2AlH, whereupon the primary alcohol was O-alkylated with 
allyl bromide to deliver tetraene 110 in excellent yield. Exposure of tetraene 110 to 
Grubbs second generation catalyst provided excellent regioselectivity, giving a 7:1 
ratio of the five and six-membered rings. After removal of the TES group with acidic 
workup following the RCM reaction, cyclic ether 83 was isolated in 87% yield. No 
byproduct from any metathesis reaction of the acetylene was identified.  
O
TIPS
TESO
H H
HO (COCl)2, DMSO
i-Pr2NEt, CH2Cl2
1. i-Bu2AlH
Et2O
O
TESO
H H
O OMe
TIPS
O
TIPS
HO
H HO
TESO
H H
O
87%
TIPS
C6H6, 80
oC
then p-TsOH, MeOH
94% 91%
2. allyl bromide
NaH, THF
then
Ph3P=CHCO2Me
5-mem : 6-mem = 7 : 1
G2
106 109
83110
 
Scheme 24. Synthesis of C7-C17 Fragment 
1.2.5 Cross Metathesis to Couple C18-C34 and C7-C17 Fragments 
With fragments 78 and 83 in hand, the key cross metathesis reaction was 
undertaken. The disubstituted internal olefin of each fragment was expected to be 
significantly less reactive than the mono-substituted terminal olefin towards 
ruthenium alkylidene insertion under cross metathesis conditions. As a result, a 
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chemoselective cross metathesis reaction between the two terminal vinyl groups of 
these compounds was anticipated.  
The most challenging aspect of cross metathesis was the pursuit of high 
selectivity for the desired intermolecular cross product with minimal amount of 
competing homodimerization. Several literature reports have revealed that high 
cross metathesis selectivity can be realized when an olefin of high reactivity is 
reacted with an olefin of lower reactivity.30 It was therefore our primary goal to first 
differentiate between the reactivities of each fragment’s terminal olefin. While the 
reactive sites of both fragments were structurally similar, we envisioned that 
differentiation could be achieved by protecting one fragment with a sterically bulky 
and/or electron-withdrawing group. To test this hypothesis, we prepared several 
diene derivatives with different protecting groups, and compared their reactivities by 
subjecting them to the same homodimerization conditions (Scheme 25). 
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Scheme 25. Identification of Cross Metathesis Coupling Partners 
Unprotected allylic alcohols 78 and 83 exhibited rapid homodimerization upon 
exposure to Grubbs second generation catalyst. Protection of allylic alcohol 83 as its 
MOM ether 111 led to a much slower homodimerization of the corresponding alkene, 
suggesting a reduced reactivity. Further increasing the size of the protecting group 
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to TES completely inhibited homodimerization, resulting in full recovery of starting 
material 83. Thus, we selected unprotected allylic alcohol 78 and the slow reacting 
MOM-protected allylic alcohol 111 as coupling partners for future investigations 
based on the general rule that olefins with different reactivity should lead to a 
selective cross metathesis reaction. 
One common strategy to minimize homodimerization during cross metathesis 
is to slowly add the more reactive coupling partner via syringe pump to a mixture of 
the less reactive olefin and the ruthenium catalyst. Several literature precedents 
have successfully applied this experimental procedure to obtain better yields of the 
selective cross metathesis products.30 These encouraging results led us to attempt 
the cross metathesis reaction by slowly adding one equivalent of alcohol 78 via 
syringe pump to a refluxing solution of the less reactive MOM ether 111 and Grubbs 
second generation catalyst in dichloromethane. When the addition was complete 
after 12 hours, however, cross metathesis product 113 was obtained in only 34% 
yield as the best result, along with bis-THP 114, the homodimer of 78, and 
recovered monomer 111 (Scheme 26). More careful examination of reaction 
progress revealed that allylic alcohol 78 homodimerized instantaneously upon 
addition to the reaction mixture. The resulting homodimer reacted with MOM ether 
111 to deliver the cross product. This observation thus defeated the purpose of 
utilizing the slow syringe pump addition. To further understand the reactivity of 
homodimer 114 towards cross metathesis, purified 114 was premixed with two 
equivalents of MOM ether 111, followed by treatment with Grubbs catalyst, to deliver 
a similar 30% yield of cross product 113. These results suggested that the initially 
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formed homodimer 114 was the reactive species, obviating the need for syringe 
pump addition. 
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Scheme 26. Cross Metathesis via Syringe Pump Addition 
A simplified and more reliable experimental procedure was thus pursued. 
Several catalysts and reaction conditions were investigated and it was found that 
exposure of a 1:1 mixture of alkenes 78 and 111 to the Hoveyda-Grubbs second 
generation catalyst yielded the desired cross-coupling product 113 in 68% yield as a 
6:1 mixture of E:Z olefin isomers, along with 13% of recovered alkene 111 and 23% 
of the homodimer 114 (Scheme 27). Using the Grubbs second generation catalyst 
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Scheme 27. Cross Metathesis via Pre-Mixing of Fragments 78 and 111 
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gave a lower yield of 53% under similar reaction conditions. As both E and Z olefin 
isomers would be eventually reduced to the same alkane, the mixture of olefins was 
carried forward together in due steps. 
1.2.6 Completion of the Total Synthesis of (-)-Mucocin 
In order to complete the total synthesis of (-)-mucocin, the terminal TIPS 
protecting group of 113 was readily removed (Scheme 28). The resultant alkyne 115 
was coupled with known vinyl iodide 8222 under Sonogashira coupling conditions31 
to provide polyenyne 116. The use of Pd(PPh3)2Cl2 as a precatalyst proved superior 
to Pd(PPh3)4 (82% vs 50% yield). Several conditions were subsequently investigated 
to selectively hydrogenate the pentaenyne moiety of 116 while keeping the 
butenolide fragment intact. Following literature precedents, however, use of 
Wilkinson’s catalyst led to non-selective hydrogenation of all unsaturated carbon-
carbon bonds. Similar results were observed during application of the poisoned 
platinum catalyst (Pt/C, SMe2) system developed by the Marshall group. Eventually, 
hydrogenation with diimide generated in situ from tosylhydrazide32 proved to be 
selective, affording the desired butenolide 117 in 77% yield. The total synthesis of (-
)-mucocin was subsequently accomplished by concomitant removal of the MOM, 
PMB and benzyl protecting groups with BF3•OEt2 in Me2S. Synthetic (-)-mucocin (1) 
was identical in all aspects (1H, 13C, MS, [α]24D) to the natural product. 
1.3 Summary 
In summary, the enantioselective total synthesis of (-)-mucocin has been 
accomplished with 19 steps in the longest linear sequence from commercially 
available 5-hexyn-1-ol. This convergent synthesis combined asymmetric glycolate  
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Scheme 28. Completion of the Total Synthesis of (-)-Mucocin 
aldol additions with ring-closing metatheses to construct cyclic ethers. In addition, a 
relay ring-closing metathesis strategy was successfully applied to the regioselective 
formation of an intermediate dihydrofuran. Finally, the two complex alkene fragments 
were coupled via a selective cross metathesis reaction.  
CHAPTER 2 
STUDIES TOWARD THE ASYMMTRIC TOTAL SYNTHESIS OF BRIANTHEIN A 
2.1 Background 
2.1.1 Isolation and Biological Activities of Brianthein A 
Brianthein A (118), a member of the briarane-type diterpenoids, was first 
isolated from the Indonesian gorgonian Briareum excavatum in 2001 (Figure 5).33 
Since the discovery of the first briarane-type metabolite in 1977 by Burks,34 over four 
hundred members of this family have been discovered from various organisms.35 All 
members feature the briarane carbon skeleton containing a trans-fused bicyclo[8.4.0] 
system, a quaternary carbon stereocenter at the ring junction as well as a fused γ–
lactone. Extensive spectroscopic analysis (MS, 1H, 13C and 2D NMR) further 
revealed that brianthein A is highly functionalized, bearing five contiguous 
stereocenters and three acetoxyl groups. The absolute stereochemistry of 118 was 
eventually elucidated by applying modified Mosher’s method to the partially 
deacetylated derivatives of 118. 
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Figure 5. Brianthein A (118) 
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The biogenetic origin of briarane-type diterpenoids was proposed to involve 
the formation of cembranes from four isoprene units, followed by C3, C8-cyclization 
and oxidation to complete the biosynthesis (Scheme 29).35a 
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3
8
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C-3, C-8
cyclization O
O
[O]
briaranes  
Scheme 29. Proposed Biosynthesis of Briaranes 
Among numerous members of the briarane family that exhibit a wide range of 
interesting biological activities including cytotoxic, anti-inflammatory, antiviral, 
insecticidal and immunomodulation, Brianthein A was the first member reported to 
modulate multi-drug resistance (MDR) in tumor cells. In particular, Brianthein A has 
been demonstrated to completely reverse the resistance to colchicines in KB-C2 
cells and showed little cytotoxicity at 10 μg/mL concentration.33 The mechanism of 
action was believed to involve the blockage of P-glycoprotein (P-gp), an 
overexpressed membrane protein serves as an ATP-dependent efflux pump of anti-
cancer drugs during the development of MDR. Structure activity relationship (SAR) 
studies showed that all three acetoxyl groups and the 11,12-olefin of brianthein A 
are crucial for its bioactivity. Subsequent computational studies further suggested 
the importance of the spatial arrangement of all three acetoxyl groups for the binding 
of brianthein A to P-gp. 
2.1.2 Previous Synthetic Efforts Toward Briarane-Type Diterpenoids 
 Briarane-type diterpenoids have attracted considerable amount of synthetic 
endeavors due to their structural complexity and interesting biological activities. 
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While several groups described the partial syntheses, there is currently no total 
synthesis of any member of this family. 
2.1.2.1 Procter’s Synthetic Efforts Toward Solenolide F 
In 1997, Procter and co-workers reported their studies on the synthesis of 
solenolide F (119), a briarane type diterpenoid with anti-inflammatory activity.36 To 
generate the ten-membered ring, their strategy relied on the chromium (II)-mediated 
cyclization of an aldehyde-vinyl iodide substrate containing a six-membered ring. 
Procter first investigated the feasibility of this cyclization using a model system 120, 
and a three-component coupling of 122, 123, 124 was envisioned to provide fast 
access to the cyclization precursor 121 (Scheme 30). 
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Scheme 30. Proctor’s Retrosynthetic Analysis of Solenolide F (119) 
 In the synthetic direction, Michael addition of Grignard reagent 123 to 3-
methylcyclohexen-2-one (122) installed the quaternary carbon stereocenter, 
followed by trapping the resulting enolate as its silyl enol ether 125 (Scheme 31). 
Upon treatment with methyl lithium, the enolate was regenerated and served as a 
nucleophile to add to the second Michael acceptor 124. The resulting Michael 
adduct underwent elimination to yield an inseparable 1:1 mixture of α,β-unsaturated 
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esters 126 in 65% combined yield over three steps. In order to separate the two 
diastereomers, a three-step sequence was conducted to first reduce both the ketone 
and ester functional groups, then remove the ketal protecting group, and finally 
selectively protect the primary alcohol. The resulting alcohols 127 and 128 proved to 
be separable by column chromatography. 
O O
Me
O CO2Me
Me
O
Me
O O
Me
ClMg
+
CuI, TMEDA
TMSCl
THF, -78 oC
O O
Me
OTMS
Me 1. MeLi, THF
CO2MePhOS
2. CCl4, CaCO3
65% three steps
1. LiAlH4
2. H2SO4
71% two steps
3. TBSCl, Et3N
Me
OH
CH2OTBS
Me
H
O
Me
OH
CH2OTBS
Me
H
O+
27% 25%1:1 dr
122 123 125
124
126 127 128
H
 
Scheme 31. 
 To study the effect of substrate conformation on the cyclization of ten-
membered rings, both cis isomer 127 and trans isomer 128 were elaborated 
independently to the cyclization precursors (Scheme 32). Cis isomer 127 was first 
protected as its methyl ether, followed by Takai reaction to form vinyl iodide 129 as 
an inseparable 1:1 mixture of E:Z olefin isomers. The subsequent deprotection-
oxidation sequence set the stage for the key cyclization reaction. Treatment of the 
resulting aldehyde-vinyl iodide 130 with excess anhydrous chromium (II) chloride 
and nickel (II) chloride in DMSO afforded 30% of the desired ring-closure product 
131 under optimized conditions, along with substantial amount of acyclic terminal 
alkene 132, presumably generated from E-vinyl iodide.  
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Scheme 32. 
All attempts to cyclize the analogous intermediate 133 derived from the trans 
isomer 128 yielded no desired bicycle, but only reduction product 134 (Scheme 33). 
Proctor and co-workers rationalized that the favorable conformation of 133 placed 
the two reaction termini too far apart from each other, thereby preventing cyclization. 
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Scheme 33.  
2.1.2.2 Nantz’s Synthetic Efforts Toward Solenolide F 
 In 1997, Nantz and co-workers described the formation of two chiral 
quaternary carbon-containing fragments in their progress towards the total synthesis 
of solenolide F (Scheme 34).37 By constructing the six-membered ring at the late 
stage of the synthesis, Nantz proposed to close the ten-membered ring via a 
McMurry coupling of dialdehyde 135, which would be derived from epoxide 136 and 
aldehyde 137. Both 136 and 137 contained quaternary carbon stereocenters, and a 
similar methylation-epoxide opening strategy was envisioned to construct each 
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fragment from the corresponding epoxide alcohols 138 and 139. Finally, a common 
intermediate 140 would give arise to both 138 and 139. 
Me O
Me
O
MeMe
AcO
H
AcO
OH
OH
Solenolide F (119)
OHC
OHC
O
Me
O
MeMe
RO
OR
O
OHC
OO
Me
OBn
1
7
8
17
3
17
8 7
1
3
3
1
7
8 17
BnO
OH
O
BnO
OH
O
ODTS
OH
BnO
HO
31
8 17
7
DTSO
135
136 138
139137
140
+
Scheme 34. Nantz’s Retrosynthetic Analysis of Solenolide F (119) 
 The common precursor 140 was prepared in five steps from commercially 
available 1,3-dihydroxyacetone (Scheme 35). Treatment of 140 with one equivalent 
of n-BuLi, followed by reaction with dimethylthexylsilyl chloride led to formation of a 
separable 1:1 mixture of monosilylated alcohols 141 and 142. Allylic alcohol 141 was 
exposed to standard Sharpless epoxidation conditions, and the resulting epoxide 
143 underwent a Swern oxidation-Wittig olefination-deprotection sequence to afford  
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epoxide alcohol 138 in 44% overall yield. The subsequent regioselective methylation 
at the more substituted epoxide carbon to install quaternary stereocenter proved to 
be challenging. When epoxide 138 was treated with three equivalents of 
trimethylaluminum, a condition originally developed by Roush,38 the desired diol 144 
was obtained in 50% yield under optimized conditions. The synthesis of fragment 
136 was further completed via a standard two-step conversion of 1,2-diol to epoxide. 
The formation of fragment 137 began with the conversion of allylic alcohol 
142 to epoxide 139 under Sharpless conditions (Scheme 36). Subsequent 
methylation to the less substituted carbon of the epoxide proceeded smoothly upon 
treatment with an excess of lithium dimethylcuprate, followed by protection of the 
resulting diol as acetonide 145. Deprotection of the benzyl group and Swern 
oxidation of the resulting alcohol furnished the synthesis of fragment 137. 
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Scheme 36. 
With both fragments in hand, Nantz and co-workers are currently studying the 
convergent assembly of the ten-membered ring 135. 
2.1.2.3 Iguchi’s Synthetic Efforts Toward Pachyclaulide B 
 Pachyclavulide B (146), recently isolated from Okinawan soft coral 
Pachyclavularia violacea,39 demonstrates moderate growth-inhibitory activity against 
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cancer cells (SNB-75) of the central nervous system. In 2006, Iguchi and co-workers 
reported an enantioselective synthesis of the six-membered ring 147 of 
pachyclavulide B (Scheme 37).40 Iguchi proposed that cyclohexene 147 could be 
prepared from epoxide 148, which would be derived from an enantio- and 
diastereoselective asymmetric epoxidation of achiral substrate 149. 
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Scheme 37. Iguchi’s Retrosynthetic Analysis of Pachyclavulide B (146) 
Prepared from 2,6-dimethylbenzoic acid through Birch reduction followed by 
methyl ester formation, diene 149 was subjected to Shi’s asymmetric epoxidation41 
conditions to afford the desired epoxide enantiomer 148 in 44% yield with 87% ee 
and 82% de (Scheme 38). Conversion of epoxide 148 to allylic alcohol 150 was 
further achieved via a three-step sequence of ester reduction, TBDPS protection of 
the resulting alcohol and epoxide elimination. Treatment of 150 with ethyl vinyl ether 
in the presence of NIS gave rise to iodide 151 in 80% yield, setting the stage for the 
subsequent intramolecular radical cyclization to construct the quaternary 
stereocenter. Disappointingly, however, the desired 5,6-bicycle 152 was obtained in 
only 32% yield, along with a significant amount of iodine-reduced and 6-endo 
cyclized byproducts. Ketal 152 was further manipulated to α-hydroxy lactone 153 in 
four steps. Subsequent reduction and oxidative cleavage provided aldehyde 154 
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with one-carbon degradation. Finally, Grignard addition of vinylmagnesium chloride 
to 154 provided diol 147 as a single diastereomer in quantitative yield. 
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2.1.3 Overview of Synthetic Methods Utilized for Stereoselective Formation of 
Quaternary Carbon Stereocenters 
 
Several methods have been utilized in the previous partial syntheses of 
briarane-type diterpenoids to install the all-carbon quaternary stereocenters at the 
ring junction, including Michael addition,36 epoxide opening,37 and  radical 
cyclization.40 These approaches generally suffered from low product yields to poor 
stereochemical control. As a result, an efficient strategy that can circumvent these 
limitations for the construction of quaternary stereocenters in the briarane-type 
diterpenoids would be highly desirable.  
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The construction of all-carbon quaternary centers has always been 
synthetically challenging. The difficulty for their formation stems from the steric 
congestion imposed by the four attached carbons. When all four substituents 
attached to the quaternary carbon differ, the control of absolute configuration at the 
stereocenters becomes even more challenging. Consequently, very few 
stereoselective carbon-carbon bond-forming reactions are available for constructing 
the quaternary stereocarbons.42  
The majority of the early reported methods utilized chiral auxiliaries to control 
the stereochemistry of the newly formed quaternary carbons. Despite the drawback 
of stoichiometric use of chiral auxiliaries, this approach generally provides high 
levels of stereoselectivity over a wide range of substrates. More recently, the utility 
of enantioselective catalytic transformations to install quaternary stereocenters has 
also been employed due to their great synthetic efficiency. In the following sections, 
several of the most important and useful asymmetric quaternary-carbon-forming 
reactions will be discussed, including both stoichiometric and catalytic processes. 
2.1.3.1 Michael Additions and Direct Alkylations 
Conjugate additions of carbon nucleophiles, usually tetrasubstituted enolates 
and enamines, to α,β-unsaturated carbonyl compounds (Michael addition) or their 
SN2 substitution to haloalkanes (alkylation) are one of the most popular approaches 
toward the synthesis of quaternary stereocenters. In 1984, Meyers43 reported the 
application of cyclic lactam 155 as chiral auxiliary for the asymmetric alkylation to 
form quaternary stereocenters. Since then, several chiral auxiliaries have been 
developed, and some representative examples are shown in Figure 6. 
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Figure 6. Chiral Auxiliaries Utilized in Asymmetric Alkylations 
There had been very limited success in the development of metal-catalyzed 
asymmetric Michael addition prior to the breakthrough of Sodeoka and co-workers in 
2002 (Scheme 39). 44  Sodeoka reported that in the presence of novel chiral 
palladium complex 157, Michael addition of 1,3-dicarbonyl compound 156 to methyl 
vinyl ketone generated quaternary stereocenters, for the first time, with >90% ee at 
relatively high temperature.  
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Scheme 39. Metal-Catalyzed Enantioselective Michael Addition 
Several useful catalytic asymmetric phase-transfer alkylation reactions have 
been studied as well. For example, Bhattacharya and co-workers discovered that the 
asymmetric alkylation of ketone 158 with allyl chloride derivative 159 proceeded  
efficiently in the presence of chiral quaternary ammonium salt 160 to produce ketone 
161 bearing a quaternary α-stereocenter (Scheme 40).45 
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Scheme 40. Catalytic Asymmetric Phase Transfer Alkylation 
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2.1.3.2 Diels-Alder Reactions 
 The Diels-Alder reactions have been widely exploited in the construction of 
quaternary carbons. When electron-rich dienes react with electron-poor prochiral 
dienophiles containing 1,1-disubstituted double bonds, quaternary stereocenters are 
formed within the cyclohexene framework. Upon complexation of the electron-
withdrawing group with a chiral Lewis acid catalyst, the reactivity of the dienophile is 
further enhanced, and one prochiral face is selected to result in the preferential 
formation of one stereoisomer. For example, a Salen-Cr(164)-catalyzed Diels-Alder 
reaction of siloxydiene carbamate 162 and 2-ethylpropenal (163) to form 
cycloadduct 165 was employed as a key step in the total synthesis of (+)-
aspidospermidine (166) (Scheme 41).46 
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Scheme 41. Chiral Lewis Acid Catalyzed Diels-Alder Reaction 
The application of removable auxiliary-mediated chiral dienes provides an 
alternative approach to introduce chirality into Diels-Alder adducts. As shown by 
Rawal and co-workers, chiral diene 167 reacted with methacrolein under mild 
conditions to produce the corresponding endo diastereomer 168 containing a 
quaternary stereocenter (Scheme 42). The auxiliary was later removed, followed by 
further elaboration to finish the asymmetric total synthesis of (-)-elemene (169). 
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Scheme 42. Chiral Auxiliary Mediated Diels-Alder Reaction 
2.1.3.3 Asymmetric Allylations via Palladium π-Allyl Intermediates 
 
 Palladium-catalyzed asymmetric allylations have emerged as one of the most 
powerful tools for the controlled formation of carbon-carbon bonds with high chemo-, 
regio- and stereoselectivities. The reactions involve common palladium π-allyl 
intermediates as electrophiles to react with various nucleophiles.47 With suitable 
carbon nucleophiles and π-allyl precursors, the quaternary carbon stereocenters 
could be generated on both the nucleophile and electrophile sides. In 1997, Trost 
reported the first example of catalytic asymmetric allylation of β-ketoesters (Scheme 
43).48 High ee was obtained for various allylation products and this methodology was 
applied to a concise total synthesis of (-)-nitramine (170). 
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Scheme 43. Palladium-Catalyzed Asymmetric Allylation 
 In contrast, very few transformations involving the enantioselective 
nucleophilic addition to the 1,1-disubstituted terminus of a palladium π-allyl species 
have been developed due to severe steric hindrance. 
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2.1.3.4 Intramolecular Heck Reactions 
 Intramolecular Pd(0)-catalyzed coupling of an aryl or vinyl halide (or triflate) 
with a tethered alkene containing an additional substituent on the proximal alkene 
terminus is a broadly applicable method for simultaneously forming rings and all-
carbon quaternary stereocenters. Since the first report of the catalytic asymmetric 
variant in 1989, 49  this method has been used extensively for the asymmetric 
construction of quaternary stereocenters. As illustrated in the total synthesis of 
antibiotic xestoquinone (173),50 a sequenced 6-exo and 6-endo Heck cyclizations 
allowed the formation of oxapentacyclic ketone 172 from tricyclic triflate 171 in 
moderate enantiopurity (Scheme 44).  
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Scheme 44. Asymmetric Intramolecular Heck Reaction 
2.1.3.5 Metal-Catalyzed Cyclizations 
 Metal-catalyzed cyclizations of enynes or dienes provide another useful 
approach for the synthesis of all-carbon quaternary stereocenters, and a 
representative of this strategy is the cyclization of ynoate 174 (Scheme 45). In the 
presence of palladium and BINAP as chiral ligand, spirocyclic product 175 was 
formed in high enantioselectivity.51 
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Scheme 45. Metal Catalyzed Asymmetric Cyclization 
2.1.3.6 Claisen Rearrangements 
Since the initial discovery by L. Claisen in 1912, 52  the [3,3]-sigmatropic 
rearrangement of allyl vinyl ethers to the corresponding γ,δ-unsaturated carbonyl 
compounds has been one of the most useful and versatile carbon-carbon bond 
forming reactions in organic synthesis. In addition to the actual bond formation, 
Claisen rearrangement possesses the ability to control and predict stereochemical 
issues. The reaction therefore provides an attractive strategy for introducing 
sterically congested quaternary carbon stereocenters. 
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Figure 7. Claisen Rearrangements 
The generally accepted geometry for the transition state of Claisen 
rearrangement is a six-membered chair conformation, controlled by both steric and 
electronic effects of the system (Figure 7). The chair-like transition state determines 
that the relative stereochemistry at the newly generated vicinal stereocenters is 
governed by the relative geometry of the double bonds of the rearrangement 
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substrates. As illustrated in Figure 7, if both the allyl and vinyl olefins of the Claisen 
substrate have the same geometry, the chair-like transition state will lead to 3,4-syn 
product. Alternatively, if the geometry of the olefins differs, anti product will arise.  
When the olefins involved in the Claisen substrates are disubstituted at C1 
and/or C6, quaternary carbons can be readily generated during the rearrangements. 
In order to achieve high stereoselectivity for the newly formed quaternary 
stereocenters, several methods have been developed to precisely control the olefin 
geometry of acyclic Claisen substrates. For example, in 2007 Nelson and co-
workers described an olefin isomerization-Claisen rearrangement strategy to 
construct quaternary stereocarbons (Scheme 46). 53  In their strategy, the initial 
iridium (I) catalyzed olefin isomerization of 1,1-disubstituted allylic ether 176 
provided diene 177 with excellent control of the trisubstituted vinyl double bond 
geometry. The subsequent in situ Claisen rearrangement of the stereodefined 
substrate 177 gave rise to high diastereoselectivity of the quaternary carbon-
containing product 178. Furthermore, the C-4 substituent of enantioenriched 
substrate 176 dictated the absolute stereochemical outcome of the Claisen 
rearrangement to provide an excellent chirality transfer. 
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Scheme 46. Olefin Isomerization-Claisen Rearrangement 
Meyers and co-workers provided an excellent example of auxiliary-controlled 
Claisen rearrangement (Scheme 47).54 Upon S-allylation of chiral bicyclic thiolactam 
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179, S-allylthioenamine 180 was formed with both tetrasubstituted vinyl and allyl 
olefins embedded in ring structures to fix the olefin geometry. Subsequent Claisen 
rearrangement of diene 180 occurred selectively from the top face of the bicyclic 
system to afford the desired product 181 in high yield and diastereoselectivity. Two 
vicinal quaternary stereocenters were generated during this reaction and 181 was 
further elaborated to accomplish a concise total synthesis of (-)-trichodiene (182). 
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Scheme 47. Auxiliary-Controlled Claisen Rearrangement 
MacMillan and co-workers recently reported the first catalytic asymmetric 
acyl-Claisen rearrangement to install quaternary stereocenters (Scheme 48).55 In the 
presence of chiral Lewis acid 184, 1,5-diene 185, prepared via the acylation of N-
allylmorpholine derivative 183 with a ketene generated in situ, underwent Claisen 
rearrangement to give syn diastereomer 186 in high enantioselectivity and good 
yield.  
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Scheme 48. Catalytic Asymmetric Acyl-Claisen Rearrangement 
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2.1.4 Ring-closing Metathesis for the Cyclization of Ten-membered 
Carbocycles 
 
 In addition to the quaternary carbon stereocenter, another challenge in the 
synthesis of briarane-type diterpenoids involves the construction of the ten-
membered carbocycles. It is well known that the formation of a ten-membered ring 
via intramolecular cyclization methods is synthetically challenging for many reasons, 
including unfavorable transannular interactions, entropic effects, as well as torsional 
and angular deformations associated with medium-sized rings. The discovery and 
development of ring-closing metathesis (RCM) in the past decade had a tremendous 
impact in organic synthesis, particularly in the area of medium-sized ring cyclizations. 
For example, RCM can tolerate a wide range of functional groups due to its mild 
reaction conditions, thereby allowing the preparation of complex molecules that are 
often difficult to prepare by other means. In contrast to the vast number of examples 
shown in the construction of seven to nine-membered carbocycles and 
heterocycles,56 limited reports are available for the construction of ten-membered 
rings via RCM. Furthermore, most of the documented RCM mediated cyclization of 
ten-membered rings worked only with heterocycles.  
In 2001, Koskinen and co-workers reported the first example of ten-
membered carbocycle formation via RCM (Scheme 49).57 When a 2:1 mixture of 
both syn and anti aldol adducts 187 was subjected to Grubbs first generation 
catalyst, only 11% of the desired ten-membered ring-closure product 188 was 
obtained, along with a significant amount of oligomerization products. Protecting the 
free alcohols as their TBS ethers 189 proved to introduce additional conformational-
control element to the ring-closure substrates. As a result, a 62% combined yield of 
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three diastereomeric ten-membered ring products was obtained under the same 
RCM conditions. 
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OTBS OTBSO O O
OTBS
OTBS
35% 16% 11%
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O OHOOH
188 11%
0.56 mM CH2Cl2
40 oC
10 mol% G1
0.56 mM CH2Cl2
40 oC
10 mol% G1
187 syn /ant i = 2:1
189 syn /ant i = 2:1  
Scheme 49. Cyclization of Ten-membered Carbocycles via RCM Reactions 
 Another example that demonstrated the importance of fine-tuning the RCM 
substrates for successful formation of ten-membered carbocycles was reported by 
Gennari and co-workers.58 In the attempt to synthesize cis-fused 6,10 bicyclic core 
of eleutheside analogues, Gennari et al. discovered that RCM substrates with 
different protecting groups and/or opposite configurations at the allylic and 
homoallylic alcohols, provided drastically different yields of the corresponding ten-
membered ring-closure products under similar reaction conditions (Table 2). 
Table 2. Effects of Alcohol Protecting Groups on the Cyclization of Ten-membered 
Carbocycles via RCM 
 
R3
H
H
Me
Me
H
R3
H
CH2Cl2, 40 oC
R1
R4
R2
R5
R2
R4
R1
R5
10 mol% G2
 
R1 R2 R3 R4 R5 Yield 
OTBDPS H OH H OPMP 82%  
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OTBDPS H OPiv H OPMP 52% 
OTBDPS H OPiv H OH 21% 
H OTBDPS OPiv OH H 24% 
H OAc OTBDPS OMe H N. R. 
H OPiv OTBDPS OH or OAc H N. R. 
H OPiv -OC(Me)2O- H N. R. 
 
 In comparison to the construction of 1,2-disubstituted cyclodecenes, the 
cyclization to form trisubstituted olefins via RCM is more challenging because the 
more sterically hindered 1,1-disubstituted alkenes are less reactive towards the 
ruthenium carbene insertion. A breakthrough in the RCM mediated formation of 
trisubstituted cyclodecene was reported by Barrett and co-workers during the total 
synthesis of ent-Clavilactone B (192) in 2006 (Scheme 50). 59  After extensive 
optimization, it was found that the syringe pump addition of Grubbs second 
generation catalyst and tetrafluorobenzoquinone over 12 hours to a 0.03 M solution 
of diene 190 in toluene at 80 oC, with concomitant removal of the ethylene formed 
during the reaction, gave the desired ring-closure product 191 in 65% yield.  
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Scheme 50. Construction of Ten-membered Carbocycle via RCM in the Total Synthesis of ent-
Clavilactone B (192) 
 
 Barrett observed that upon treatment with ruthenium catalyst, the mono-
substituted olefin of diene 190 underwent a fast homodimerization to give both E and 
Z olefin isomers. As fresh catalyst was continuously added to the dimer via syringe 
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pump, these dimers slowly cyclized with the 1,1-disubstituted alkene to form the 
desired ten-membered ring. In addition to dimers, other byproducts observed during 
the reaction mainly arose from isomerization of olefins along the aliphatic chain, both 
in the starting material and the dimers. However, addition of tetrafluorobenzoquinone 
largely suppressed these isomerizations, as originally reported by Grubbs. 60 
Furthermore, the pre-installation of lactone proved to be crucial for the successful 
RCM reaction, as no desired ring-closure product was observed otherwise under 
similar reaction conditions. Finally, it was vital to eliminate ethylene formed as 
byproduct during the reaction in order to obtain reproducible results. 
2.2 Retrosynthetic Analysis of Brianthein A 
 The structural complexity and unique biological activity of brianthein A, as well 
as the lack of a total synthesis of any member of the briarane-type diterpenoids 
stimulated our interest in the total synthesis of brianthein A. The common structural 
challenges of briarane-type diterpenoids, including the trans-fused 6,10 bicycle and 
the quaternary carbon stereocenter at the ring junction, provided us the opportunity 
to develop a general synthetic strategy that would allow access to a variety of other 
briarane-type natural products.  
 From a retrosynthetic viewpoint (Scheme 51), the γ-lactone of brianthein A 
would be elaborated from α-hydroxy ketone 193 via an esterification-intramolecular 
olefination sequence. The previous success of forming oxygen heterocycles via ring-
closing metathesis in the Crimmins laboratory led to the selection of ring-closing 
metathesis as the key steps to construct both the six- and ten-membered 
carbocycles of the bicyclic skeletal core. The synthesis of the RCM substrate, 
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tetraene 194, hinged upon the development and application of a diastereoselective 
dianionic Claisen rearrangement of β-hydroxy ester 195 to simultaneously install 
both the quaternary C1 and tertiary C10 stereogenic centers.  
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Scheme 51. Retrosynthetic Analysis for Brianthein A 
2.3 Development of An Asymmetric Thiazolidinethione Aldol- Thioimide 
Transesterification-Dianionic Claisen Rearrangement Strategy for the 
Stereoselective Construction of All-Carbon Quaternary Stereocenters 
 
2.3.1 Dianionic Claisen Rearrangements - Reaction Design 
 As noted earlier, the relative stereochemistry of the vinyl and allyl double 
bonds is conserved for the newly formed σ-bonds through a six-membered chair-like 
transition state during the Claisen rearrangements. Consequently, the precise 
control of the double bond geometry is critical in order to achieve high 
diastereoselectivity of the Claisen products. In order to construct the C1 quaternary 
carbon of brianthein A via a diastereoselective Claisen rearrangement, we 
envisioned that the β-hydroxyl group of allylic ester 195 provided an excellent handle 
for the stereodefined formation of the 1,5-diene Claisen substrate (Scheme 52).  
In particular, upon treatment of β-hydroxy allylic ester 195 with more than two 
equivalents of strong base, both the hydroxyl proton and the less acidic proton alpha 
to the ester would be deprotonated. The resulting dianion would exist as a highly 
ordered six-membered chelate 196 involving a lithium cation, two oxygen anions and 
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the embedded enolate double bond. Because of the strong interaction between the 
hard lithium cation and hard oxygen anions, the chelate structure should remain 
intact even at elevated temperature to provide rigorous stereocontrol of the enolate 
geometry during the subsequent in situ Claisen rearrangement. Preferentially 
proceeding via the well-defined chair-like transition states, the Claisen 
rearrangement has two possible transition states. While transition state B should be 
disfavored due to the severe steric interaction between R1 and R2, transition state A 
would lead to the desired diastereomer 197 as the major product, containing both a 
quaternary and an adjacent tertiary carbon stereocenter. 
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Scheme 52. Rationale For the Diastereoselective Dianionic Claisen Rearrangement 
 In the 1980s, Kurth and co-workers reported a few examples of dianionic 
Claisen rearrangement involving β-hydroxy esters (Scheme 53).61 ,62  Kurth et al. 
found that only moderate yield and diastereoselectivity were obtained for acyclic β-
hydroxy allylic ester substrate 198. However, higher yield and diastereoselectivity 
were observed when the allyl double bond of substrate 199 was embedded in a six-
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membered ring. Unfortunately, the findings in their study were solely based upon 
racemic substrates, and no application of the dianionic Claisen rearrangement for 
quaternary carbon construction was reported. 
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Scheme 53. Seminal Studies of Dianionic Claisen Rearrangements by Kurth and co-workers 
 In order to test the feasibility of the dianionic Claisen rearrangement to 
construct quaternary all-carbon stereocenters, we initially employed a simplified 
ester 200 for the model study (Figure 8). We reasoned that the simplified ester, with 
a shorter bottom side chain, should exhibit similar electronic and steric properties 
surrounding the Claisen-occurring sites as the actual Claisen substrate 195. In 
addition, the Claisen product obtained from simplified ester 200 could be readily 
elaborated to contain an additional three carbons, providing intermediates similar to 
the Claisen product derived from the more complex ester 195. 
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Figure 8. Simplified and Complex Claisen Substrates 
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2.3.2 Synthesis and Dianionic Claisen Rearrangement of Simplified Substrate 
2.3.2.1 First Generation Synthesis of Simplified β-Hydroxy Ester – 
Condensation of Acid with Alcohol 
 
 The synthesis of ester 200 was initially envisioned to involve a conventional 
condensation reaction between acid 201 and alcohol 202 (Scheme 54). While the 
alcohol fragment 202 was a known compound,63 acid 201 would be prepared via the 
thiazolidinethione propionate aldol methodology previously developed in the 
Crimmins laboratory. In order to synthesize the required aldehyde 204 for the aldol 
reaction, an asymmetric glycolate alkylation reaction of N-glycolyloxazolidinone 204 
would be employed. 
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Scheme 54. Retrosynthetic Analysis of Ester 200 – First Generation 
The synthesis of alcohol 202 began with the mono-protection of commercially 
available 1,3-propanediol as its TBS ether, followed by Swern oxidation of the 
remaining free alcohol to deliver aldehyde 206 in 75% yield over two steps (Scheme 
55). The subsequent olefination with stabilized Wittig reagent produced α,β-
unsaturated ester 207 in 99% yield, followed by selective 1,2-reduction with i-Bu2AlH 
to give allylic alcohol 202 in 98% yield. 
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Scheme 55. Synthesis of Alcohol Fragment 202 
 The preparation of acid 201 began with an asymmetric glycolate alkylation of 
PMB glycolylimide 205 with methallyl iodide to give the alkylated product 208 in 78% 
yield and excellent diastereoselectivity (Scheme 56). Reductive removal of the chiral 
auxiliary, followed by Swern oxidation of the resulting alcohol gave the 
corresponding aldehyde 204 in 92% overall yield, setting the stage for the 
subsequent thiazolidinethione propionate aldol addition. 
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Scheme 56. Synthesis of Aldehyde 204 
In the late 1990s, the Crimmins laboratory developed the titanium-mediated 
diastereoselective propionate aldol reactions based on the use of thiazolidinethione 
chiral auxiliaries.64,65 In this methodology, both the Evans syn aldol adduct (211) or 
non-Evans syn aldol adduct (213) could be prepared from the same propionate 209 
depending on the nature and amount of base utilized in the reaction (Figure 9). The 
difference in facial selectivity of the aldol additions is proposed to be resulted from 
changes in the mechanistic pathways between chelated and non-chelated transition 
states. By employing one equivalent of amine base, the high nucleophilicity of the 
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thiocarbonyl of thiazolidinethione favors its coordination with the metal center, 
leading to a highly ordered chelated transition state 212. The second equivalent of 
amine, however, coordinates to the titanium, thus preventing further coordination of 
the thiocarbonyl to the metal center and resulting in the dipole-minimized non-
chelated transition state 210. 
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Figure 9. Crimmins’ Asymmetric Thiazolidinethione Propionate Aldol Additions 
 Based on this methodology, aldehyde 204 was treated with the titanium 
enolate of N-propionylthiazolidinethione 209. With only one equivalent of 209, TiCl4, 
(-)-sparteine and NMP, the aldol reaction suffered from low conversion even after 
prolonged reaction time (Table 3, entry 1). However, when two equivalents of 
enolates were utilized, the desired Evans syn aldol adduct 203 was obtained in 
excellent yield and diastereoselectivity (entry 2). Furthermore, the excess propionate 
utilized in the reaction could be easily recovered from the reaction mixture. Using i-
Pr2NEt as base for the enolate formation led to a similar combined yield of aldol 
products, but much lower diastereoselectivity (entry 3). As illustrated in entry 4, 
replacing NMP with (-)-sparteine resulted in lower yield and diminished 
diastereoselectivity. 
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Table 3. Optimization of Thiazolidinethione Propionate Aldol Involving Aldehyde 204 
Me
OPMB
H S N
S O
Me
Me
OPMB
OH
Bn
O
S N
S
Me
O
Bn
+
thiazolidinethione
propionate aldol
CH2Cl2, 12 hr
-78 oC to -20 oC
209 204 203  
Entry 209 TiCl4 Base Yield d.r. 
1 1.0 eq 1.0 eq 1.0 eq (-)-sparteine, 1.0 eq NMP 45%  N.D.
2 2.0 eq 2.1 eq 2.1 eq (-)-sparteine, 2.1 eq NMP 96% 10:1
3 2.0 eq 2.1 eq 2.1 eq i-Pr2NEt, 2.1 eq NMP 91% 2:1 
4 2.0 eq 2.1 eq 4.2 eq (-)-sparteine 69% 6:1 
 
 Upon silylation of aldol adduct 203, the resulting TES ether 214 was treated 
with lithium hydroxide and hydrogen peroxide to provide acid 201 in 76% yield 
(Scheme 57). The subsequent condensation of acid 201 and alcohol 202 was 
problematic under DCC coupling conditions, giving only 40% yield of the desired 
ester 215 along with a large amount of N-acylurea byproduct. However, a much 
higher 71% yield was obtained when EDC was employed. The resulting bis-silyl 
ether 215 was next subjected to various deprotection conditions, in order to 
selectively remove the secondary TES group in the presence of primary TBS group. 
However, all the conditions tested led to no reaction, unselective deprotection or  
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Scheme 57.  
 60
decomposition. The results suggested that both the secondary TES and primary 
TBS protecting groups of 215 had comparable stabilities under these conditions.  
 At this point, a two-step sequence of deprotecting both silyl groups followed 
by selective primary alcohol re-protection, or changing the protecting group(s) at 
earlier stage of the synthesis seemed to be necessary for the preparation of the 
desired free β-hydroxy allylic ester 200. However, the only moderate yield of forming 
acid 201 via hydrolysis, as well as EDC coupling between acid 201 and alcohol 202, 
led us to re-examine our synthetic plan in order to develop a more efficient route. 
2.3.3.2 Second Generation Synthesis of Simplified β-Hydroxy Ester – 
Exploiting the Versatility of Thiazolidinethione Auxiliary 
 
 As note earlier, one advantage of the Crimmins thiazolidinethione aldol is the 
ability to access both Evans syn and non-Evans syn aldol diastereomers from the 
same starting propionate by simply varying the reaction conditions. Another unique 
feature of the Crimmins aldol is the versatility of thiazolidinethione chiral auxiliaries 
(Figure 10). In comparison to the Evans oxazolidinone auxiliaries, the use of more 
labile thiazolidinethione as leaving group permits the corresponding aldol adducts 
211 to be used in many more organic transformations. For example, in addition to 
the reduction to alcohols with lithium or sodium borohydride, 211 can be selectively 
reduced to the corresponding aldehydes upon treatment with i-Bu2AlH. Unlike 
oxazolidinones, the highly reactive 211 can react with carbon nucleophiles to 
generate β-ketoesters and β-ketophosphonates directly.66 Furthermore, in contrast 
to the strong Lewis acid-mediated transamination of oxazolidinone aldol adducts, 
only mild imidazole is necessary to promote the conversion of thiazolidinethione 
aldol adducts 211 to the corresponding Weinreb amides and other simple amides.64 
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Figure 10. Versatility of Thiazolidinethione Chiral Auxiliaries 
In addition, transesterification of thiazolidinethione aldol adducts with simple alcohols, 
such as methanol and benzyl alcohol, have been reported to occur in the presence 
of imidazole and/or pyridine as nucleophilic catalysts (Scheme 58).64, 67  
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Scheme 58. Transesterification of Thiazolidinethione Aldol Adducts with Simple Alcohols 
Given the general utility of the methodology, the Crimmins group had 
extensively utilized the thiazolidinethione aldol in several natural product 
syntheses.68 To further demonstrate the versatility of thiazolidinethione auxiliaries, 
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we decided to examine the reaction of propionate aldol adduct 203 with alcohol 202, 
as an alternative strategy to prepare ester 200 (Scheme 59). While no alcohols as 
complex as 202 had been reported to participate in transesterification with thioimide, 
it was anticipated that the allylic alcohol would be sufficiently reactive for the reaction 
to proceed. 
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Scheme 59. Retrosynthetic Analysis of Ester 200 – Second Generation 
As both aldol adduct 203 and allylic alcohol 202 were prepared via multi-step 
syntheses, a 1:1 mixture of each coupling partner was utilized to maximize the 
reaction efficiency. Consequently, stoichiometric amount of imidazole as well as sub-
stoichiometric amount of DMAP were employed to provide necessary acceleration of 
the reaction. Furthermore, due to the bimolecular nature of the reaction, minimal 
amount of CH2Cl2 was added as solvent to allow high reaction concentration.  
During the transesterification reaction, complete conversion of 
thiazolidinethione 203 to imidazolide 216 was observed within a few hours of 
reaction (Scheme 60). The subsequent reaction of intermediate 216 with allylic 
alcohol 202 occurred at a much slower rate. After a total of 72 hours stirring at room 
temperature, intermediate 216 was completely consumed and we were pleased to 
discover that the desired ester 200 was obtained in 80% isolation yield. A major 
byproduct of this reaction was identified to be diester 217, resulting from a second 
acylation taking place to the secondary β-hydroxyl group.  
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Scheme 60. Transesterification of Thiazolidinethione 203 with Alcohol 202  
2.3.3.3 Diastereoselective Dianionic Claisen Rearrangement of Simplified Ester  
With ester 200 in hand, we next focused on the key dianionic Claisen 
rearrangement reaction. Lithium diisopropylamide (LDA) was added to ester 200 at -
78 oC. After stirring for two hours at -78 oC, the reaction mixture was slowly warmed 
to room temperature over a period of two hours, followed by another six hours stir at 
the same temperature, and an additional twelve hours at reflux. Upon workup, the 
crude acid was directly subjected to the subsequent methylation reaction with freshly 
prepared diazomethane. While the acid was difficult to purify by column 
chromatography, the conversion to its corresponding methyl ester significantly 
simplified the purification and analysis processes.  
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Scheme 61. Diastereoselective Dianionic Claisen Rearrangement of Simplified Ester 200 
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To our delight, methyl ester 218 was obtained in 41% yield over the two steps 
(Scheme 61). Later, lithium hexamethyldisilazide (LiHMDS) proved to be superior to 
LDA as base, providing methyl ester 218 in 65% yield and 98:2 diastereoselectivity 
following the identical Claisen-methylation sequence. Alcohol 202 was isolated in 
20-25% yield as the major byproduct, presumably generated as the ester enolate 
undergoing deacylation (Scheme 62). The other product from this possible reaction 
pathway, ketene, should be extremely reactive and immediately involved in a series 
of subsequent reactions to become unidentifiable. 
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Scheme 62. Possible Reaction Pathway for the Formation of Alcohol Byproduct 
In order to optimize the reaction conditions, we investigated several 
parameters, and found that temperature played a critical role in the success of this 
reaction. For example, no rearrangement product was observed after 24 hours at 
room temperature, suggesting that high temperature was required to overcome the 
energy barrier for the [3,3] sigmatropic rearrangement involving the tetrasubstituted 
vinyl olefin and trisubstituted allyl olefin to form two highly congested vicinal carbon 
stereocenters. Furthermore, when the reaction mixture was not stirred for at least 
several hours before heating to reflux, a diminished yield of the Claisen product 218 
was observed (<20%) with a significant amount of alcohol byproduct 202 (>50%). 
We also found that the amount of base was not an important factor in the 
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rearrangement reaction, giving essentially the same yields when excess base was 
utilized.  
We next prepared several derivatives from methyl ester 218, in order to 
confirm the stereochemistry of both newly generated stereocenters (Scheme 63). 
Lithium aluminum hydride reduction of ester 218 afforded 1,3-diol 219, which was 
protected as acetonide 220. The resulting six-membered ring should preferentially 
adopt a chair conformation and place the large substituents at the pseudo-equatorial 
positions. Spectroscopic studies indicated that no NOE signal was observed 
between the methyl group on the quaternary carbon and its adjacent carbinol proton, 
suggesting that both substituents were at the axial positions of the chair conformer, 
therefore trans to each other as predicted. Diol 219 was also converted to benzoyl 
esters, 221 and 222. Both esters were in solid forms, but failed to produce usable 
crystals for X-ray studies despite numerous attempts for the recrystallization. 
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Scheme 63. Efforts Toward Determining the Stereochemistry of Claisen Product 218 
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2.3.4 Synthesis and Dianionic Claisen Rearrangement of Complex Substrates 
 Encouraged by the promising result of simplified ester 200 as the 
rearrangement substrate, we next prepared the complex Claisen rearrangement 
substrates containing all the carbons in the ten-membered ring of brianthein A. The 
titanium-mediated asymmetric glycolate aldol was undertaken to deliver the desired 
Evans syn aldol adduct 224 in 90% yield with 10:1 diastereoselectivity (Scheme 64). 
Silyl protection of the alcohol, followed by reductive auxiliary cleavage provided 
alcohol 225 in 88% yield. The hydroxyl group was displaced with cyanide under 
Mitsunobu conditions to give nitrile 226 in 80% yield, which was subsequently 
reduced with i-Bu2AlH. The resulting aldehyde 227 was converted to allylic alcohol 
228 via olefination with stabilized Wittig reagent followed by selective 1,2-reduction 
of the resultant α,β-unsaturated ester. Direct displacement of thioimide 203 with 
allylic alcohol 228 proceeded smoothly to generate the complex allylic ester 219 in  
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75% yield, further demonstrating the generality of the transesterification strategy. 
 Standard dianionic Claisen rearrangement–methylation sequence was next 
applied to ester 229. However, the desired methyl ester 230 was obtained in only 
27% yield, along with alcohol 228 as the major byproduct (37%) (Scheme 65). The 
cause of low yield was speculated to be the bulky TES protecting group, which 
interfered with the organization of the chair-like transition state of Claisen 
rearrangement. As a result, the ester enolate underwent deacylation to form alcohol 
byproduct 228, as well as additional undesired reaction pathways. To verify our 
hypothesis, diol 231 was prepared by deprotecting the TES group of 229 under 
acidic conditions. Gratifyingly, upon subjection of 231 to the Claisen-methylation 
conditions, the desired rearrangement product 232 was obtained in 57% yield 
(unoptimized) with higher than 20:1 diastereoselectivity. This result suggested that 
the steric interaction between substituents played a critical role in the success of the 
dianionic Claisen rearrangements. 
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Scheme 65. Diastereoselective Dianionic Claisen Rearrangement of Complex Ester 229 
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2.4 Ring-Closing Metathesis for the Construction of the trans-Fused 6,10 
Bicycle of Brianthein A 
 
2.4.1 Tandem Ring-Closing Metathesis Strategy  
With the success of the diastereoselective dianionic Claisen rearrangements, 
we next focused on the construction of the trans fused 6,10-bicyclic ring system of 
brianthein A. A tandem ring-closing metathesis of tetraene 233 was envisioned to 
form both rings in one pot. As illustrated in scheme 66, the ruthenium catalyst was 
anticipated to preferentially insert to the mono-substituted C12 alkene of tetraene 
233 for both steric and electronic reasons. The resulting C12 metal carbene 234 
would likely react with the disubstituted alkene at C11 to give the six-membered ring 
235, since the formation of the alternative eight or nine-membered rings with olefins 
at C5 or C6 should suffer significantly increased ring strains. The regenerated 
ruthenium catalyst should subsequently insert to the mono-substituted C6 alkene of 
236, reacting with the terminal 1,1-disubstituted alkene at C5 to form the trans fused 
6,10-bicycle 237. 
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 In order to prepare the tandem metathesis substrate, Claisen product 232 
was first protected as bis-TES ether 238 in 89% yield (Scheme 67). The subsequent 
reduction of methyl ester 238 with i-Bu2AlH was complicated by the partial loss of 
TES protecting group despite low reaction temperature (-78 oC) and slow addition 
rate, giving only 55% of the desired product. Swern oxidation of the resulting primary 
alcohol afforded aldehyde 239 for the subsequent asymmetric allylation. We first 
examined the asymmetric allylation protocol developed by Brown 69  using 
diisopinocampheylborane as the chiral element. While these conditions have proven 
to be successful for various aldehydes, the highly congested α-quaternary carbon 
and two β-tertiary carbons of aldehyde 239 significant reduced the reactivity of the 
carbonyl group toward the Brown reagents. Consequently, no allylation was 
observed at -78 oC, the standard temperature in Brown protocol, and the aldehyde 
was consumed only after prolonged stirring at room temperature using excess 
allylating reagents. Another problem that we encountered during the Brown allylation 
of 239 was the inconsistent diastereoselectivity. In most cases, the same homoallylic 
alcohol diastereomer was obtained as the major product with each allyl 
diisopinocampheylborane enantiomer. In order to confirm the stereochemistry of the 
allylation products, we had to employ a different allylation approach. Aldehyde 239 
was thus exposed to allylmagnesium bromide, and two separable diastereomers 
were produced in 1:1 ratio. Both homoallylic alcohols were converted to several 
derivatives independently, and extensive 2D NMR studies confirmed that the desired 
anti 1,3-diol 240 was slightly more polar than the syn diastereomer.  
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 Upon switching to the more robust TBS groups to protect Claisen product 232, 
the once low-yielding i-Bu2AlH reduction of methyl ester proceeded smoothly with 
minimal loss of protecting groups (Scheme 68). Furthermore, an improved 2:1 
diastereoselectivity was observed when bis-TBS aldehyde 242 was subjected to 
allylmagnesium bromide in Et2O. After column chromatography, the desired 1,3-anti 
diastereomer 243 was isolated in 65% yield, with the configuration at each 
stereocenter identical to that of the natural product. 
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Before further optimization of the asymmetric allylation of aldehydes, we first 
investigated the key tandem ring-closing metathesis reactions (Scheme 69). Upon 
exposure to 10 mol% Grubbs second generation catalyst in refluxing benzene, 
tetraene 243 was completely consumed within ten minutes, as indicated by the 
disappearance of the starting material and the formation of a clean new spot on TLC. 
Heating the reaction mixture over an extended time did not lead to any change to the 
reaction. The product isolated after column chromatography proved to be triene 244 
with only the six-membered ring closed. To facilitate the formation of the second ten-
membered ring, several reaction parameters were studied, including catalyst type 
(Grubbs first and second generation catalysts, Hoveyda-Grubbs catalyst), catalyst 
loading, solvent system (CH2Cl2, ClCH2CH2Cl, benzene, toluene) and reaction 
temperature. Unfortunately, none of the above reaction conditions resulted in the 
construction of the desired bicycle 245.  
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Scheme 69. Unsuccessful Tandem Ring-closing Metathesis of Tetraene 243 and 246 a-g 
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Steric and electronic properties of alcohol protecting groups are well known to 
affect the reactivity of nearby alkenes toward metathesis reactions. These properties 
became even more important in constructing ten-membered rings as demonstrated 
by Gennari and co-workers.58 In order to optimize the RCM substrates, we prepared 
several analogous tetraenes 246 a-g from 243, bearing different protecting groups, 
such as electron-withdrawing acetate and benzoate, sterically bulky TES as well as 
smaller MOM groups (Scheme 69). Anti 1,3-diols were also protected as acetonides 
to impose additional conformational constraint to the metathesis substrates. 
Unfortunately, all tetraenes failed to form the desired ten-membered ring-closure 
products under various conditions investigated. 
Inspired by several reports suggesting that free allylic hydroxyl groups exert a 
large activating effect on the RCM reaction rate,70 we set out to prepare similar RCM 
substrates by treating 243 with acids (Scheme 70). Unselective TBS deprotection 
occurred to give two products, 248 and 249, each bearing a free allylic and 
homoallylic alcohol, and both producing only six-membered ring-closure products  
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under RCM conditions. While the free allylic alcohol of diol 249 remained intact 
under RCM conditions, triol 248 underwent isomerization to yield methyl ketone and 
ethyl ketone exclusively even in CH2Cl2 at room temperature. 
2.4.2 Stepwise Ring-Closing Metathesis Strategy 
 We expected the lack of allylic alcohol at C7 in tetraene 250 should increase 
the reactivity of its adjacent C6 alkene, therefore leading to a more facile ten-
membered ring formation. The enhanced reactivity of the C6 olefin of 250, on the 
other hand, would result in an undesired mixture of ring-closure products, 251 and 
252, during the tandem RCM due to indiscriminate insertion of ruthenium catalyst to 
the equally reactive mono-substituted C12 and C6 olefins (Scheme 71). In order to 
avoid the unselective reactions, a stepwise RCM strategy was employed to construct 
each ring separately. 
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Scheme 71. Unselective Ring Formation of Tetraene 250 under Tandem RCM Conditions 
 
β-Hydroxy methyl ester 218, derived from the Claisen rearrangement of 
simplified ester 200, was protected as TBS ether 253 in 99% yield, followed by an i-
Bu2AlH reduction-Swern oxidation sequence to convert the methyl ester to aldehyde 
254 in 91% overall yield (Scheme 72). Treatment of aldehyde 254 with allyl-
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magnesium bromide at -78 oC provided a separable 3:1 mixture of diastereomers 
with a 72% isolation yield of the desired anti-diol 255. The first ring-closing 
metathesis was subsequently performed by subjecting triene 255 to Grubbs second 
generation catalyst. The desired six-membered ring product 256 was obtained in 
98% yield, followed by protection of the resulting secondary alcohol to afford TBS 
ether 257 in 94% yield.  
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Scheme 72. 
An unexpected observation arose during the RCM reaction involving the TBS 
protected homoallylic alcohol 258 (Scheme 72). Upon treatment of 258 with the 
Grubbs catalyst, both of the six- and eight-membered ring products, 257 and 259, 
were obtained in 1:1 ratio as an inseparable mixture. We reasoned that the 
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formation of eight-membered ring product 259 was due to conformational changes of 
the RCM substrate. The additional homoallylic TBS group brought the C12 and C5 
olefins of triene 258 spatially close to each other, therefore overcoming the usually 
unfavorable entropic effects associated with the eight-membered ring formation. 
To set the stage for the second RCM reaction, C7 was elaborated to contain 
three additional carbons. The primary TBS protecting group of tris-TBS ether 257 
was selectively deprotected under mild acidic conditions to afford alcohol 260 in 88% 
yield (Scheme 73). A subsequent Swern oxidation-Grignard addition sequence 
produced a separable 1:1 mixture of homoallylic alcohols 261a-b, differing in the 
configuration at C8. As a ketone functionality was eventually designed for C8, both 
diastereomers were independently subjected to the subsequent RCM reactions for 
the preparation of ten-membered rings. Upon exposure of each homoallylic alcohol 
to ruthenium catalyst, n-butyl ketone 262 was obtained as the major product. As 
noted earlier, Barrett and co-workers discovered that addition of benzoquinone 
additive could suppress the formation of similar isomerization byproducts in their 
RCM reaction towards the ten-membered ring of ent-clavilactone B. Consequently, 
we followed their conditions by adding 1,4-benzoquinone and ruthenium catalyst via 
syringe pump, as well as removing ethylene formed during the reaction by 
continuously bubbling argon through the reaction mixture. However, the modified 
reaction conditions only resulted in the undesirable n-butyl ketone 262.  
Each diastereomeric homoallylic alcohol, 261a and 263b, was subsequently 
protected as acetates 263a and 263b to avoid isomerization involving the free 
alcohol (Scheme 73). In spite of the small amount of catalyst employed (10%) under 
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Scheme 73. 
dilute conditions (<1 mM concentration), treatment of acetate under RCM conditions 
only generated homodimerization products 264 with both E and Z geometry at the 
newly formed C-C double bond. Further increasing catalyst loading led to cross 
metathesis with styrene from the Grubbs catalyst to produce 265. Re-subjecting the 
isolated homodimerization products to the same RCM reaction did not deliver any 
ring-closure product but a small amount of cross metathesis product 265 after 
prolonged reaction time. To explore the effects of protecting groups on the RCM 
substrates, we prepared several triene analogues, including triacetates and 
acetonides to further impose conformational constraints. Unfortunately, none of the 
triene analogues produced any desired ten-membered ring-closure products, and in 
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all cases homodimerization and cross metathesis with styrene were the only 
identified events. 
In contrast to the unreactive C6 olefin of tetraene 243 utilized in the previous 
tandem RCM attempts, the C6 olefins of RCM substrates without the C7 allylic 
alcohols underwent homodimerization and cross metathesis in the stepwise RCM 
approach. This result suggested an increased reactivity of the C6 olefins as we 
originally designed. However, we postulated that upon initial catalyst insertion to C6, 
the rate of RCM mediated ten-membered ring formation must be slower than that of 
the competing intermolecular reactions (dimerization and cross metathesis) even 
under high dilution conditions. Consequently, the lack of reactivity toward the desired 
cyclization led us to explore other factors that might influence the RCM reaction. 
2.4.3 Effects of Olefin Substitution on the Ten-membered Ring Cyclization via 
RCM 
 
In comparison to the mono-substituted olefins, the additional methyl group on 
the corresponding 1,1-disubstituted olefins is known to reduce the olefin reactivity 
towards metathesis mainly due to steric reasons. Furthermore, the additional methyl 
substituent might change substrate conformation, leading to different results during 
conformation-sensitive medium-ring cyclization. In order to study the influence of 
olefin substitution on the RCM-mediated ten-membered ring cyclization, we decided 
to remove the methyl group from the C5 olefin of triene 261. 
To prepare the corresponding mono-substituted analogues, the most direct 
approach would involve initial asymmetric alkylation with allyl iodide instead of 
methallyl iodide. We suspected that the presence of two mono-substituted olefins at 
C5 and C12 olefins of triene 266 might result in the formation of both the desired six-
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membered ring 267 and undesired eight-membered ring 268 during the first RCM 
reaction (Scheme 74). However, we envisioned that manipulation of the alcohol 
protecting groups should favor the desired ring product over the undesired one. 
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The synthesis of the analogous RCM substrates started from the asymmetric 
glycolate alkylation of PMB glycolylimide 205 with allyl iodide to give the alkylated 
product 269 in 81% yield and excellent diastereoselectivity (Scheme 75). The next 
steps involved the thiazolidinethione aldol-thioimide transesterification-dianionic 
Claisen rearrangement sequence to provide an efficient synthesis of methyl ester 
273, bearing a mono-substituted olefin at C5. Methyl ester 273 was next converted 
to triene in preparation for the first RCM reaction. It was discovered that upon 
treatment with G2 catalyst, the triol triene 275 afforded the highest level of selectivity 
of the two ring-closure products (3:1), favoring the desired six-membered ring 276. 
Upon further elaboration of 276, triene 279a and 279b were obtained as a 1:1 
mixture of separable diastereomers, each containing two mono-substituted olefins to 
be involved in the subsequent RCM reactions. 
 79
S N
S
Me
O
S N
S O
Me OPMB
OH
Bn
Bn
TiCl4, (-)-sparteine
NMP, CH2Cl2
-78 oC to -20 oC
I
O
OPMB
NO
O
i-Pr
O
NO
O
i-Pr
OPMB
1. NaBH4
THF/H2O
OPMB
H
O
85%
THF
-78 oC to -45 oC
81%, 20:1 dr
NaN(SiMe3)2
2. (COCl)2, DMSO
NEt3, CH2Cl2
98%
imidazole
cat. DMAP
CH2Cl2
HO
Me
OTBS
1. TBSOTf, 2,6-lutidine
CH2Cl2, 95%
2. i-Bu2AlH, CH2Cl2, 90%
O
O OH
OPMBMe
OTBS
Me
Me
OTBS
MeO
O
OPMB
OH
Me
H
1. LiN(SiMe3)2, THF
-78 oC to 65 oC
2. CH2N2, Et2O
58%, 98:2 dr
3. (COCl)2, DMSO
NEt3, CH2Cl2, 91% Me
OTBS
H
O
OPMB
OTBS
Me
H
Me
OH
HO
OPMB
OH
Me
H
1. CH2=CHCH2MgBr
Et2O, -78
oC
43%, 1:1 dr
2. TBAF, THF, 86%
G2
C6H6
80 oC
Me
OH
HO
OPMB
OH
Me
H
1. TBSOTf
2,6-lutidine
CH2Cl2
2. p-TSA
MeOH
Me
OH
TBSO
OPMB
OTBS
Me
H
1. (COCl)2, DMSO
NEt3, CH2Cl2, 93%
2. CH2=CHCH2MgBr
+
OPMB
OTBS
Me
HMe
OTBS
TBSO
3 : 1
Me
HMe
AcO
OTBSTBSO
8
OPMB
279a and 279b
76%
205 269 270
271 272
273 274
275 276 277
278
5
Et2O, 0 oC
3. Ac2O, DMAP, pyr.
 
Scheme 75. Synthesis of Analogous RCM Substrates (Yields Unoptimized) 
 
 Remarkably, upon treatment of the less polar triene 279a with Grubbs second 
generation catalyst in refluxing toluene, the major product isolated was the 6,10-
bicycle 280, as confirmed by 1H NMR and mass spectrometry (Scheme 76). The 
yield and geometry of the newly formed double bond was not determined due to 
insufficient amount of material. In contrast to the unsuccessful cyclization of the 
 80
analogous triene 263, which contained an additional C5 methyl group, the formation 
of bicycle 280 nevertheless suggested that the C5 olefin substitution played a 
significant role in the RCM-mediated ten-membered ring cyclization. 
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Scheme 76. Successful Ten-membered Ring Cyclization via RCM Involving Two Mono-
substituted Olefins 
 
At this point, one potentially strategy to complete the synthesis of brianthein A 
involved the installation of the required C5 methyl group to the C5-C6 double bond 
of bicycle 280. However, the similar electronic and steric properties associated with 
both carbons of the C5-C6 double bond, as well as the presence of another olefin in 
the six-membered ring of bicycle 280, posed a serious selectivity challenge. As a 
result, we decided to explore other factors that would affect the RCM-mediated ten-
membered ring cyclization involving a 1,1-disubstituted olefin and a mono-
substituted olefin. 
2.4.4 Effects of Conformational Constraints on the Ten-membered Ring 
Cyclization via RCM 
 
 We postulated that the mono-substituted alkene and 1,1-disubstituted alkene 
participated in the failed RCM reactions were not in close enough proximity to form 
the ten-membered ring-closure product containing trisubstituted alkene. While 
disappointing, these results nevertheless demonstrated the challenge in the 
cyclization of ten-membered ring due to unfavorable transannulation interactions and 
entropic effects. However, we believed that introduction of the appropriate 
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conformational constraints to the cyclization precursors should restrict the degrees 
of rotational freedom of both terminal olefins, and thereby reduce the entropy barrier 
for cyclization. Based on thorough analysis of molecular models, we predicted that 
trans-fused 6,6 bicycle 281 (Figure 11), formed by inversion of the stereocenter at 
C14 followed by protection of the resulting syn 1,3-diol as acetonide, should adopt a 
more favorable conformation to bring the two alkene-containing side chains spatially 
close to each other, thus facilitating the RCM reaction.  
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Figure 11. Modified RCM Substrate Containing Proper Conformational Constraints  
 The preparation of the modified RCM substrate 281, with inverted 
stereocenter at C14, began with asymmetric allylation of aldehyde 254, an 
intermediate previously utilized in the stepwise RCM strategy. While Brown allylation 
of the more complex aldehyde 239 proved to be challenging, as discussed in 
Chapter 2.4.1, we hoped that a more careful examination of reaction conditions 
might lead to favorable formation of syn 1,3-diol 282 (Scheme 77). With only one 
equivalent of freshly prepared Brown reagent, no reaction was observed to occur to 
the highly sterically congested aldehyde 254 even after stirring at room temperature 
for 24 hours. When excess Brown reagent was utilized (3-5 equivalent), the 
aldehyde was finally consumed at -20oC after prolonged reaction time, but with 
inconsistent diastereoselectivity. These results suggested that upon coordination, 
both aldehyde 254 and B-allyldiisopinocamphenylborane might be too bulky to 
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organize the required chair-like transition state for allylation to occur intramolecularly. 
Only in the presence of excess boron reagent, could intermolecular delivery of allyl 
group happen to both prochiral faces of the aldehyde unselectively. To minimize the 
steric congestion, we modified the allylation conditions according to Leighton by 
employing smaller cyclic silanes as asymmetric reagents. 71  Unfortunately, no 
reaction was observed with stoichiometric amount of reagent. 
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Scheme 77. Unsuccessful Asymmetric Allylation of Aldehyde 254 
 We next explored the strategy of stereoselectively reducing β-hydroxy 
carbonyl compounds to generate the syn 1,3-diol 285 (Scheme 78).72 We initially 
planned to prepare the β-hydroxy ketone 284 from methyl ester 218 via Weinreb 
amide intermediate 283. In an effort to follow literature precedents,73 methyl ester 
218 was subjected to Me(OMe)NH•HCl in the presence of i-PrMgCl, but led to no 
Weinreb amide even after heating in reflux THF. The lack of reactivity was likely due 
to steric hindrance around the carbonyl group. 
 The presence of the β-hydroxyl group also suggested the possibility of Lewis-
acid-mediated substrate-controlled asymmetric allylation of aldehyde 286. While 
several literature precedents demonstrated selective reduction of α-gem-dimethyl β- 
hydroxy methyl esters to the corresponding aldehydes with i-Bu2AlH, treatment of 
ester 218 with i-Bu2AlH resulted in unselective formation of both aldehyde 286 and  
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Scheme 78. 
diol 219 under various solvent and temperature conditions (Scheme 79). As an 
alternative strategy to prepare aldehyde 286, ester 218 was first reduced to diol 219, 
followed by selective oxidation of the primary alcohol to aldehyde. The combination 
of TEMPO and PhI(OAc)274 provided the best selectivity for the desired aldehyde 
286 (78% yield) with trace amount of ketone resulting from oxidation of the 
secondary alcohol. Other oxidation conditions, including TPAP-NMO, Dess-Martin, 
failed to provide selectivity between two alcohols.  
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Scheme 79. 
 With β-hydroxy aldehyde 286 in hand, several Lewis acids were screened in 
the presence of allyltributyltin as allyl nucleophile for the substrate-controlled 
asymmetric allylation (Table 4). Trimethylaluminum provided the highest level of 
diastereoselectivity favoring the desired syn 1,3-diol 285 (>20:1). However, addition 
of methyl group from trimethylaluminum to the aldehyde was an undesirable side 
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reaction, causing inconsistent yield (20-80%) of homoallylic alcohol 285. 
Dimethylaluminum chloride and methylaluminum dichloride generated less 
methylation byproduct, but suffered from reduced diastereoselectivity (4-6:1). The 
reaction was further complicated by the formation of retro-aldol products, 
presumably due to the increased Lewis acidity. Other Lewis acids (SnCl4, TiCl4, 
AlCl3, BF3•OEt2, TMSOTf) led to no reaction or decomposition of starting material. 
The free alcohol at the β position was then protected as TMS ether, and subjected to 
similar allylation reactions. Unfortunately, no desired syn diol product was produced 
in acceptable yield with several Lewis acids tested. 
Table 4. Stereoselective Allylation Attempts 
Me
OTBS
O
Me
OPMB
OH
Me
H
H
Me
OTBS
Me
OPMB
OH
Me
H
HO
SnBu3
Lewis acid
286 285  
Lewis acid Diastereoselectivity
syn:anti 
Yield Side Reactions 
AlMe3 >20:1 20-80% methyl addition 
AlMe2Cl or AlMeCl2 4-6:1 ~50% retro-aldol 
TiCl4, SnCl4, AlCl3 
BF3•OEt2, TMSOTf 
N.D. N.D. 
N.R. or 
Decomposition 
 
Before further optimization of the diastereoselective formation of syn 1,3-diol, 
we decided to first explore the key RCM reactions. It was found that treatment of 
aldehyde 254 with allyl magnesium bromide at room temperature formed a 
separable 1:1 mixture of two diastereomers (Scheme 80). Oxidation of the undesired 
anti 1,3-diol 255 with Dess-Martin reagent, followed by i-Bu2AlH reduction generated 
a 5:6 mixture of two diastereomeric alcohols. After two iterations, 65% overall yield 
 85
of the desired syn 1,3-diol 282 was obtained and ready for the first RCM reaction. 
Upon exposure of triene 282 to Grubbs second generation catalyst in refluxing 
toluene, the desired six-membered ring-closure product 287 was obtained in 96% 
yield. Subsequent removal of both TBS protecting groups was achieved by treating 
with tetrabutylammonium fluoride. The resulting triol 288 was exposed to 2,2-
dimethoxypropane to protect the syn 1,3-diol as acetonide. The primary alcohol was 
protected as a labile MOP group under the same conditions, which was easily 
removed upon extraction with 10% HCl to give the desired alcohol 289 in 89% yield.  
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Scheme 80. 
We submitted alcohol 289, a colorless crystalline solid for X-ray 
crystallographic analysis (Figure 12). The X-ray data confirmed that the 
configurations of C1, C2, C3, C10, and C14 stereocenters were each as expected, 
therefore definitely proving that the dianionic Claisen rearrangement proceeded 
through a chair-like transition state to give the desired diastereomer. 
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Figure 12. X-ray Crystallographic Structure of Alcohol 289 
 Alcohol 289 was then oxidized to afford the corresponding aldehyde 290 in 
94% yield under Swern protocol. The aldehyde was subsequently treated with allyl 
magnesium bromide to produce a 1:1 mixture of two homoallylic alcohols 291a and 
291b (Scheme 81). Both diastereomers were separated by column chromatography 
and each free alcohol was subjected to RCM conditions independently. As observed 
earlier for diastereomeric trienes 261a and 261b, isomerization was the major event 
observed upon treating 291a or 291b with ruthenium catalyst in refluxing CH2Cl2 and 
toluene.  
To avoid this undesired side reaction, each alcohol was protected as the 
corresponding acetate 292a and 292b. Upon exposure of 292b to Grubbs second 
generation catalyst in refluxing toluene, the starting material was completely 
consumed in ten minutes. To our greatest delight, the ten-membered ring-closure 
product 293 was obtained in 90% yield, and extensive spectroscopic studies 
confirmed that the newly formed double bond was Z in geometry, identical to that of 
the natural product. In contrast, triene 292a, differing from 292b simply in the 
configuration at C8, only led to homodimerization occurring at the mono-substituted 
C6 alkene under the same reaction conditions, demonstrating the importance of fine-
tuning RCM substrates for successful ten-membered ring cyclization. 
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Scheme 81. 
As a ketone was eventually required at C8 for future construction of the 
lactone of brianthein A, we also prepared RCM substrate 294 with the ketone 
functionality pre-installed (Scheme 82). Homodimerization was observed when 294 
was treated with Grubbs catalyst in refluxing CH2Cl2, and isomerization to enone 295 
occurred in refluxing toluene. In both cases, no desired RCM product was obtained. 
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Encouraged by the successful cyclization of triene 291b, we set out to 
prepare more complex RCM substrates with an additional oxygen functionality 
installed at C7 (Scheme 83). Aldehyde 290 was thus subjected to the asymmetric 
protocols developed by Brown75 and Hafner76 to form syn and anti C7,C8 vic-diols, 
296 and 297, respectively. Both 296 and 297 had the same configuration at C7, 
identical to that of the natural product. While the configuration at C8 was opposite in 
296 and 297, the C8 hydroxyl group in each compound would be converted to the 
corresponding ketone functionally later in the synthesis. The different configuration 
at C8 of 296 and 297, would provide us the opportunity to investigate the influence 
of stereochemistry on the RCM reaction. Unfortunately, no reaction occurred when 
either substrate was subjected to the Grubbs second generation catalyst in several 
solvent systems. Protection of each C8 alcohol as acetate or oxidation to ketone 
also did not lead to desired cyclization products from the corresponding trienes. 
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Knowing that the protecting group on C7 allylic alcohol might decrease the 
accessibility of its nearby C6 olefin towards catalyst insertion during the RCM 
reaction, we next investigated acetonide 298 with a free allylic alcohol (Scheme 84). 
We also re-visited the tandem RCM strategy as we anticipated that the four olefins 
of 298 should have different reactivity towards ruthenium catalyst insertion. Upon 
treatment of tetraene 298 with either Grubbs or Hoveyda-Grubbs catalyst, the six-
membered ring was cyclized instantaneously. The closure of ten-membered ring 301 
was indeed observed, however, only in trace amount (<10%) under several solvent 
and temperature conditions tested. The major byproducts proved to be methyl 
ketone 299 and ethyl ketone 300, resulting from the isomerization of free allylic 
alcohol, as observed previously for RCM of tetraene 248.  
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Scheme 84. 
 The low yield of fully functionalized bicycle 301 obtained from tandem RCM of 
tetraene 298 prevented practical scale-up of the reaction. As a result, the next task 
toward the completion of the total synthesis was to install the hydroxyl group at C7 of 
the trans-fuse 6,10-bicycle 293 in preparation for subsequent construction of γ-
lactone. The acetate protecting group of 293 was subsequently removed under 
reductive conditions, followed by Dess-Martin oxidation of the resulting alcohol 302 
to afford ketone 303 in 83% yield over two steps (Scheme 85). 
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2.5 Proposed Completion of the Asymmetric Total Synthesis of Brianthein A 
 To complete the total synthesis of brianthein A, ketone 303 will be oxidized to 
α-hydroxy ketone 304 via an asymmetric Davis’ Oxaziridine oxidations 77  or 
Rubottom oxidation 78  (Scheme 86). Both oxidation strategies involve an initial 
enolization of ketone 303. We anticipate that the more acidic α-proton at C7 should 
be preferentially deprotonated upon treatment with base, allowing the subsequent 
oxidation to selectively occur at the desired C7 position. Transesterification of 
alcohol 304 with acid chloride 305 should afford phosphonate 306, followed by an 
intramolecular Horner-Wadsworth-Emmons olefination to form γ-lactone 307. 79 
Protecting group manipulation will be subsequently conducted with selective removal 
of the acetonide group under acidic conditions, followed by treatment with DDQ to 
deliver the five-membered PMP acetal 308. The resulting alcohol will be subjected to 
an oxidation-reduction sequence to invert the stereochemistry at C14, providing 
alcohol 309 with the configuration at each stereocenter identical to the natural 
product. Finally, removal of the cyclic PMP acetal and protection of the resulting triol 
as tri-acetate should afford the natural product brianthein A. 
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Scheme 86. Proposed Completion of the Total Synthesis of Brianthein A 
2.6 Summary 
In summary, a novel asymmetric aldol addition-thioimide transesterification-
dianionic Claisen rearrangement strategy was developed during my synthetic efforts 
toward the asymmetric total synthesis of bioactive natural product brianthein A. This 
strategy highlighted the utility and versatility of the thiazolidinethione-mediated 
propionate aldol methodology previously developed in the Crimmins laboratories, 
and allowed rapidly access to several complex intermediates containing all-carbon 
quaternary stereocenters in high yield and diastereoselectivity. 
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Synthesis of the highly functionalized trans-fused 6,10-bicyclic core 
framework of brianthein A was accomplished. Ring-closing metathesis was utilized 
as the key cyclization strategy, and the introduction of an appropriate conformational 
constraint to the cyclization substrate proved to be crucial to the success of forming 
the challenging ten-membered carbocycle. 
CHAPTER 3 
EXPERIMENTAL 
3.1 Materials and Methods 
Infrared (IR) spectra were obtained using a JACSO FT/IR 460-plus and a 
Nicolet Magna-IR 560 instruments. Proton and carbon nuclear magnetic resonance 
(1H and 13C NMR) spectra were recorded on the following instruments: Bruker model 
DRX 400 (1H at 400 MHz; 13C at 100 MHz) and Bruker model DRX 500 (1H at 500 
MHz, 13C at 125 MHz). Chemical shifts are reported in ppm with residual 
undeuterated solvent peaks as internal reference for 1H NMR: CHCl3 (7.24) and 
deuterated solvent shifts for 13C NMR: CDCl3 (77.0). Multiplicities are reported as (s) 
singlet, (d) doublet, (t) triplet, (q) quartet and (m) multiplet. Coupling constants (J) 
are given in Hz. Optical rotations were determined using a JACSO P1010 
polarimeter. Mass spectra were obtained using a Micromass Quattro II (triple quad) 
instrument with nano-electrospray ionization.  
Thin layer chromatography (TLC) was conducted on silica gel 60 F254 TLC 
plates purchased from Sorbent Technologies, Inc. Flash chromatography was 
carried out using silica gel (60 Å, 40 to 63 µm) purchased from Sorbent 
Technologies, Inc. Diethyl ether (Et2O), tetrahydrofuran (THF), dichloromethane 
(CH2Cl2) and toluene were dried by passing through a column of neutral alumina 
under nitrogen immediately prior to use. Alkylamines and benzene were distilled 
from calcium hydride immediately prior to use. Anhydrous N,N-dimethylformamide 
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(DMF) was purchased from Aldrich chemical company in 1L Sure/SealTM bottles. 
Pivaloyl chloride was distilled and stored over 4 Å molecular sieves. Titanium (IV) 
iso-propoxide was distilled under reduced pressure and stored in a dark desiccator. 
All other reagents and solvents were used as received from the manufacturer. All air 
and water sensitive reactions were performed in flasks flame dried under a positive 
flow of argon and conducted under argon atmosphere. 
3.2 Experimental for Chapter 1 
 
OTHPC10H21
O
 
Epoxide 85. A stirring solution of alcohol 84 (231 mg, 1.08 mmol) and dihydropyran 
(492 µL, 5.39 mmol) in CH2Cl2 (10 mL) was cooled in an ice/water bath, into which 
was added pyridinium p-toluenesulfonate (27 mg, 0.11 mmol). After 10 min, the 
reaction mixture was allowed to warm to room temperature and stirred overnight. 
Half saturated NaHCO3 solution was added to quench the reaction. The organic 
layer was separated and the aqueous layer was extracted twice with CH2Cl2. The 
combined organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography (10% EtOAc/hexanes) gave 292 mg 
(91%) of the THP ether as a colorless oil: 1H (400 MHz, CDCl3) δ 4.76-4.58 (m, 1H), 
3.94-3.81 (m, 1H), 3.62-3.56 & 3.25-3.20 (m, 1H), 3.48-3.42 (m, 1H), 2.94-2.84 (m, 
1H), 2.79-2.68 (m, 2H), 1.86-1.36 (m, 8H), 1.24 (m, 16H), 0.86 (t, J = 6.8 Hz, 3H); 
13C (100 MHz, CDCl3) δ 98.8, 97.0, 78.3, 73.5, 62.17, 62.14, 53.7, 53.0, 46.7, 44.7, 
33.2, 32.7, 31.8, 30.7, 30.6, 29.6, 29.5, 29.4, 29.2, 25.4, 25.3, 25.2, 24.8, 22.6, 19.5, 
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19.3, 14.0; IR (film) 2925, 2854, 1467, 1118, 1078, 1023 cm-1; MS (ESI) calculated 
for C18H34O3  [M+H]+: 299.3, found 299.3. 
 
OTHP
HO
C10H21  
Alcohol 86. A solution of trimethylsulfonium iodide (10.20 g, 49.98 mmol) in THF (50 
mL) was cooled to -15 oC. n-BuLi (1.6 M in hexane, 29.8 mL, 47.78 mmol) was 
added dropwise via addition funnel and the resulting solution was stirred for 1 h at -
15 oC. A solution of epoxide 85 (3.656 g, 12.23 mmol) in THF (10 mL) was added 
and a cloudy suspension was formed. The reaction was allowed to slowly warm to 
25 oC over 1 h, stirred for an additional 1 h, and quenched with water at 0 oC. The 
layers were separated and the aqueous layer was extracted twice with 50% 
EtOAc/hexanes. The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (15% 
EtOAc/hexanes) gave 3.67 g (96%) of allylic alcohol 86 as a colorless oil: 1H (400 
MHz, CDCl3) δ 5.94-5.80 (m, 1H), 5.30-5.15 (m, 2H), 4.78-4.33 (m, 1H), 4.26-3.98 
(m, 1H), 3.95-3.88 (m, 1H), 3.73-3.62 (m, 1H), 3.54-3.47 (m, 1H), 2.37 (s, 1H), 1.88-
1.32 (m, 8H), 1.24 (m, 16H), 0.86 (t, J = 6.6 Hz, 3H); 13C (100 MHz, CDCl3) δ 136.75, 
136.70, 116.5, 116.2, 102.4, 97.4, 85.4, 79.2, 74.8, 73.5, 65.2, 62.9, 32.0, 31.8, 31.2, 
30.8, 29.6, 29.53, 29.49, 29.45, 29.41, 29.2, 25.9, 25.7, 25.3, 24.9, 22.6, 21.3, 19.8, 
14.0; IR (film) 3433 (br), 2924, 2854, 1135, 1075, 1026 cm-1; MS (ESI) calculated for 
C19H36O3  [M+H]+: 313.3, found 313.3. 
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Alcohol 87. Sodium hydride (1.048 g, 26.21 mmol, 60% dispersion in mineral oil) 
was washed three times with hexanes, suspended in THF (40 mL) and cooled in an 
ice/water bath. Alcohol 86 (4.095 g, 13.10 mmol) in THF (10 mmol) was added 
dropwise into the reaction and the solution was stirred for 10 min at 0 oC. Benzyl 
bromide (2.34 mL, 19.67 mmol) was added slowly, followed by tetrabutylammonium 
iodide (484 mg, 1.31 mmol). The reaction was allowed to warm to room temperature 
and stirred overnight. Half-saturated NH4Cl solution was added to quench the 
reaction at 0 oC and the reaction mixture was allowed to warm to room temperature. 
The layers were separated and the aqueous layer was extracted two more times 
with 50% EtOAc/hexanes. The combined organic layers were dried over Na2SO4 
and concentrated under reduced pressure. The crude product was passed through a 
silica gel plug, concentrated and used immediately for next reaction without further 
purification. 
The crude material obtained in the previous step was dissolved in CH2Cl2 (40 mL) 
and MeOH (20 mL). The solution was cooled to 0 oC, into which p-toluenesulfonic 
acid (249 mg, 1.31 mmol) was added. After another 20 min, the reaction mixture was 
warmed to room temperature and stirred overnight. Half-saturated NaHCO3 solution 
was then added to quench the reaction. The layers were separated and the aqueous 
layer was extracted three more times with 50% EtOAc/hexanes. The combined 
organic layers were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (10% EtOAc/hexanes) gave 3.573 g (86%) of 
 97
alcohol 87 as a colorless oil: 1H (400 MHz, CDCl3) δ 7.31 (m, 5H), 5.83 (ddd, J = 
17.3, 10.3, 7.9 Hz, 1 H), 5.37 (dd, J = 10.6, 1.8 Hz, 1H), 5.28 (dd, J = 17.4, 1.7 Hz, 
1H), 4.49 (AB, JAB =11.9, ΔνAB = 99.6 Hz, 2H), 3.71 (m, 2H), 2.18 (d, J = 3.7 Hz, 1H), 
1.42 (m, 2H), 1.23 (m, 16H), 0.86 (t, J = 6.8 Hz, 3H); 13C (100 MHz, CDCl3) δ 138.3, 
134.5, 128.3, 127.7, 127.6, 120.1, 83.6, 73.2, 70.2, 32.2, 31.9, 29.6, 29.57, 29.55, 
29.3, 25.7, 22.6, 14.1; IR (film) 3461 (br), 3066, 3030, 2925, 2854, 1496, 1455, 1424, 
1389, 1304, 1206, 1068 cm-1; [α]24D = -28.7o (c 3.48, CH2Cl2); MS (ESI) calculated 
for C21H34O2  [M+Na]+: 341.3, found 341.4. 
O
BnO
C10H21
OH
O  
Acid 88. Sodium hydride (433 mg, 10.8 mmol, 60% dispersion in mineral oil) was 
washed three times with hexane, suspended in THF (2.5 mL) and cooled in an 
ice/water bath. A solution of bromoacetic acid (608 mg, 4.33 mmol) in THF (1 mL) 
was added dropwise via syringe. After stirring for 30 min at 0 oC, alcohol 87 (1.15 g, 
3.61 mmol) in DMF (3.5 mL) was added dropwise to the stirring solution. The 
reaction mixture was stirred for 30 min at 0 oC, followed by warming to room 
temperature. After 2 h, TLC indicated that the reaction was complete and water was 
added slowly at 0 oC to quench the reaction. The solution was then acidified to pH 2 
by the addition of 10% HCl. The layers were separated and the aqueous layer was 
further extracted twice with EtOAc. The combined organic extracts were washed 
with saturated NaCl solution, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography (25% EtOAc/hexanes) gave 1.16 g 
(86%) of the glycolic acid 88 as a colorless oil: 1H (400 MHz, CDCl3) δ 10.63 (br, 1H), 
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7.30 (m, 5H), 5.85 (ddd, J = 17.4, 10.2, 8.8 Hz, 1H), 5.46 (dd, J = 10.4, 1.2 Hz, 1H), 
5.29 (dd, J = 17.4, 1.2 Hz, 1H), 4.57 (AB, JAB = 12.0, ΔνAB = 116.0 Hz, 2H), 4.16 (AB, 
JAB = 17.2, ΔνAB = 121.5 Hz, 2H), 3.77 (dd, J = 8.6, 2.9 Hz, 1H), 3.48 (dt, J = 6.6, 3.1 
Hz, 1H), 1.47 (m, 1H), 1.21 (m, 17H), 0.86 (t, J = 6.9 Hz, 3H); 13C (100 MHz, CDCl3) 
δ 172.3, 136.8, 132.6, 128.6, 128.2, 128.1, 121.5, 84.4, 81.6, 70.2, 68.9, 31.8, 31.3, 
29.55. 29.51, 29.47, 29.4, 29.3, 25.4, 22.6, 14.1; IR (film) 3184 (br), 3070, 3032, 
2922, 2855, 1764, 1732, 1455, 1425, 1362, 1248, 1123, 1066 cm-1; [α]25D = -2.8o (c 
1.58, CH2Cl2); MS (ESI) calculated for C23H36O4  [M+H]+: 377.4, found 377.4. 
 
O
BnO
C10H21
O
ON
O
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Glycolate 89. To a solution of the previous glycolic acid (267 mg, 0.714 mmol) in 
THF (3.5 mL) was added triethylamine (150 µL, 1.07 mmol), and the mixture was 
cooled to -78 oC. Pivaloyl chloride (130 µL, 1.07 mmol) was added dropwise via 
syringe. After stirring at -78 oC for 10 min, the mixture was warmed to 0 oC, stirred 
for 1 h and cooled to -78 oC. In a separate flask, a solution of (R)-4-benzyl-2-
oxazolidinone (215 mg, 1.21 mmol) in THF (2 mL) was cooled to -78 oC, into which 
n-BuLi (1.55 M in hexane, 730 µL, 1.14 mmol) was added dropwise via syringe. After 
stirring for 15 min at -78 oC, the resulting solution was transferred via cannula to the 
mixed anhydride prepared above, and stirred for an additional 10 min. The reaction 
mixture was slowly warmed to room temperature and allowed to stir overnight. Half-
saturated NH4Cl solution was then added to quench the reaction. The organic layer 
was separated and the aqueous layer was extracted two more times with EtOAc. 
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The combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure. Purification by flash chromatography (15% EtOAc/hexanes) 
recovered 43 mg of the glycolic acid and provided 303 mg (80%, 95% brsm) of 
glycolate 89 as a colorless oil: 1H (400 MHz, CDCl3) δ 7.31 (m, 8H), 7.15 (d, J = 7.6 
Hz, 2H), 5.98 (ddd, J = 17.5, 10.4, 8.0 Hz, 1H), 5.36 (dd, J = 10.5, 1.7 Hz, 1H), 5.27 
(dd, J = 17.5, 1.5 Hz, 1H), 4.89 (AB, JAB = 17.9, ΔνAB = 22.2 Hz, 2H), 4.47 (AB, JAB = 
12.0, ΔνAB = 107.9 Hz, 2H), 4.57 (m, 1H), 4.09 (m, 2H), 3.82 (dd, J = 8.1, 3.3 Hz, 1H), 
3.65 (dt, J = 7.8, 3.6 Hz, 1H), 3.25 (dd, J = 13.3, 3.3 Hz, 1H), 2.55 (dd, J = 13.4, 9.8 
Hz, 1H), 1.61 (m, 1H), 1.47 (m, 1H), 1.24 (m, 16H), 0.86 (t, J = 6.8 Hz, 3H); 13C (100 
MHz, CDCl3) δ 170.4, 153.2, 138.6, 135.1, 134.8, 129.3, 128.8, 128.2, 127.22, 
127.19, 119.4, 83.7, 82.9, 70.7, 70.2, 66.9, 54.6, 37.5, 31.8, 31.2, 29.6, 29.52, 29.50, 
29.46, 29.2, 25.7, 22.6, 14.0; IR (film) 3067, 3029, 2930, 2853, 1779, 1717, 1498, 
1454, 1393, 1350, 1262, 1137cm-1; [α]28D = -64.6o (c 1.37, CH2Cl2); MS (ESI) 
calculated for C33H45NO5  [M+H]+: 536.3, found 536.5. 
 
O
BnO
C10H21
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Aldol adduct 90. A stirring solution of glycolate 89 (5.472 g, 10.22 mmol) in CH2Cl2 
(70 mL) was cooled to -78 oC and TiCl4 (1.120 mL, 10.22 mmol) was added 
dropwise. The resultant light yellow solution was stirred for 10 min before 
diisopropylethylamine (4.45 mL, 25.5 mmol) was added dropwise, causing the 
solution to become dark-blue color. After stirring at -78 oC for 2 h, the enolate 
 100
mixture was allowed to slowly warm to -45 oC over 2 h, stirred for an additional 1 h at 
-45 oC, and cooled to -78 oC again. N-methyl-2-pyrrolidinone (985 µL, 10.22 mmol) 
was added slowly and the reaction mixture was stirred for 10 min at -78 oC before 
freshly distilled acrolein (3.41 mL, 51.1 mmol) was added slowly. The solution was 
allowed to stand at -78 oC for 2 h, slowly warmed to -40 oC and stirred for another 2 
h. Half-saturated NH4Cl solution was then added at -40 oC to quench the reaction, 
followed by warming the mixture to room temperature. The organic layer was 
separated and the aqueous solution was further extracted three times with CH2Cl2. 
The combined organic solution was then dried over Na2SO4 and concentrated under 
reduced pressure. Purification by flash chromatography (20% EtOAc/hexanes) 
yielded 4.626 g (77%) of a 11:1 mixture of aldol adduct 90 and other minor 
diastereomers as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.32 (m, 8H), 7.02 (d, J = 
7.2 Hz, 1H), 6.14 (ddd, J = 17.5, 10.2, 8.9 Hz, 1H), 6.04 (ddd, J = 17.1, 10.5, 5.2 Hz, 
1H), 5.60 (d, J = 2.7 Hz, 1H), 5.38 (ddd, J = 17.3, 1.5, 1.4 Hz, 1H), 5.37 (dd, J = 10.3, 
1.9 Hz, 1H), 5.24 (ddd, J = 10.5, 1.4, 1.4 Hz, 1H), 5.19 (dd, J = 17.4, 1.7 Hz, 1H), 
4.40 (AB, JAB = 12.2, ΔνAB = 57.5 Hz, 2H), 4.45 (m, 1H), 4.31 (m, 1H), 3.98 (t, J = 8.5 
Hz, 1H), 3.80 (m, 1H), 3.78 (dd, J = 9.1, 2.8 Hz, 1H), 3.65 (dd, J = 8.8, 2.0 Hz, 1H), 
3.18 (dd, J = 13.2, 3.0 Hz, 1H), 2.60 (d, J = 8.8 Hz, 1H), 1.58 (m, 1H), 1.53 (dd, J = 
13.1, 11.3Hz, 1H), 1.43 (m, 1H), 1.26 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H); 13C (100 
MHz, CDCl3) δ 170.5, 153.5, 138.4, 137.3, 135.8, 133.9, 129.2, 128.7, 128.3, 127.3, 
127.2, 126.9, 120.2, 116.4, 85.4, 84.5, 82.0, 73.5, 70.4, 66.5, 55.4, 36.7, 32.0, 31.8, 
29.47, 29.45, 29.35, 29.2, 26.0, 22.6, 14.0; IR (film) 3547 (br), 3065, 3029, 2928, 
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2856, 1771, 1716, 1498, 1455, 1394, 1212, 1115 cm-1; [α]26D = +16.3o (c 1.13, 
CH2Cl2); MS (ESI) calculated for C36H49NO6  [M+H]+: 592.4, found 592.4. 
O
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TES ether 96. A stirring solution of alcohol 90 (944 mg, 1.60 mmol) and 2,6-lutidine 
(820 µL, 5.58 mmol) in CH2Cl2 (10 mL) was cooled to 0 oC. Triethylsilyl 
trifluoromethanesulfonate (540 µL, 2.39 mmol) was added dropwise and the reaction 
mixture was allowed to warm to room temperature. After stirring for 1 h, saturated 
NaHCO3 solution was added to quench the reaction and the mixture was extracted 
twice with CH2Cl2. The combined organic solution was dried over NaSO4 and 
concentrated under reduced pressure. Purification by flash chromatography (1-8% 
EtOAc/hexanes) yielded 1.127 g (98%) of the TES ether as a light yellow oil: 1H (400 
MHz, CDCl3) δ 7.31 (m, 8H), 7.10 (d, J = 7.8 Hz, 2H), 6.03 (ddd, J = 17.4, 10.3, 8.7 
Hz, 1H), 5.97 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 5.69 (m, 1H), 5.30 (dd, J = 10.4, 2.0 
Hz, 1H), 5.20 (ddd, J = 17.4, 1.5, 1.4 Hz, 1H), 5.15 (dd, J = 17.6, 2.0 Hz, 1H), 5.13 
(ddd, J = 10.5, 1.6, 1.4 Hz, 1H), 4.42 (AB, JAB = 12.2, ΔνAB = 59.0 Hz, 2H), 4.40 (m, 
2H), 3.93 (t, J = 8.0 Hz, 1H), 3.85 (dd, J = 9.0, 2.3 Hz, 1H), 3.70 (m, 1H), 3.63 (dd, J 
= 8.8, 2.7 Hz, 1H), 3.23 (dd, J = 12.9, 2.7 Hz, 1H), 1.88 (t, J = 12.0, 1H), 1.56 (m, 
1H), 1.43 (m, 1H), 1.24 (m, 16H), 0.90 (t, J = 7.9 Hz, 9H), 0.87 (t, J = 6.7 Hz, 3H), 
0.57 (q, J = 7.9 Hz, 6H); 13C (100 MHz, CDCl3) δ 171.0, 153.2, 138.6, 137.3, 136.1, 
134.9, 129.4, 128.8, 128.3, 127.6, 127.3, 127.0, 119.5, 116.2, 84.50, 84.48, 75.3, 
70.3, 66.2, 55.9, 37.4, 31.9, 31.8, 29.61, 29.57, 29.3, 25.9, 22.7, 14.1, 6.8, 4.7; IR 
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(film) 3065, 3028, 2925, 2854, 1784, 1710, 1497, 1456, 1382, 1348, 1209, 1107 cm-
1; [α]27D = -26.0o (c 3.63, CH2Cl2); MS (ESI) calculated for C42H63NO6Si  [M+H]+: 
706.4, found 706.6. 
O
OHBnO
C10H21
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Alcohol 97. A solution of the previous oxazolidinone 96 (3.568 g, 5.051 mmol), 
MeOH (410 µL, 10.1 mmol) in Et2O (50 mL) was cooled in an ice/water bath. Lithium 
borohydride (2.0 M in THF, 5.05 mL, 10.1 mmol) was added dropwise via syringe. 
After stirring for 2 h at 0 oC, saturated sodium potassium tartrate solution (30 mL) 
was added. The mixture was allowed to warm to room temperature and stirred 
vigorously for another 5 h. The organic layer was separated and the aqueous layer 
was extracted three times with Et2O. The combined organic extracts were washed 
with saturated NaCl solution, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography (8% EtOAc/hexanes) yielded 2.565 g 
(95%) of alcohol 97 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.30 (m, 5H), 5.91 
(ddd, J = 17.3, 10.6, 8.6 Hz, 1H), 5.88 (ddd, J = 17.3, 10.5, 5.3 Hz, 1H), 5.27 (dd, J = 
10.3, 1.8 Hz, 1H), 5.25 (ddd, J = 17.2, 2.0, 1.7 Hz, 1H), 5.22 (dd, J = 17.4, 1.7 Hz, 
1H), 5.10 (ddd, J = 10.6, 1.8, 1.7 Hz, 1H), 4.49 (AB, JAB = 12.0, ΔνAB = 113.8 Hz, 1H), 
4.24 (td, J = 5.3, 1.6 Hz, 1H), 3.74 (dd, J = 8.6, 2.7 Hz, 1H), 3.65 (m, 1H), 3.50 (m, 
2H), 1.52 (m, 1H), 1.32 (m, 1H), 1.23 (m, 16H), 0.94 (t, J = 7.9 Hz, 9H), 0.86 (t, J = 
6.8 Hz, 3H), 0.58 (q, J = 7.9 Hz, 6H); 13C (100 MHz, CDCl3) δ 137.8, 137.1, 134.4, 
128.4, 127.9, 127.7, 120.1, 115.2, 83.8, 83.0, 82.3, 73.4, 70.1, 62.3, 32.2, 31.9, 29.7, 
29.6, 29.5, 29.3, 25.8, 22.7, 14.1, 6.8, 4.8; IR (film) 3481 (br), 3078, 3030, 2954, 
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2926, 2875, 2855, 1456, 1418, 1240, 1084 cm-1; [α]28D = -43.0o (c 1.70, CH2Cl2); MS 
(ESI) calculated for C32H56O4Si  [M+H]+: 533.4, found 533.4. 
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Triene 98. A solution of oxalyl chloride (2.0 M in CH2Cl2, 2.54 mL, 5.08 mmol) in 
CH2Cl2 (25 mL) was cooled to -78 oC and dimethyl sulfoxide (720 µL, 10.2 mmol) 
was added slowly. After stirring for 15 min at -78 oC, alcohol 97 (2.237 g, 4.20 mmol) 
in CH2Cl2 (5 mL) was added slowly. The resulting solution was stirred for 15 min 
followed by the dropwise addition of triethylamine (2.95 mL, 21.2 mmol). After 
stirring for another 15 min at -78 oC, the reaction mixture was warmed to 0 oC and 
stirred for an additional 2 h. Water was added to quench the reaction and the 
organic layer was separated. The aqueous solution was further extracted three times 
with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was then passed through 
a silica gel plug, concentrated and used immediately for next reaction without further 
purification. 
A solution of methyltriphenylphosphonium bromide (2.999 g, 8.395 mmol) in toluene 
(20 mL) was heated to reflux and about 15 mL toluene was distilled off to 
azeotropically remove moisture. The mixture was cooled to 0 oC, and potassium tert-
butoxide (848 mg, 7.56 mmol) in THF (25 mL) was added slowly. The yellow solution 
was allowed to stir for 1 h before the freshly prepared aldehyde in THF (5 mL) was 
added dropwise. After stirring for 2 h at 0 oC, the reaction mixture was quenched by 
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water and warmed to room temperature. The organic layer was separated and the 
aqueous layer was further extracted with 50% EtOAc/hexanes. The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (5% EtOAc/hexanes) yielded 1.844 g (83%) of 
triene 98 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.30 (m, 5H), 5.88 (ddd, J = 
17.2, 10.5, 4.9 Hz, 1H), 5.79 (ddd, J = 17.5, 10.5, 7.6 Hz, 1H), 5.67 (ddd, J = 17.4, 
10.3, 6.9 Hz, 1H), 5.08-5.27 (m, 6H), 4.46 (AB, JAB = 11.9, ΔνAB = 86.6 Hz, 2H), 4.21 
(tt, J = 5.1, 1.5 Hz, 1H), 3.87 (dd, J = 6.7, 5.7 Hz, 1H), 3.74 (dd, J = 7.6, 4.5 Hz, 1H), 
3.49 (td, J = 6.5, 4.6 Hz, 1H), 1.58 (m, 1H), 1.47 (m, 1H), 1.24 (br, 16H), 0.93 (t, J = 
7.9 Hz, 9H), 0.86 (t, J = 6.7 Hz, 3H), 0.58 (q, J = 7.8 Hz, 6H); 13C (100 MHz, CDCl3) 
δ 138.8, 137.5, 136.3, 135.8, 128.1, 127.6, 127.3, 118.1, 117.8, 115.1, 83.2, 82.5, 
79.4, 74.1, 70.5, 31.9, 30.4, 29.9, 29.3, 25,4, 22.7, 14.1, 6.8, 4.9; IR (film) 3077, 
3028, 2925, 2875, 1456, 1420, 1239, 1088 cm-1; [α]27D = -42.2o (c 2.44, CH2Cl2); MS 
(ESI) calculated for C33H56O3Si  [M+Na]+: 551.4, found 551.4. 
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Allylic alcohol 78. A solution of triene 98 (195 mg, 0.369 mmol) in benzene (37 mL) 
was degassed by heating to reflux for 30 min. Grubbs second generation catalyst 
[Cl2(PCy3)(IMes)Ru=CHPh] (31 mg, 0.037 mmol) was added and the solution was 
stirred at reflux under an argon atmosphere for 2 h before being allowed to cool to 
room temperature. p-Toluenesulfonic acid (7 mg, 0.037 mmol), MeOH (1 mL) and 
CH2Cl2 (2 mL) were added to the reaction mixture and the solution was allowed to 
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stir in the air for 2 h. Saturated NaHCO3 was added to quench the reaction. The 
organic layer was separated and the aqueous layer was further extracted twice with 
EtOAc. The combined organic layers were dried over Na2SO4 and concentrated 
under reduced pressure. Purification by flash chromatography (15% EtOAc/hexanes) 
yielded 113 mg (79%) of cyclic ether 78 as a light yellow oil: 1H (400 MHz, CDCl3) δ 
7.33 (m, 5H), 5.99 (ddd, J = 10.4, 1.9, 1.8 Hz, 1H), 5.87 (ddd, J = 17.2, 10.6, 6.6 Hz, 
1H), 5.77 (ddd, J = 10.4, 1.4, 1.4 Hz, 1H), 5.36 (ddd, J = 17.3, 1.2, 1.2 Hz, 1H), 5.26 
(ddd, J = 10.4, 1.2, 1.0 Hz, 1H), 4.59 (AB, JAB = 11.6, ΔνAB = 48.3 Hz, 2H), 3.97 (m, 
1H), 3.92 (td, J = 6.5, 2.8 Hz, 1H), 3.74 (dddd, J = 8.5, 2.9, 1.8, 1.6 Hz, 1H), 3.39 (td, 
J = 8.4, 2.6 Hz, 1H), 2.64 (s, 1H), 1.82 (m, 1H), 1.44 (m, 1H), 1.26 (br, 16H), 0.88 (t, 
J = 7.0 Hz, 3H); 13C (100 MHz, CDCl3) δ 138.0, 136.2, 128.5, 128.4, 127.9, 127.8, 
127.7, 118.0, 77.5, 77.2, 75.3, 74.6, 71.2, 32.4, 31.9, 29.61, 29.57, 29.3, 25.4, 22.7, 
14.1; IR (film) 3457 (br), 3033, 2924, 2856, 1455, 1379, 1302, 1121, 1090 cm-1; 
[α]27D = -112.9o (c 2.49, CH2Cl2); MS (ESI) calculated for C25H38O3  [M+Na]+: 409.3, 
found 409.4. 
 
HO
TIPS
 
Alcohol 100. To a stirring solution of 5-hexyn-1-ol 99 (1.96 g, 20.0 mmol) in THF (40 
mL) was added ethylmagnesium chloride (2.0 M in THF, 21 mL, 42 mmol) dropwise 
via addition funnel. The reaction mixture was heated to reflux for 16 h and turned 
into a cloudy white solution. The reaction was then cooled to room temperature and 
triisopropylchlorosilane (4.28 mL, 20.0 mmol) in THF (20 mL) was added via addition 
funnel. The mixture was allowed to reflux for 6 h before being cooled to room 
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temperature. 10% HCl was added to quench the reaction. The organic layer was 
separated and the aqueous layer was extracted three more times with EtOAc. The 
combined organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure. Purification by vacuum distillation afforded the TIPS protected alkyne (4.08 
g, 80%) as a colorless oil: bp = 121-127 oC (2 mmHg); 1H (400 MHz, CDCl3) δ 3.59 (t, 
J = 6.1 Hz, 2H), 2.32 (br, 1H), 2.23 (t, J = 6.6 Hz, 2H), 1.61 (m, 4H), 1.00 (m, 21H); 
13C (100 MHz, CDCl3) δ 108.7, 80.3, 62.1, 31.7, 25.1, 19.5, 18.5, 17.6, 11.2; IR (film) 
3328 (br), 2943, 2864, 2172, 1464, 1045 cm-1; MS (ESI) calculated for C15H30OSi  
[M+Na]+: 255.2, found 255.2. 
 
HO
TIPS
 
Allylic alcohol 101. A solution of oxalyl chloride (2.0 M in CH2Cl2, 0.44 mL, 0.88 
mmol) in CH2Cl2 (5 mL) was cooled to -78 oC and dimethyl sulfoxide (130 µL, 1.76 
mmol) was added slowly. After stirring for 15 min at -78 oC, the previous alcohol (187 
mg, 0.734 mmol) in CH2Cl2 (2 mL) was added slowly. The resulting solution was 
stirred for 15 min followed by the dropwise addition of diisopropylethylamine (640 µL, 
3.67 mmol). After stirring for another 15 min at -78 oC, the reaction mixture was 
warmed to 0 oC and stirred for an additional 1 h. Water was added to quench the 
reaction and the organic layer was separated. The aqueous solution was further 
extracted three times with CH2Cl2. The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was passed 
through a silica gel plug, concentrated under reduced pressure and used 
immediately for next reaction without further purification. 
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To a flask fitted with a dry ice condenser and an addition funnel was added 
magnesium turnings (88.7 mg, 3.65 mmol), THF (2 mL) and a small crystal of iodine. 
A solution of vinyl bromide (260 µL, 3.65 mmol) in THF (3 mL) was added to the 
addition funnel and added dropwise to the reaction flask. After addition, the mixture 
was allowed to stir for 30 min at room temperature before being cooled in an 
ice/water bath. Freshly prepared aldehyde in THF (2 mL) was added dropwise at 0 
oC and the reaction mixture was subsequently warmed to room temperature. After 
stirring for 30 min, the reaction was quenched by slowly adding 10% HCl at 0 oC, 
warmed to room temperature and stirred at room temperature for 15 min. The 
organic layer was separated and the aqueous layer was extracted three times with 
50% EtOAc/hexanes. The combined organic layers were washed with saturated 
NaHCO3, H2O, saturated NaCl, respectively, dried over Na2SO4 and concentrated 
under reduced pressure. Purification by flash chromatography (10% EtOAc/hexanes) 
yielded 171 mg (83%) of allylic alcohol 101 as a colorless oil: 1H (400 MHz, CDCl3) δ 
5.83 (ddd, J = 17.1, 10.5, 6.3 Hz, 1H), 5.19 (ddd, J = 17.2, 1.4, 1.3 Hz, 1H), 5.07 
(ddd, J = 10.4, 1.2, 1.1 Hz, 1H), 4.13 (td, J = 6.0, 5.8 Hz, 1H), 2.26 (td, J = 6.5, 1.6 
Hz, 2H), 1.76 (d, J = 4.2 Hz, 1H), 1.61 (m, 4H), 1.02 (m, 21H); 13C (100 MHz, CDCl3) 
δ 141.1, 114.6, 108.6, 80.5, 72.6, 35.9, 24.6, 19.6, 18.6, 11.3; IR (film) 3364 (br), 
2943, 2866, 2171, 1463, 991 cm-1; MS (ESI) calculated for C17H32OSi  [M+Na]+: 
303.2, found 303.2. 
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Alcohol 102. To a suspension of 4 Å activated molecular sieves in CH2Cl2 (30 mL) 
was added racemic allylic alcohol 101 (2.717 g, 9.687 mmol), followed by (+)-
dicyclohexyltartrate (457 mg, 1.45 mmol) in CH2Cl2 (10 mL). The reaction mixture 
was cooled to -20 oC in a cryotrol instrument and titanium tetraisopropoxide (286 µL, 
0.969 mmol) was added. After stirring for 30 min, tert-butyl hydroperoxide (4.7 M, 
1.44 mL, 6.78 mmol) was added and the reaction was allowed to stir at -20 oC. After 
7 d, 1H analysis indicated that the reaction was 52% complete. Consequently, the 
reaction was poured into a freshly prepared 0 oC ferrous sulfate (8.079 g, 29.06 
mmol)/citric acid (2.792 g, 14.53 mmol) solution (30 mL H2O) and stirred vigorously 
for 10 min. Vacuum filtration was subsequently utilized to remove the molecular 
sieves from the reaction mixture. The organic layer was then separated and the 
aqueous layer was extracted three times with CH2Cl2. The combined organic 
extracts were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (10% EtOAc/hexanes) yielded 1.1664 g of 
allylic alcohol 102 as a colorless oil: 1H (400 MHz, CDCl3) δ 5.83 (ddd, J = 17.1, 10.5, 
6.3 Hz, 1H), 5.19 (ddd, J = 17.2, 1.4, 1.3 Hz, 1H), 5.07 (ddd, J = 10.4, 1.2, 1.1 Hz, 
1H), 4.13 (td, J = 6.0, 5.8 Hz, 1H), 2.26 (td, J = 6.5, 1.6 Hz, 2H), 1.76 (d, J = 4.2 Hz, 
1H), 1.60 (m, 4H), 1.02 (m, 21H); 13C (100 MHz, CDCl3) δ 141.1, 114.6, 108.6, 80.5, 
72.6, 35.9, 24.6, 19.6, 18.6, 11.3; IR (film) 3364 (br), 2943, 2866, 2171, 1463, 991 
cm-1; [α]27D = -1.2o (c 5.32, CH2Cl2); MS (ESI) calculated for C17H32OSi  [M+Na]+: 
303.2, found 303.2. 
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Acid 103. Sodium hydride (1.462 g, 36.55 mmol, 60% dispersion in mineral oil) was 
washed three times with hexane, suspended in THF (8 mL) and cooled in an 
ice/water bath. A solution of bromoacetic acid (2.052 g, 14.77 mmol) in THF (2 mL) 
was added dropwise via syringe. After stirring for 1 h at 0 oC, alcohol 102 (3.491 g, 
12.18 mmol) in DMF (10 mL) was added dropwise to the stirring solution. The 
reaction mixture was stirred for 15 min at 0 oC before being allowed to warm to room 
temperature. After 3 h, TLC indicated that the reaction was complete and water was 
added slowly to quench the reaction at 0 oC. The solution was then acidified to pH 2 
by the addition of 10% HCl. The layers were separated and the aqueous layer was 
further extracted twice with EtOAc. The combined organic extracts were washed 
with H2O and saturated NaCl solution, dried over Na2SO4 and concentrated under 
reduced pressure. Purification by flash chromatography (25% EtOAc/hexanes) gave 
4.060 g (98%) of the glycolic acid as a colorless oil: 1H (400 MHz, CDCl3) δ 9.81 (br, 
1H), 5.63 (ddd, J = 17.2, 10.3, 8.1 Hz, 1H), 5.27 (dd, J = 10.3, 1.4, 0.5 Hz, 1H), 5.23 
(ddd, J = 17.2, 1.2, 0.8 Hz, 1H), 4.06 (AB, JAB = 17.1, ΔνAB = 43.4 Hz, 2H), 3.77 (td, J 
= 6.7, 6.6 Hz, 1H), 2.25 (m, 2H), 1.67 (m, 4H), 1.01 (m, 21H); 13C (100 MHz, CDCl3) 
δ 175.8, 137.3, 118.8, 108.5, 81.9, 80.5, 64.8, 33.9, 24.4, 19.5, 18.6, 11.2; IR (film) 
3077 (br), 2941, 2865, 2171, 1734, 1464, 1429, 1246, 1126 cm-1; [α]28D = +27.5o (c 
3.51, CH2Cl2); MS (ESI) calculated for C19H34O3Si  [M+Na]+: 361.2, found 361.1. 
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Glycolate 104. To a solution of the previous glycolic acid 103 (440 mg, 1.30 mmol) in 
THF (6.5 mL) was added triethylamine (199 µL, 1.43 mmol), and the mixture was 
cooled to -78 oC. Pivaloyl chloride (160 µL, 1.30 mmol) was added dropwise via 
syringe. After stirring at -78 oC for 10 min, the mixture was warmed to 0 oC, stirred 
for 1 h and cooled to -78 oC again. In a separate flask, a solution of (R)-4-benzyl-2-
oxazolidinone (300 mg, 1.69 mmol) in THF (3.3 mL) was cooled to -78 oC, into which 
n-BuLi (2.44 M in hexane, 640 µL, 1.56 mmol) was added dropwise via syringe. After 
stirring for 15 min at -78 oC, the resulting solution was transferred via cannula to the 
mixed anhydride prepared above, and stirred for an additional 10 min. The reaction 
mixture was then slowly warmed to room temperature and allowed to stir overnight. 
Half-saturated NH4Cl was added to quench the reaction. The organic layer was 
separated and the aqueous layer was extracted two more times with EtOAc. The 
combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography (20% EtOAc/hexanes) recovered 140 
mg of the glycolic acid and provided 456 mg (78%, 100% brsm) of a 24:1 mixture of 
glycolate 16 and its diastereomer (determined by HPLC analysis ) as a colorless oil: 
1H (400 MHz, CDCl3) δ 7.28 (m, 3H), 7.16 (d, J = 6.6 Hz, 2H), 5.68 (ddd, J = 17.8, 
9.8, 8.0 Hz, 1H), 5.21 (dd, J = 14.2, 2.5 Hz, 2H), 4.63 (m, 1H), 4.60 (AB, JAB = 17.9, 
ΔνAB = 29.1 Hz, 2H), 4.22 ( dd, J = 9.0, 8.0 Hz, 1H), 4.16 (dd, J = 9.2, 3.0 Hz, 1H), 
3.84 (dt, J = 13.2, 6.9 Hz, 1H), 3.26 (dd, J = 13.5, 3.1 Hz, 1H), 2.79 (dd, J = 13.5, 9.4 
Hz, 1H), 2.28 (m, 2H), 1.72 (m, 4H), 1.02 (m, 21H); 13C (100 MHz, CDCl3) 170.3, 
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153.2, 137.8 134.9, 129.3, 128.8, 127.3, 118.1, 108.6, 81.5, 80.2, 67.6, 67.0, 54.6, 
37.6, 34.1, 24.4, 19.5, 18.5, 11.1; IR (film) 3065, 3028, 2943, 2865, 2170, 1791, 
1714, 1464, 1393, 1351, 1275, 1259, 1133, 1050 cm-1; [α]27D = -10.8o (c 8.87, 
CH2Cl2); MS (ESI) calculated for C29H43NO4Si  [M+NH4]+: 515.3, found 515.4. 
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Aldol adduct 105. A stirring solution of glycolate 104 (631 mg, 1.27 mmol) in CH2Cl2 
(8 mL) was cooled to -78 oC and TiCl4 (139 µL, 1.27 mmol) was added dropwise. 
The resultant light yellow solution was stirred for 10 min before diisopropylethyl-
amine (550 µL, 3.17 mmol) was added dropwise, causing the solution to become 
dark-blue color. After stirring at -78 oC for 2 h, N-methyl-2-pyrrolidinone (122 µL, 
1.27 mmol) was added slowly and the reaction mixture was stirred for 10 min at -78 
oC before freshly distilled acrolein (0.43 mL, 6.34 mmol) was added dropwise. The 
solution was allowed to stand at -78 oC for 2 h, slowly warmed to -40 oC and stirred 
for another 2 h. Half-saturated NH4Cl solution was then added at -40 oC to quench 
the reaction, followed by warming the mixture to room temperature. The organic 
layer was separated and the aqueous solution was further extracted three times with 
CH2Cl2. The combined organic solution was then dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (20% 
EtOAc/hexanes) recovered 74 mg (12%) of glycolate 104 and yielded 572 mg (82%, 
93% brsm) of a 4:1 mixture of aldol adduct 105 and other minor diastereomers as a 
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light yellow oil: 1H (400 MHz, CDCl3) δ 7.29 (m, 3H), 7.19 (d, J = 7.0 Hz, 2H), 5.90 
(ddd, J = 17.1, 10.5, 5.5 Hz, 1H), 5.62 (ddd, J = 17.3, 10.2, 8.6 Hz, 1H), 5.30 (ddd, J 
= 17.3, 1.4, 1.3 Hz, 1H), 5.28-5.23 (m, 2H), 5.18 (ddd, J = 10.5, 1.4, 1.3 Hz, 1H), 
5.16 (dd, J = 17.3, 1.4 Hz, 1H), 4.66 (m, 1H), 4.35 (m, 1H), 4.20 (m, 2H), 3.75 (ddd, 
J = 12.6, 7.6, 4.9 Hz, 1H), 3.31 (dd, J = 13.3, 3.3 Hz, 1H), 2.83 (dd, J = 13.4, 9.4 Hz, 
1H), 2.53 (d, J = 8.7 Hz, 1H), 2.31 (t, J = 6.5 Hz, 2H), 1.71 (m, 4H), 1.02 (m, 21H); 
13C (100 MHz, CDCl3) δ 170.5, 153.4, 137.7, 137.0, 135.0, 129.4, 129.0, 127.5, 
119.0, 116.5, 108.8, 80.5, 80.3, 76.7, 73.5, 66.9, 55.6, 37.8, 34.4, 24.5, 19.6, 18.6, 
11.3; IR (film) 3480 (br), 2942, 2865, 2169, 1781, 1709, 1390, 1212, 1117 cm-1; 
[α]26D = -12.0o (c 1.82, CH2Cl2); MS (ESI) calculated for C32H47NO5Si  [M+H]+: 554.3, 
found 554.4. 
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TES ether 105a. A stirring solution of alcohol 105 (115 mg, 0.208 mmol) and 2,6-
lutidine (150 µL, 1.04 mmol) in CH2Cl2 (2 mL) was cooled to 0 oC. Triethylsilyl 
trifluoromethanesulfonate (140 µL, 0.625 mmol) was added dropwise and the 
reaction mixture was allowed to warm to room temperature. After stirring for 1 h, 
saturated NaHCO3 was added to quench the reaction and the mixture was extracted 
twice with CH2Cl2. The combined organic solution was dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (10% 
EtOAc/hexanes) yielded 140 mg (100%) of the TES ether as a light yellow oil: 1H 
(400 MHz, CDCl3) δ 7.29 (m, 3H), 7.21 (d, J = 6.6 Hz, 2H), 5.93 (ddd, J = 17.3, 10.5, 
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6.2 Hz, 1H), 5.68 (ddd, J = 17.2, 10.4, 8.0 Hz, 1H), 5.51 (d, J = 5.8 Hz, 1H), 5.21 (m, 
2H), 5.17 (ddd, J = 17.1, 1.6, 1.4 Hz, 1H), 5.11 (ddd, J = 10.6, 1.5, 1.4 Hz, 1H), 4.54 
(m, 1H), 4.38 (td, J = 6.0, 1.2 Hz, 1H), 4.12 (m, 2H), 3.70 (m, 1H), 3.32 (dd, J = 13.3, 
3.1 Hz, 1H), 2.78 (dd, J = 13.3, 9.7 Hz, 1H), 2.28 (m, 2H), 1.69 (m, 4H), 1.01 (m, J = 
21H), 0.90 (t, J = 7.9 Hz, 9H), 0.56 (q, J = 7.9 Hz, 6H); 13C (100 MHz, CDCl3) δ 
171.2, 153.0, 138.0, 137.0, 135.2, 129.4, 128.8, 127.3, 118.2, 116.0, 108.9, 80.4, 
80.1, 76.8, 66.4, 55.9, 38.0, 34.3, 24.5, 19.5, 18.5, 11.2, 6.7, 4.6; IR (film) 3087, 
3030, 2943, 2866, 2170, 1790, 1706, 1463, 1387, 1326, 1210, 1109, 1001 cm-1; 
[α]23D = -27.8o (c 6.08, CH2Cl2); MS (ESI) calculated for C38H61NO5Si2  [M+Na]+: 
690.4, found 690.5. 
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Alcohol 106. A solution of the previous oxazolidinone (790 mg, 1.18 mmol), MeOH 
(96 µL, 2.36 mmol) in Et2O (10 mL) was cooled to 0 oC. Lithium borohydride (2.0 M 
in THF, 1.18 mL, 2.36 mmol) was added dropwise via syringe. After stirring for 2 h, 
saturated sodium potassium tartrate solution (6 mL) was added. The mixture was 
allowed to warm to room temperature and stirred vigorously overnight. The organic 
layer was separated and the aqueous layer was extracted three times with Et2O. 
The combined organic extracts were washed with saturated NaCl solution, dried 
over Na2SO4 and concentrated under reduced pressure. Purification by flash 
chromatography (10% EtOAc/hexanes) yielded 520 mg (89%) of alcohol 106 as a 
light yellow oil: 1H (400 MHz, CDCl3) δ 5.94 (ddd, J = 17.3, 10.7, 5.0 Hz, 1H), 5.69 
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(ddd, J = 17.3, 10.3, 8.0 Hz, 1H), 5.29 (ddd, J = 17.2, 1.9, 1.8 Hz, 1H), 5.22-5.14 (m, 
3H), 4.33 (m, 1H), 3.81 (dd, J = 13.5, 7.4 Hz, 1H), 3.71 (m, 1H), 3.56 (m, 2H), 2.29 (t, 
J = 4.6 Hz, 1H), 2.24 (t, J = 6.4 Hz, 2H), 1.62 (m, 4H), 1.03 (m, 21H), 0.93 (t, J = 8.0 
Hz, 9H), 0.58 (q, J = 8.0 Hz, 6H); 13C (100 MHz, CDCl3) δ 139.3, 136.7, 117.1, 115.6 
108.6, 80.9, 80.5, 78.5, 74.1, 61.5, 34.5, 24.6, 19.7, 18.6, 11.2, 6.7, 4.7; IR (film) 
3482 (br), 2942, 2866, 2171, 1463, 1082, 1004 cm-1; [α]24D = -19.0o (c 4.00, CH2Cl2); 
MS (ESI) calculated for C28H54O3Si2  [M+Na]+: 517.4, found 517.4. 
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α,β-Unsaturated ester 109. A solution of oxalyl chloride (2.0 M in CH2Cl2, 2.15 mL, 
4.30 mmol) in CH2Cl2 (20 mL) was cooled to -78 oC and dimethyl sulfoxide (610 µL, 
8.61 mmol) was added slowly. After stirring for 15 min at -78 oC, alcohol 106 (1.420 
g, 2.87 mmol) in CH2Cl2 (5 mL) was added slowly. The resulting solution was stirred 
for 15 min followed by the dropwise addition of diisopropylethylamine (3.00 mL, 
17.22 mmol). After stirring for another 15 min at -78 oC, the reaction mixture was 
warmed to 0 oC and stirred for an additional 2 h. Methyl (triphenylphosphoranylidene) 
acetate (1.918 g, 5.74 mmol) was added and the reaction mixture was warmed to 
room temperature. After stirring overnight, water was added to quench the reaction 
and the organic layer was separated. The aqueous solution was further extracted 
three times with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (5% 
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EtOAc/hexanes) yielded 1.481 g (94%) of α,β-unsaturated ester 109 as a light 
yellow oil: 1H (400 MHz, CDCl3) δ 6.80 (dd, J = 15.8, 5.7 Hz, 1H), 5.93 (dd, J = 15.9, 
1.5 Hz, 1H), 5.77 (ddd, J = 17.1, 10.4, 5.3 Hz, 1H), 5.63 (ddd, J = 17.3, 10.2, 7.9 Hz, 
1H), 5.20 (ddd, J = 17.3, 1.7, 1.6 Hz, 1H), 5.18 (dd, J = 10.4, 1.6 Hz, 1H), 5.13 (dd, J 
= 17.0, 1.8 Hz, 1H), 5.09 (ddd, J = 10.0, 1.7, 1.6 Hz, 1H), 4.17 (tdd, J = 5.5, 1.4, 1.3 
Hz, 1H), 3.96 (td, J = 5.8, 1.3 Hz, 1H), 3.72 (s, 3H), 3.67 (dd, J = 7.5, 6.5 Hz, 1H), 
2.24 (t, J = 6.8 Hz, 2H), 1.61 (m, 4H), 1.03 (m, 21H), 0.92 (t, J = 7.9 Hz, 9H), 0.57 (q, 
J = 7.8 Hz, 6H); 13C (100 MHz, CDCl3) δ 166.6, 146.0, 138.8, 136.8, 122.6, 117.6, 
116.0, 108.7, 79.5, 78.9, 74.8, 51.5, 34.6, 24.6, 19.7, 18.6, 11.3, 6.8, 4.9; IR (film) 
2963, 2866, 2171, 1731, 1463, 1271, 1166, 1118, 1078 cm-1; [α]28D = -21.5o (c 2.02, 
CH2Cl2); MS (ESI) calculated for C28H54O3Si2  [M+Na]+: 571.4, found 571.4. 
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Alcohol 109a. A solution of α,β-unsaturated ester 109 (280 mg, 0.510 mmol) in Et2O 
(5 mL) was cooled to -78 oC and i-Bu2AlH (1.0 M in heptane, 1.53 mL, 1.53 mmol) 
was added dropwise. After stirring for 3 h at -78 oC, MeOH (41 µL, 1.02 mmol) was 
added to quench the excess i-Bu2AlH and the reaction was allowed to warm to room 
temperature. A saturated solution of sodium potassium tartrate (5 mL) was added 
and the mixture was stirred overnight. The organic layer was separated and the 
aqueous layer was extracted three more times with EtOAc. The combined organic 
extracts were dried over Na2SO4 and concentrated under reduced pressure. 
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Purification by flash chromatography (10% EtOAc/hexanes) yielded 256 mg (96%) of 
the alcohol as a light yellow oil: 1H (400 MHz, CDCl3) δ 5.84 (ddd, J = 17.2, 10.6, 5.3 
Hz, 1H), 5.76 (dt, J = 15.5, 5.4 Hz, 1H), 5.63 (ddd, J = 17.2, 10.6, 7.9 Hz, 1H), 5.50 
(ddt, J = 15.6, 7.3, 1.4 Hz, 1H), 5.25-5.04 (m, 4H), 4.13 (m, 3H), 3.74 (m, 2H), 2.23 
(m, 2H), 1.60 (m, 4H), 1.03 (m, 21H), 0.92 (t, J = 8.0 Hz, 9H), 0.57 (q, J = 8.0 Hz, 
6H); 13C (100 MHz, CDCl3) δ 139.2, 137.6, 133.2, 128.7, 116.9, 115.2, 108.9, 80.3, 
79.6, 77.6, 75.0, 63.2, 34.5, 24.7, 19.6, 18.6, 11.3, 6.8, 4.8; IR (film) 3338 (br), 2943, 
2866, 2171, 1463, 1240, 1073, 1005 cm-1; [α]27D = -6.6o (c 1.72, CH2Cl2); MS (ESI) 
calculated for C30H56O3Si2  [M+Na]+: 543.4, found 543.4. 
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Tetraene 110. Sodium hydride (279 mg, 6.98 mmol, 60% dispersion in mineral oil) 
was washed three times with hexane, suspended in THF (7 mL) and cooled in an 
ice/water bath. A solution of alcohol 109a (1.213 g, 2.33 mmol) in THF (2 mL) was 
added dropwise via syringe. After stirring for 10 min at 0 oC, distilled allyl bromide 
(610 µL, 6.98 mmol) was added, followed by tetrabutylammonium iodide (86 mg, 
0.23 mmol). The reaction was warmed to room temperature and stirred for 5 h. Half-
saturated NaHCO3 was added to quench the reaction at 0 oC and the reaction 
mixture was allowed to warm to room temperature. The layers were separated and 
the aqueous layer was extracted two more times with EtOAc. The combined organic 
layers were dried over Na2SO4 and concentrated under reduced pressure. 
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Purification by flash chromatography (5% EtOAc/hexanes) yielded 1.225 g (95%) of 
tetraene 110 as a light yellow oil: 1H (400 MHz, CDCl3) δ 5.95-5.79 (m, 2H), 5.69-
5.57 (m, 2H), 5.48 (ddt, J = 15.8, 7.5, 1.2 Hz, 1H), 5.25 (ddt, J = 19.0, 3.4, 1.7 Hz, 
1H), 5.18-5.09 (m, 4H), 5.07 (ddd, J = 10.6, 1.8, 1.7 Hz, 1H), 4.13 (tdd, J = 5.5, 1.5, 
1.4 Hz, 1H), 3.97 (d, J = 5.7 Hz, 2H), 3.94 (dt, J = 5.6, 1.4 Hz, 2H), 3.74 (m, 2H), 
2.22 (t, J = 6.7 Hz), 1.60 (m, 4H), 1.03 (m, 21H), 0.92 (t, J = 7.9 Hz, 9H), 0.57 (q, J = 
7.9 Hz, 6H); 13C (100 MHz, CDCl3) 139.2, 137.8, 137.7, 134.8, 130.55, 130.51, 
116.9, 115.1, 108.9, 80.2, 79.8, 77.6, 75.0, 70.6, 70.1, 34.6, 24.8, 19.7, 18.6, 11.3, 
6.8, 4.9; IR (film) 2943, 2865, 2172, 1464, 1140, 1075 cm-1; [α]26D = -3.4o (c 1.08, 
CH2Cl2); MS (ESI) calculated for C33H60O3Si2  [M+Na]+: 583.4, found 583.4. 
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Allylic alcohol 83. A solution of tetraene 110 (141.3 mg, 0.252 mmol) in benzene (25 
mL) was degassed by heating to reflux for 30 min. Grubbs second generation 
catalyst [Cl2(PCy3)(IMes)Ru=CHPh] (21.4 mg, 0.025 mmol) was added and the 
solution was stirred at reflux under an argon atmosphere. After 5 min, TLC indicated 
that the reaction was complete, and the solution was allowed to cool to room 
temperature. p-toluenesulfonic acid (4.8 mg, 0.025 mmol), MeOH (1 mL) and CH2Cl2 
(1 mL) were added to the reaction mixture and the solution was allowed to stir in the 
air for 5 h. Saturated NaHCO3 was added to quench the reaction. The organic layer 
was separated and the aqueous layer was further extracted twice with CH2Cl2. The 
combined organic layers were dried over Na2SO4 and concentrated under reduced 
 118
pressure. Purification by flash chromatography (15% EtOAc/hexanes) yielded 76.3 
mg (87%) of cyclic ether 83 as a light yellow oil: 1H (400 MHz, CDCl3) δ 5.88 (ddd, J 
= 6.2, 1.8, 1.5 Hz, 1H), 5.85 (ddd, J = 16.9, 10.6, 6.1 Hz, 1H), 5.74 (ddd, J = 6.1, 1.8, 
1.7 Hz, 1H), 5.35 (ddd, J = 17.3, 1.4, 1.3, Hz, 1H), 5.22 (ddd, J = 10.5, 1.4, 1.3 Hz, 
1H), 4.90 (dddd, J = 5.5, 5.4, 1.8, 1.7 Hz, 1H), 4.68 (tdd, J = 5.9, 1.9, 1.7 Hz, 1H), 
3.96 (dddd, J = 6.0, 3.8, 1.5, 1.2 Hz, 1H), 2.32 (d, J = 3.8 Hz, 1H), 2.27 (t, J = 6.7 Hz, 
2H), 1.64 (m, 4H), 1.03 (m, 21H); 13C (100 MHz, CDCl3) δ 136.6, 132.1, 126.5, 117.1, 
108.7, 88.9, 85.8, 80.4, 75.7, 34.9, 24.4, 19.9, 18.6, 11.3; IR (film) 3438 (br), 2943, 
2865, 2170, 1462, 1092, 994 cm-1; [α]22D = -116.5o (c 0.48, CH2Cl2); MS (ESI) 
calculated for C21H36O2Si  [M+Na]+: 371.3, found 371.3. 
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MOM ether 111. To a solution of alcohol 83 (116 mg, 0.333 mmol) and 4-
dimethylaminopyridine (4 mg, 0.03 mmol) in CH2Cl2 (2 mL) was added 
diisopropylethylamine (295 µL, 1.67 mmol). The reaction was cooled to 0 oC and 
chloromethyl methyl ether (115 µL, 1.49 mmol) was added dropwise. After stirring for 
30 min at 0 oC, the reaction was warmed to room temperature and allowed to stir 
overnight. Half-saturated NH4Cl solution was added to quench the reaction and 
CH2Cl2 was added to dilute the mixture. The organic layer was separated and the 
aqueous layer was extracted three more times with CH2Cl2. The combined organic 
extracts were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (5% EtOAc/hexanes) yielded 116.2 mg (89%) 
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of MOM ether 111 as a light yellow oil: 1H (400 MHz, CDCl3) δ 5.85 (d, J = 6.1 Hz, 
1H), 5.77 (d, J = 6.1 Hz, 1H), 5. 71 (ddd, J = 17.5, 10.2, 7.4 Hz, 1H), 5.29 (ddd, J = 
17.1, 1.7, 1.0 Hz, 1H), 5.25 (ddd, J = 10.6, 1.7, 1.0 Hz, 1H), 4.85 (m, 1H), 4.65 (AB, 
JAB = 6.6, ΔνAB = 35.8 Hz, 2H), 4.02 (m, 1H), 3.36 (s, 3H), 2.25 (t, J = 6.6 Hz, 2H), 
1.63 (m, 4H), 1.03 (m, 21H); 13C (100 MHz, CDCl3) δ 134.6, 131.7, 126.8, 119.1, 
108.8, 94.1, 87.7, 85.8, 80.3, 79.2, 55.3, 34.8, 24.4, 19.9, 18.6, 11.3; IR (film) 2942, 
2865, 2170, 1464, 1152, 1078, 1038 cm-1; [α]25D = -79.1o (c 0.66, CH2Cl2); MS (ESI) 
calculated for C23H40O3Si  [M+H]+: 393.3, found 393.4. 
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Trieneyne 113. To a solution of unprotected allylic alcohol 78 (19.8 mg, 50.5 µmol) 
and MOM protected allylic alcohol 83 (19.5 mg, 50.5 µmol) in CH2Cl2 (0.5 mL) was 
added Hoveyda-Grubbs second generation catalyst [Cl2(IMes)Ru=CH-o-Oi-PrC6H4] 
(3 mg, 5 µmol). The solution was stirred for 3 h under an argon atmosphere at room 
temperature, heated to reflux for 17 h and cooled to room temperature. Purification 
by flash chromatography (10-25-40% EtOAc/hexanes) recovered 3 mg (13%) of 
MOM protected allylic alcohol 83, yielded 4 mg (23%) of the homodimer of 78 (114) 
and 25 mg (68%) of a 6:1 mixture of the cross metathesis product 113 and its Z,Z,Z 
double bond isomer as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.32 (m, 5H), 5.98 
(d, J = 10.3 Hz, 1H), 5.84 (d, 6.4 Hz, 1H), 5.81-5.62 (m, 4H), 4.84 (m, 2H), 4.63 (AB, 
JAB = 6.6 Hz, ΔνAB = 46.4 Hz, 2H), 4.57 (AB, JAB = 11.6 Hz, ΔνAB = 48.6 Hz, 2H), 
4.07 (dd, J = 7.1, 5.6 Hz, 1H), 3.95 (m, 2H), 3.71 (d, J = 8.5 Hz, 1H), 3.36 (m, 1H), 
 120
3.35 (s, 3H), 2.53 (d, J = 3.4 Hz, 1H), 2.25 (t, J = 6.7 Hz, 2H), 1.79 (m, 1H), 1.62 (m, 
4H), 1.43 (m, 2H), 1.24 (m, 16H), 1.03 (m, 21H), 0.86 (t, J = 6.7 Hz, 3H); 13C (100 
MHz, CDCl3) δ 138.0, 133.3, 131.8, 129.4, 128.7, 128.4, 128.0, 127.8, 127.7, 126.8, 
108.8, 94.0, 87.7, 85.8, 80.3, 78.0, 77.6, 77.2, 74.5, 74.1, 71.2, 55.3, 34.8, 32.5, 
31.9, 29.7, 29.65, 29.60, 29.3, 25.4, 24.4, 22.7, 19.9, 18.6, 14.1, 11.3; IR (film) 3452 
(br), 2924, 2863, 2170, 1464, 1382, 1309, 1263, 1211, 1150, 1092, 1035 cm-1; [α]28D 
= -112.2o (c 1.10, CH2Cl2); MS (ESI) calculated for C46H74O6Si  [M+Na]+: 773.5, 
found 773.8. 
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Alkyne 115. To a solution of TIPS protected alkyne 113 (37.6 mg, 50.1 µmol) in THF 
(0.25 mL) was added tetrabutylammonium fluoride (1.0 M in THF, 100 µL, 100 µmol). 
The mixture was stirred at room temperature overnight. Dimethyl sulfoxide (0.5 mL) 
was added to the reaction and the solution was concentrated under reduced 
pressure. Purification by flash chromatography (30% EtOAc/hexanes) afforded 26 
mg (87%) of alkyne 115 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.32 (m, 5H), 
5.98 (d, J = 10.4 Hz, 1H), 5.84 (d, J = 6.2 Hz, 1H), 5.81-5.62 (m, 4H), 4.85 (m, 2H), 
4.63 (AB, JAB = 6.7, ΔνAB = 46.9 Hz, 2H), 4.57 (AB, JAB = 11.4, ΔνAB = 48.2 Hz, 2H), 
4.07 (dd, J = 6.9, 5.7 Hz, 1H), 3.96 (m, 2H), 3.71 (d, J = 8.4 Hz, 1H), 3.38 (m, 1H), 
3.35 (s, 3H), 2.53 (br, 1H), 2.19 (td, J = 6.9, 2.7 Hz, 2H), 1.92 (t, J = 2.5 Hz, 1H), 
1.82 (m, 2H), 1.62 (m, 4H), 1.43 (m, 2H), 1.24 (m, 16H), 0.86 (t, J = 6.6 Hz, 3H); 13C 
(100 MHz, CDCl3) δ 138.0, 133.3, 131.7, 129.4, 128.7, 128.4, 128.0, 127.8, 127.7, 
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126.9, 94.0, 87.8, 85.7, 84.3, 78.0, 77.6, 77.2, 74.5, 74.1, 71.2, 68.4, 55.3, 34.7, 
32.5, 31.9, 29.69, 29.65, 29.59, 29.3, 25.4, 23.9, 22.7, 18.4, 14.1; IR (film) 3458 (br), 
3311, 3032, 2923, 2855, 1455, 1378, 1302, 1255, 1210, 1151, 1094, 1038 cm-1; 
[α]28D = -161.8o (c 0.66, CH2Cl2); MS (ESI) calculated for C37H54O6  [M+Na]+: 617.4, 
found 617.5. 
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Pentaenyne 116. A solution of alkyne 115 (13 mg, 22 µmol), iodide 82 (9 mg, 22 
µmol) in triethylamine (1 mL) was cooled to 0 oC. Bis(triphenylphosphine)palladium 
(II) dichloride (1.5 mg, 2.2 µmol) was added and the mixture was stirred for 10 min, 
followed by the addition of copper (I) iodide (1.2 mg, 6.7 µmol). After stirring for 10 
min, the reaction was allowed to warm to room temperature and stirred for another 
2.5 h. Water and EtOAc were added to the reaction. The organic layer was 
separated and the aqueous layer was extracted three more times with EtOAc. The 
combined organic solution was extracted with 10% HCl, H2O, saturated NaHCO3 
and saturated NaCl solution, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography (40% EtOAc/hexanes) afforded 16 
mg (82%) of the coupling product 116 as a light yellow oil: 1H (400 MHz, CDCl3) δ 
7.32 (m, 5H), 7.18 (d, J = 8.7 Hz, 2H), 7.06 (s, 1H), 6.84 (d, J = 8.7 Hz, 1H), 6.07-
5.61 (m, 8H), 4.96 (q, J = 6.4 Hz, 1H), 4.86 (m, 2H), 4.64 (AB, JAB = 6.8, ΔνAB = 46.8 
Hz, 2H), 4.57 (AB, JAB = 11.6, ΔνAB = 48.8 Hz, 2H), 4.45 (AB, JAB = 11.2, ΔνAB = 
 122
101.2 Hz, 2H), 4.07 (m, 2H), 3.96 (m, 2H), 3.77 (s, 3H), 3.71 (dd, J = 8.2, 1.1 Hz, 
1H), 3.38 (m, 1H), 3.35 (s, 3H), 2.52 (m, 3H), 2.32 (t, J = 6.9 Hz, 2H), 1.81 (m, 1H), 
1.63 (m, 4H), 1.43 (m, 2H), 1.35 (d, J = 6.8 Hz, 3H), 1.24 (m, 16H), 0.86 (t, J = 6.5 
Hz, 3H); 13C (100 MHz, CDCl3) δ173.7, 159.2, 152.0, 140.8, 138.0, 133.4, 131.7, 
130.0, 129.7, 129.5, 129.3, 128.7, 128.4, 128.0, 127.8, 127.7, 126.9, 113.8, 113.4, 
94.0, 91.6, 87.8, 85.8, 78.3, 78.1, 77.62, 77.57, 77.2, 76.6, 74.5, 74.1, 71.2, 70.3, 
55.34, 55.27, 34.9, 32.5, 31.9, 31.2, 29.7, 29.65, 29.6, 29.3, 25.4, 24.1, 22.7, 19.5, 
19.0, 14.1; IR (film) 3454 (br), 2925, 2854, 1754, 1612, 1514, 1455, 1319, 1249, 
1080, 1031 cm-1; [α]29D = -122.6o (c 0.23, CH2Cl2); MS (ESI) calculated for C54H72O10  
[M+Na]+: 903.5, found 903.5. 
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Alcohol 117. To a refluxing solution of pentaenyne 116 (7.6 mg, 8.6 µmol) and p-
toluenesulfonyl hydrazide (112 mg, 0.604 mmol) in dimethoxyethane (0.86 mL) was 
added a solution of sodium acetate (56.6 mg, 0.690 mmol) in H2O (0.86 mL) over 4 
h via syringe pump. After cooling to room temperature, H2O and EtOAc were added 
to dilute the reaction mixture. The organic layer was separated and the aqueous 
layer was further extracted three times with EtOAc. The combined organic layers 
were washed three times with 10% HCl, followed by saturated NaHCO3 and 
saturated NaCl, dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (33-40% EtOAc/hexanes) afforded 5.4 mg 
(77%) of the reduction product 117 as a light yellow oil: 1H (500 MHz, CDCl3) δ 7.31 
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(m, 5H), 7.21 (d, J = 8.7 Hz, 1H), 7.06 (s, 1H), 6.84 (d, J = 8.7 Hz, 2H), 4.96 (q, J = 
6.9 Hz, 1H), 4.75 (AB, JAB = 7.1, ΔνAB = 80.3 Hz, 2H), 4.52 (AB, JAB = 11.6, ΔνAB = 
82.0 Hz, 2H), 4.42 (AB, JAB = 10.9, ΔνAB = 23.5 Hz, 2H), 3.96 (td, J = 6.8, 6.7 Hz, 
1H), 3.85 (m, 1H), 3.78 (s, 3H), 3.64 (tt, J = 5.9, 5.9 Hz, 1H), 3.47 (td, J = 5.7, 5.2 Hz, 
1H), 3.41 (m, 1H), 3.37 (s, 3H), 3.17 (td, J = 8.6, 1.6 Hz, 1H), 3.12 (td, J = 8.7, 1.5 
Hz, 1H), 3.04 (m, 1H), 2.58 (d, J = 3.1 Hz, 1H), 2.48 (d, J = 5.8 Hz, 2H), 2.22 (m, 1H), 
1.93 (m, 4H), 1.59 (m, 2H), 1.36 (d, J = 6.9 Hz, 3H), 1.23 (m, 16H), 0.86 (t, J = 6.5 
Hz, 3H); 13C (125 MHz, CDCl3) δ 174.0, 159.2, 151.5, 138.5, 130.64, 130.62, 129.4, 
128.4, 127.8, 127.6, 113.8, 96.8, 81.0, 80.7, 80.2, 79.7, 79.3, 77.5, 77.2, 76.5, 73.6, 
71.0, 70.7, 55.7, 55.3, 35.8, 33.9, 32.25, 32.19, 31.9, 29.8, 29.67, 29.65, 29.5, 29.3, 
29.2, 29.1, 28.9, 28.6, 28.4, 26.8, 26.7, 26.3, 25.5, 25.2, 22.7, 19.1, 14.1; IR (film) 
3480 (br), 2925, 2854, 1756, 1669, 1613, 1586, 1514, 1455, 1352, 1318, 1302, 1250, 
1096, 1030 cm-1; [α]29D = -21.8o (c 0.19, CH2Cl2); MS (ESI) calculated for C54H84O10  
[M+Na]+: 915.6, found 915.5. 
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(-)-mucocin (1). A solution of alcohol 117 (2.7 mg, 3.0 µmol) in dry dimethyl sulfide 
(0.3 mL) was cooled to -10 oC and BF3·OEt2 (40 µL, 300 µmol) was added. The 
reaction was stirred for 1 h at -10 oC and allowed to slowly warm to room 
temperature over 1 h. Saturated NH4Cl and EtOAc were then added to dilute the 
reaction mixture. The organic layer was separated and the aqueous layer was 
further extracted three times with EtOAc. The combined organic layers were dried 
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over Na2SO4 and concentrated under reduced pressure. Purification by flash 
chromatography (50-75-100% EtOAc/hexanes) afforded 1.6 mg (85%) of 1 as a light 
yellow oil: 1H (500 MHz, CDCl3) δ 7.16 (s, 1H), 5.04 (qd, J = 6.6, 1.0 Hz, 1H), 3.89-
3.80 (m, 2H), 3.78 (dt, J = 7.1, 7.1 Hz, 1H), 3.46 (m, 1H), 3.41 (t, J = 7.3 Hz, 1H), 
3.25 (td, J = 9.0, 5.0 Hz, 1H), 3.13 (t, J = 7.4 Hz, 1H), 3.03 (td, J = 8.7, 1.5 Hz, 1H), 
2.51 (d, J = 15.4 Hz, 1H), 2.38 (dd, J = 15.4, 8.2 Hz, 1H), 2.10 (m, 1H), 1.97 (m, 2H), 
1.81 (m, 1H), 1.75-1.17 (m, 44H), 1.41 (d, J = 6.6 Hz, 3H), 0.86 (t, J = 6.6 Hz, 3H); 
13C (125 MHz, CDCl3) δ 174.6, 151.8, 131.2, 82.0, 81.9, 80.2, 79.3, 78.0, 73.8, 73.5, 
70.6, 70.0, 37.4, 35.6, 33.4, 32.6, 32.4, 32.0, 31.9, 29.7, 29.6, 29.54, 29.45, 29.4, 
29.3, 28.8, 28.7, 28.3, 26.9, 26.2, 25.52, 25.47, 22.7, 19.1, 14.1; IR (film) 3421 (br), 
2925, 2854, 1742, 1457, 1319, 1083 cm-1; [α]24D = -16.4o (c 0.11, CH2Cl2); MS (ESI) 
calculated for C37H66O8  [M+Na]+: 661.5, found 661.5. 
5.3 Experimental for Chapter 2 
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Alkylation adduct 208. Into a flask equipped with an addition funnel and a low-
temperature thermometer was added sodium bis(trimethylsilyl)amide (0.80 M in 
toluene/THF, 62.6 mL, 50.07 mmol, 1.5 eq) and 250 mL of THF. The solution was 
cooled to –78 oC and a solution of glycolate 205 (10.26 g, 33.38 mmol, 1.0 eq) in 
THF (50 mL) was added slowly via addition funnel to keep the internal temperature 
below –65 oC. After stirring for 30 minutes at –78 oC, methallyl iodide (89.5 wt% in 
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pentane, 33.92 g, 166.91 mmol, 5.0 eq) was added to the reaction mixture dropwise 
via addition funnel. The solution was allowed to stir for 2 h at –78 oC, slowly warmed 
to -45 oC over 1 h and stirred for an additional 1 h at -45 oC. The reaction was 
subsequently quenched by the addition of half-saturated aqueous NH4Cl, followed 
by warming to room temperature. The layers were separated and the aqueous layer 
was extracted three times with EtOAc. The organic layers were combined, dried over 
Na2SO4, and concentrated under reduced pressure. Purification by flash column 
chromatography (12.5-17-25% EtOAc/hexanes) provided 9.51 g (79%) of the alkene 
as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.24 (d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.4 
Hz, 2H), 5.26 (dd, J = 8.4, 3.6 Hz, 1H), 4.80 (s, 2H), 4.44 (AB, JAB = 11.2 Hz, ∆νAB = 
27.2 Hz, 2H), 4.33 (m, 1H), 4.18 (m, 2H), 3.76 (s, 3H), 2.49 (dd, J = 13.8, 3.8 Hz, 
1H), 2.37 (dd, J = 13.6, 8.8 Hz, 1H), 2.25 (m, 1H), 1.75 (s, 3H), 0.86 (d, J = 7.2 Hz, 
3H), 0.80 (d, J = 6.8 Hz, 3H); 13C (100 MHz, CDCl3) δ 172.8, 159.2, 153.5, 141.0, 
129.9, 129.5, 113.6, 113.5, 75.4, 72.3, 63.8, 58.1, 55.1, 41.1, 28.3, 22.3, 17.7, 14.7; 
IR (film) 3076, 2965, 1779, 1711, 1613, 1514, 1389, 1248 cm-1; [α]23D = +83.1o (c 
4.32, CH2Cl2); MS (ESI) calculated for C20H27NO5 [M+Na]+: 342.2, found: 342.2. 
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Alcohol 208a. To a stirring solution of oxazolidinone 208 (15.78 g, 43.66 mmol, 1.0 
eq) in THF (200 mL) and water (65 mL) was added sodium borohydride (2.48 g, 
65.49 mmol, 1.5 eq) at 0 oC. After 10 min at 0 oC, the reaction mixture was allowed 
to stir for an additional 2 h at room temperature. Saturated solution of sodium 
potassium tartrate (150 mL) was then added, and the resulting mixture was stirred 
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vigorously at room temperature for 15 h. The organic layer was separated and the 
aqueous layer was further extracted three times with EtOAc. The combined organic 
layers were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (20-25% EtOAc/hexanes) gave 10.05 g (96%) 
of the desired alcohol 208a as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.25 (d, J = 
8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 4.80 (s, 1H), 4.76 (s, 1H), 4.52 (AB, JAB = 10.8 
Hz, ∆νAB = 53.6 Hz, 2H), 3.79 (s, 3H), 3.65 (m, 2H), 3.49 (m, 1H), 2.37 (dd, J = 13.8, 
5.4 Hz, 1H), 2.17 (dd, J = 13.8, 7.0 Hz, 1H), 1.93 (t, J = 3.1 Hz, 1H), 1.74 (s, 3H); 13C 
(100 MHz, CDCl3) δ 159.2, 142.0, 130.3, 129.3, 113.7, 113.0, 77.6, 71.1, 64.1, 55.1, 
39.3, 22.7; IR (film) 3409 (br), 3074, 2935, 1613, 1513, 1249, 1036 cm-1; [α]21D = -
25.4o (c 2.95, CH2Cl2); MS (ESI) calculated for C14H20O3 [M+Na]+: 259.1, found: 
259.1. 
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Aldehyde 204. A solution of oxalyl chloride (2.0 M in CH2Cl2, 20.26 mL, 40.52 mmol, 
1.2 eq) in CH2Cl2 (250 mL) was cooled to -78 oC and dimethyl sulfoxide (5.75 mL, 
81.05 mmol, 2.4 eq) was added dropwise via syringe. After stirring for 15 min at -78 
oC, a solution of alcohol 208a (7.98 g, 33.77 mmol, 1.0 eq) in CH2Cl2 (50 mL) was 
added slowly. The resulting solution was stirred for 15 min followed by the dropwise 
addition of triethylamine (29.41 mL, 168.85 mmol, 5.0 eq). After stirring for another 
15 min at -78 oC, the reaction mixture was warmed to 0 oC and stirred for an 
additional 1 h. Water was then added to quench the reaction and the organic layer 
was separated. The aqueous solution was further extracted three times with CH2Cl2. 
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The combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure. Purification by flash chromatography (12-15% EtOAc/hexanes) 
gave 7.51 g (95%) of the desired aldehyde 204 as a light yellow oil, which was used 
in the next reaction: 1H (400 MHz, CDCl3) δ 9.59 (d, J = 1.6 Hz, 1H), 7.25 (d, J = 8.0 
Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.83 (s, 1H), 4.78 (s, 1H), 4.53 (AB, JAB = 11.6 Hz, 
∆νAB = 29.6 Hz, 2H), 3.87 (m, 1H), 3.77 (s, 3H), 2.37 (d, J = 6.4 Hz, 2H), 1.70 (s, 3H); 
13C (100 MHz, CDCl3) δ 203.2, 159.4, 140.3, 129.7, 120.1, 113.9, 113.8, 81.4, 72.2, 
55.1, 38.3, 22.6. 
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Aldol adduct 203. A stirring solution of thiazolidinethione propionate 209 (3.92 g, 
14.77 mmol, 2.0 eq) in CH2Cl2 (35 mL) was cooled in an ice/water bath and TiCl4 
(1.70 mL, 15.51 mmol, 2.1 eq) was added slowly via syringe. The resultant dense 
orange precipitate was stirred for 15 min before (-)-sparteine (3.56 mL, 15.51 mmol, 
2.1 eq) was added dropwise, causing the suspension to become a homogeneous 
dark blue color solution. After stirring for 30 min at 0 oC, the enolate mixture was 
cooled to -78 oC and N-methyl-2-pyrrolidinone (3.56 mL, 15.51 mmol, 2.1 eq) was 
added slowly. The reaction mixture was stirred for 15 min at -78 oC, and the 
previously prepared aldehyde 208a (1.72 g, 7.36 mmol, 1.0 eq) was added, as a 
solution in CH2Cl2 (5 mL). After stirring an additional 2 h at -78 oC, the reaction 
mixture was allowed to slowly warm to -20 oC, and stored in a -20 oC fridge for 12 h. 
Half-saturated aqueous NH4Cl solution was added to quench the reaction and the 
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resulting mixture was stirred vigorously while warming up to room temperature. The 
layers were separated and the aqueous layer was further extracted three times with 
EtOAc. The organic layers were combined, dried over Na2SO4, and concentrated 
under reduced pressure. Purification by flash column chromatography (10-15% 
EtOAc/hexanes) provided 3.54 g (96%) of an inseparable 10:1 mixture of the desired 
aldol adduct 203 and another minor diastereomer as a bright yellow color, viscous oil: 
1H (400 MHz, CDCl3) δ 7.28 (m, 2H), 7.24 (m, 1H), 7. 21 (d, J = 8.4 Hz, 2H), 7.15 (m, 
2H), 6.79 (d, J = 8.8 Hz, 2H), 4.92 (m, 1H), 4.87 (s, 2H), 4.57 (dq, J = 7.2, 7.2 Hz, 
1H), 4.41 (AB, JAB = 10.4 Hz, ∆νAB = 51.6 Hz, 2H), 3.98 (m, 1H), 3.72 (s, 3H), 3.55 
(m, 1H), 3.15 (dd, J = 13.2, 3.6 Hz, 1H), 3.06 (dd, J = 11.4, 7.0 Hz, 1H), 2.95 (dd, J = 
13.0, 11.0 Hz, 1H), 2.67 (d, J = 11.6 Hz, 1H), 2.37 (dd, J = 13.2, 7.0 Hz, 1H), 2.31 
(dd,  J = 13.0, 7.2 Hz, 1H),  2.19 (d, J = 5.6 Hz, 1H), 1.78 (s, 3H), 1.33 (d, J = 6.8 Hz, 
3H); 13C (100 MHz, CDCl3) δ 201.0, 176.4, 159.3, 142.2, 136.5, 129.9, 129.6, 129.4, 
128.8, 127.0, 113.8, 113.5, 78.1, 73.7, 71.9, 69.2, 55.2, 41.2, 38.6, 36.4, 32.0, 22.7, 
13.8; IR (film) 3479 (br), 3028, 2935, 1693, 1513, 1455, 1343, 1252, 1166, 1058 cm-
1; [α]24D = -181.5o (c 2.75, CH2Cl2); MS (ESI) calculated for C27H33NO4S2 [M+Na]+: 
522.2, found: 522.3. 
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Ester 200. To a stirring solution of aldol adduct 203 (3.09 g, 6.19 mmol, 1.0 eq) in 
CH2Cl2 (2.5 mL), was added alcohol 202 (1.43 g, 6.19 mmol, 1.0 eq), imidazole 
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(631.9 mg, 9.28 mmol, 1.5 eq) and 4-dimethylaminopyridine (151.2 mg, 1.24 mmol, 
0.2 eq) sequentially. The resulting mixture was allowed to stir at room temperature 
for 72 hours, followed by concentration under reduced pressure. Purification by 
column chromatography (20% EtOAc/hexanes) provided 2.58 g (80%) of the desired 
β-hydroxy ester 200 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.23 (d, J = 8.4 Hz, 
2H), 6.84 (d, J = 8.4 Hz, 2H), 5.41 (t, J = 6.8 Hz, 1H), 4.83 (s, 1H), 4.81 (s, 1H), 4.45 
(AB, JAB = 10.4 Hz, ∆νAB = 75.2 Hz, 2H), 4.36 (AB, JAB = 12.0 Hz, ∆νAB = 35.6 Hz, 
2H), 3.78 (s, 3H), 3.68 (ddd, J = 8.4, 8.4, 2.2 Hz, 1H), 3.58 (t, J = 7.0 Hz, 2H), 3.53 
(ddd, J = 7.8, 7.8, 2.4 Hz, 1H), 2.72 (dq, J = 7.6, 7.2 Hz, 1H), 2.37 (m, 2H), 2.31 (d, J 
= 9.2 Hz, 1H), 2.24 (dt, J = 7.2, 6.8 Hz, 2H), 1.73 (s, 3H), 1.61 (s, 3H), 1.23 (d, J = 
7.2 Hz, 3H), 0.86 (s, 9H), 0.02 (s, 6H); 13C (100 MHz, CDCl3) δ 174.7, 159.3, 141.8, 
131.6, 130.1, 129.6, 125.9, 113.7, 113.6, 76.9, 73.4, 71.9, 70.0, 62.4, 55.2, 43.1, 
38.9, 31.5, 25.9, 22.7, 18.3, 14.1, 13.6, -5.3; IR (film) 3500 (br), 3075, 2931, 2857, 
1731, 1613, 1515, 1463, 1250, 1173, 1096, 1038 cm-1; [α]25D = +28.3o (c 4.80, 
CH2Cl2); MS (ESI) calculated for C29H48O6Si [M+Na]+: 543.3, found: 543.4. 
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Methyl ester 218. A stirring solution of hexamethyldisilazane (11.22 mL, 53.16 mmol, 
3.2 eq) in THF (125 mL) was cooled to -78 oC and n-BuLi (2.12 M in hexanes, 23.51 
mL, 49.84 mmol, 3.0 eq) was added dropwise via syringe. The resulting solution was 
stirred for 20 min at -78 oC, followed by 30 min at 0 oC, and cooled to -78 oC 
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afterward. Into this freshly prepared lithium hexamethyldisilazide solution, a solution 
of ester 200 (8.65 g, 16.60 mmol, 1.0 eq) in THF (25 mL) was added dropwise via 
syringe and stirred at -78 oC for 2 h. The solution was then allowed to slowly warm to 
room temperature over 2 h, stirred for an additional 6 h, and heated to reflux for 
another 12 h. After cooling in an ice/water bath, the reaction was quenched by slow 
addition of 10% HCl solution until the pH value was 2. The layers were separated 
and the aqueous layer was further extracted three times with EtOAc. The organic 
layers were combined, washed with saturated NaCl solution, dried over Na2SO4 and 
concentrated under reduced pressure. The crude acid was dissolved in ether (120 
mL) and cooled to 0 oC, into which freshly prepared diazomethane in Et2O was 
added slowly via pipette and gas was immediately generated. The reaction mixture 
was stirred for 10 min at 0 oC, followed by 30 min at room temperature. Excess 
diazomethane was subsequently quenched by adding acetic acid dropwise into the 
reaction mixture at 0 oC until evolution of nitrogen ceased. The reaction mixture was 
concentrated under vacuum and loaded directly to column. Purification by column 
chromatography (8-10% EtOAc/hexanes) provided 5.78 g (65%) of the desired 
methyl ester 200 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.20 (d, J = 8.8 Hz, 2H), 
6.82 (d, J = 8.8 Hz, 2H), 4.82 (m, 3H), 4.63 (s, 1H), 4.33 (AB, JAB = 10.4 Hz, ∆νAB = 
134.0 Hz, 2H), 3.77 (s, 3H), 3.62 (dd, J = 9.4, 4.2 Hz, 1H), 3.51 (m, 4H), 3.18 (s, 3H), 
3.00 (dd, J = 12.0, 2.4 Hz, 1H), 2.54 (dd, J = 13.4, 9.4 Hz, 1H), 2.41 (dd, J = 13.4, 
3.8 Hz, 1H), 1.74 (s, 3H), 1.69 (m, 1H), 1.65 (s, 3H), 1.58 (s, 3H), 1.56 (m, 1H), 1.08 
(s, 3H), 0.86 (s, 9H), 0.012 (s, 3H), 0.007 (s, 3H); 13C (100 MHz, CDCl3) δ 175.8, 
159.1, 144.1, 141.9, 129.8, 115.8, 113.6, 113.4, 75.3, 74.3, 71.0, 62.1, 55.1, 51.3, 
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50.8, 45.1, 38.1, 30.0, 25.9, 22.9, 21.4, 18.2, 15.6, -5.2; IR (film) 3561, 3447, 3076, 
2952, 2857, 1734, 1707, 1613, 1515, 1463, 1251, 1100 cm-1; [α]21D = +0.2o (c 1.94, 
CH2Cl2); MS (ESI) calculated for C30H50O6Si [M+Na]+: 557.3, found: 557.4. 
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TBS ether 253. A stirring solution of alcohol 218 (6.87 g, 12.85 mmol, 1.0 eq) and 
2,6-lutidine (2.99 mL, 25.70 mmol, 2.0 eq) in CH2Cl2 (100 mL) was cooled to -78 oC, 
and tert-butyldimethylsilyl trifluoromethanesulfonate (4.43 mL, 19.28 mmol, 1.5 eq) 
was added dropwise via syringe. The resultant mixture was stirred at -78 oC for 30 
min, and allowed to warm to room temperature. After stirring an additional 2 h at 
room temperature, half-saturated NH4Cl was added to quench the reaction. The 
layers were separated and the aqueous layer was further extracted three times with 
CH2Cl2. The combined organic layers was dried over Na2SO4 and concentrated 
under reduced pressure. Purification by flash chromatography (5% EtOAc/hexanes) 
yielded 8.24 g (99%) of the TES ether as a light yellow oil: 1H (400 MHz, CDCl3) δ 
7.22 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 4.81 (s, 1H), 4.78 (s, 2H), 4.70 (s, 
1H), 4.45 (AB, JAB = 10.8 Hz, ∆νAB = 37.6 Hz, 2H), 4.04 (d, J = 1.6 Hz, 1H), 3.77 (s, 
3H), 3.74 (m, 1H), 3.48 (m, 1H), 3.46 (s, 3H), 3.38 (m, 1H), 2.67 (dd, J = 10.8, 2.2 
Hz, 1H), 2.41 (dd, J = 14.0, 8.8 Hz, 1H), 2.22 (dd, J = 14.0, 3.6 Hz, 1H), 1.83 (m, 1H), 
1.74 (s, 3H), 1.66 (s, 3H), 1.53 (m, 1H), 1.29 (s, 3H), 0.90 (s, 9H), 0.86 (s, 9H), 0.09 
(s, 3H), 0.04 (s, 3H), 0.00 (s, 6H); 13C (100 MHz, CDCl3) δ 175.6, 158.8, 145.1, 
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143.1, 131.2, 128.8, 115.9, 113.5, 112.8, 77.5, 76.6, 71.1, 61.8, 55.2, 54.9, 50.9, 
46.6, 40.1, 31.0, 26.1, 26.0, 23.0, 21.1, 18.7, 18.3, 15.9, -3.3, -4.3, -5.3; IR (film) 
3074, 2952, 2857, 1727, 1614, 1514, 1464, 1250, 1099 cm-1; [α]22D = +7.0o (c 2.91, 
CH2Cl2); MS (ESI) calculated for C36H64O6Si2 [M+H]+: 649.4, found: 649.5. 
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Alcohol 253a. A stirring solution of methyl ester 253 (7.88 g, 12.15 mmol, 1.0 eq) in 
CH2Cl2 (100 mL) was cooled to -78 oC, into which i-Bu2AlH (1.0 M in hexanes, 36.45 
mL, 36.45 mmol, 3.0 eq) was added dropwise via addition funnel over 1 h. After 
stirring for an additional 2 h at -78 oC, MeOH was added to quench the reaction and 
the mixture was allowed to warm to room temperature. A saturated solution of 
sodium potassium tartrate (50 mL) was added and the resulting bi-phase mixture 
was stirred vigorously for 6 h. The organic layer was separated and the aqueous 
layer was extracted three more times with CH2Cl2. The combined organic extracts 
were dried over Na2SO4 and concentrated under reduced pressure. Purification by 
flash chromatography (12% EtOAc/hexanes) yielded 6.90 g (92%) of the alcohol as 
a light yellow oil: 1H (400 MHz, CDCl3) δ 7.25 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.8 Hz, 
2H), 4.89 (s, 1H), 4.86 (s, 1H), 4.80 (s, 1H), 4.77 (s, 1H), 4.49 (AB, JAB = 10.4 Hz, 
∆νAB = 70.8 Hz, 2H), 3.81 (m, 1H), 3.78 (m, 1H), 3.77 (s, 3H), 3.67 (m, 1H), 3.48 (m, 
3H), 3.25 (m, 1H), 2.57 (dd, J = 11.4, 3.4 Hz, 1H), 2.48 (dd, J = 14.0, 4.8 Hz, 1H), 
2.40 (dd, J = 14.0, 6.0 Hz, 1H), 1.77 (s, 6H), 1.61 (m, 2H), 0.88 (s, 9H), 0.86 (s, 9H), 
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0.79 (s, 3H), 0.14 (s, 3H), 0.12 (s, 3H), 0.01 (s, 6H); 13C (100 MHz, CDCl3) δ 159.2, 
142.5, 129.9, 129.5, 113.7, 113.6, 78.1, 75.6, 71.0, 67.2, 62.5, 55.2, 45.0, 40.4, 26.2, 
26.1, 22.8, 18.8, 18.4, 15.7, -3.3, -3.5, -5.2; IR (film) 3462 (br), 3076, 2963, 2857, 
1614, 1515, 1464, 1251, 1076 cm-1; [α]22D = -3.0o (c 2.75, CH2Cl2); MS (ESI) 
calculated for C35H64O5Si2 [M+H]+: 643.4, found: 643.5. 
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Aldehyde 254. A stirring solution of oxalyl chloride (2.0 M in CH2Cl2, 6.53 mL, 13.06 
mmol, 1.2 eq) in CH2Cl2 (90 mL) was cooled to -78 oC and dimethyl sulfoxide (1.85 
mL, 26.13 mmol, 2.4 eq) was added dropwise via syringe. After stirring for 15 min at 
-78 oC, alcohol 253a (6.76 g, 10.89 mmol, 1.0 eq) in CH2Cl2 (10 mL) was added 
slowly. The resulting solution was stirred for 15 min followed by dropwise addition of 
triethylamine (7.59 mL, 54.43 mmol, 5.0 eq). After stirring for another 15 min at -78 
oC, the reaction mixture was warmed to 0 oC and stirred for an additional 1 h. Water 
was then added to quench the reaction and the organic layer was separated. The 
aqueous solution was further extracted three times with CH2Cl2. The combined 
organic layers were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography (8% EtOAc/hexanes) gave 6.58 g (98%) of the 
desired aldehyde 254 as a light yellow oil: 1H (400 MHz, CDCl3) δ 9.77 (s, 1H), 7.19 
(d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.4 Hz, 2H), 4.78 (m, 3H), 4.74 (s, 1H), 4.34 (AB, JAB 
= 11.0 Hz, ∆νAB = 35.0 Hz, 2H), 3.96 (d, J = 2.0 Hz, 1H), 3.77 (s, 3H), 3.58 (m, 1H), 
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3.49 (m, 2H), 3.08 (dd, J = 11.6, 4.0 Hz, 1H), 2.24 (dd, J = 14.0, 8.4 Hz, 1H), 2.17 
(dd, J = 14.2, 4.2 Hz, 1H), 1.70 (s, 3H), 1.64 (m, 2H), 1.56 (s, 3H), 1.05 (s, 3H), 0.92 
(s, 9H), 0.88 (s, 9H), 0.16 (s, 3H), 0.08 (s, 3H), 0.03 (s, 6H); 13C (100 MHz, CDCl3) δ 
205.5, 159.0, 143.4, 142.7, 130.4, 129.1, 115.9, 113.5, 112.8, 78.3, 76.7, 71.5, 61.7, 
55.0, 54.4, 43.8, 39.3, 29.8, 26.0, 25.9, 22.8, 20.8, 18.4, 18.3, 13.1, -3.4, -3.9, -5.4. 
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Triene 282. A stirring solution of aldehyde 254 (1.08 g, 1.86 mmol, 1.0 eq) in Et2O 
(20 mL) was cooled in an ice/water bath and allyl magnesium bromide (1M solution 
in Et2O, 2.80 mL, 2.80 mmol, 1.5 eq) was added dropwise via an addition funnel. 
After stirring for an additional 2 h at 0 oC, the reaction was quenched by the addition 
of 10% HCl solution until the pH value became 2. The organic layer was separated 
and the aqueous layer was extracted three times with Et2O. The combined organic 
layers were washed with saturated NaHCO3 solution followed by saturated NaCl 
solution, dried over MgSO4 and concentration under reduced pressure. Purification 
by flash chromatography (8% EtOAc/hexanes) gave 467.0 mg (41%) of the desired 
triene 282 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.23 (d, J = 8.4 Hz, 2H), 6.81 
(d, J = 8.0 Hz, 2H), 5.80 (m, 1H), 4.87 (m, 6H), 4.52 (AB, JAB = 10.8 Hz, ∆νAB = 17.6 
Hz, 2H), 3.91 (s, 1H), 3.79 (m, 2H), 3.77 (s, 3H), 3.46 (m, 2H), 3.36 (m, 1H), 2.79 (d, 
J = 7.2 Hz, 1H), 2.52 (m, 2H), 2.30 (dd, J = 13.6, 6.0 Hz, 1H), 2.22 (m, 1H), 2.06 (m, 
1H), 2.02 (s, 6H), 1.56 (m, 1H), 0.91 (s, 9H), 0.89 (s, 3H), 0.84 (s, 9H), 0.12 (s, 3H), 
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0.10 (s, 3H), -0.03 (s, 6H); 13C (100 MHz, CDCl3) δ 159.2, 142.9, 137.8, 129.8, 129.5, 
115.5, 114.0, 113.7, 78.1, 75.5, 72.2, 62.4, 55.2,  49.3, 40.9, 36.1, 26.2, 26.0, 22.6, 
18.6, 18.3, -3.2, -3.9, -5.4; IR (film) 3437 (br), 3075, 2954, 2929, 2857, 1515, 1471, 
1252, 1077 cm-1; [α]20D = +0.8o (c 3.29, CH2Cl2); MS (ESI) calculated for C38H68O5Si2 
[M+H]+: 661.5, found: 661.5. 
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Alcohol 287. A stirring solution of triene 282 (3.10 g, 4.69 mmol, 1.0 eq) in toluene 
(500 mL) was degassed by heating to reflux for 30 min. Grubbs second generation 
catalyst [Cl2(PCy3)(IMes)Ru=CHPh] (100.0 mg, 0.12 mmol, 0.025 eq) was added 
and the solution was stirred at reflux under an argon atmosphere. After 10 min, TLC 
indicated a complete consumption of starting material and the reaction mixture was 
allowed to cool to room temperature. After stirring in the air for an additional 2 h, the 
reaction mixture was directly loaded to a silica gel column, and purification by flash 
chromatography (2-10-15% EtOAc/hexanes) gave 2.80 g (96%) of the desired 
alcohol 287 as a light brown oil: 1H (400 MHz, CDCl3) δ 7.24 (d, J = 8.0 Hz, 2H), 
6.81 (d, J = 8.0 Hz, 2H), 5.28 (s, 1H), 4.89 (s, 1H), 4.84 (s, 1H), 4.49 (s, 1H), 4.48 
(AB, JAB = 10.4 Hz, ∆νAB = 65.2 Hz, 2H), 3.89 (dd, J = 10.0, 5.4 Hz, 1H), 3.79 (s, 1H), 
3.74 (s, 3H), 3.69 (m, 2H), 3.50 (m, 1H), 2.48 (d, J = 12.8 Hz, 1H), 2.37 (dd, J = 13.6, 
9.2 Hz, 1H), 2.14 (m, 1H), 1.98 (m, 1H), 1.92 (m, 1H), 1.78 (s, 3H), 1.66 (m, 1H), 
1.64 (s, 3H), 1.49 (m, 1H), 0.88 (s, 9H), 0.87 (s, 9H), 0.76 (s, 3H), 0.12 (s, 3H), 0.09 
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(s, 3H), 0.03 (s, 6H); 13C (100 MHz, CDCl3) δ 159.2, 142.2, 135.1, 129.4, 129.3, 
120.4, 113.8, 113.6, 76.9, 74.4, 70.4, 68.0, 64.2, 55.1, 46.5, 42.9, 40.0, 32.5, 29.8, 
26.0, 25.9, 22.8, 22.3, 18.8, 18.2, 11.8, -3.3, -3.5, -5.27, -5.31; IR (film) 3438 (br), 
3076, 2954, 2929, 2856, 1614, 1515, 1252, 1089 cm-1; [α]21D = -1.7o (c 2.89, CH2Cl2); 
MS (ESI) calculated for C36H64O5Si2 [M+H]+: 633.4, found: 633.5. 
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Triol 288. A stirring solution of bis-TBS ether 287 (482.0 mg, 0.76 mmol, 1.0 eq) in 
THF (10 mL) was cooled in an ice/water bath, into which was added tetrabutyl-
ammonium fluoride (1.0 M in THF, 2.28 mL, 2.28 mmol, 3.0 eq) dropwise via syringe. 
After stirring for 10 min at 0 oC, the reaction mixture was allowed to warm to room 
temperature and stirred for an additional 5 h. Half-saturated NH4Cl solution was 
subsequently added to quench the reaction and the aqueous layer was further 
extracted three times with 50% EtOAc/hexanes. The combined organic solutions 
were dried over Na2SO4 and concentrated under reduced pressure. Purification by 
flash chromatography (50-75% EtOAc/hexanes) gave 278.1 mg (90%) of the desired 
triol 288 as a light yellow oil: 1H (400 MHz, CDCl3) δ 7.23 (d, J = 8.8 Hz, 2H), 6.82 (d, 
J = 8.4 Hz, 2H), 5.22 (s, 1H), 4.87 (s, 1H), 4.81 (s, 1H), 4.50 (AB, JAB = 10.8 Hz, 
∆νAB = 102.0 Hz, 2H), 4.26 (br, 1H), 3.83 (dd, J = 9.2, 5.6 Hz, 1H), 3.74 (m, 1H), 
3.73 (s, 3H), 3.64 (m, 2H), 3.48 (m, 1H), 3.07 (br, 2H), 2.50 (dd, J = 13.2, 2.8 Hz, 
1H), 2.44 (dd, J = 12.8, 11.0 Hz, 1H), 2.18 (m, 2H), 1.93 (m, 1H), 1.73 (s, 3H), 1.66 
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(m, 1H), 1.59 (s, 3H), 1.43 (m, 1H), 0.70 (s, 3H); 13C (100 MHz, CDCl3) δ 159.5, 
141.8, 135.4, 130.0, 128.3, 119.2, 114.4, 113.8, 74.0, 73.5, 70.1, 67.9, 63.3, 55.1, 
45.1, 41.4, 39.0, 30.6, 30.3, 22.6, 21.9, 10.8; IR (film) 3287 (br), 3076, 2913, 1613, 
1515, 1442, 1251, 1046 cm-1; [α]20D = -28.7o (c 2.24, CH2Cl2); MS (ESI) calculated 
for C24H36O5 [M+Na]+: 427.3, found: 427.3. 
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Alcohol 289. Alcohol 289 (275.0 mg, 0.68 mmol, 1.0 eq) was dissolved in 5 mL 2,2-
dimethoxypropane and 1 mL DMF, followed by addition of p-toluenesulfonic acid 
(11.7 mg, 0.068 mmol, 0.1 eq). The resulting reaction mixture was stirred at room 
temperature for 6 h, before saturated NaHCO3 solution was added to quench the 
reaction. The layers were separated and the aqueous layer was extracted three 
times with EtOAc. The combined organic layers were washed with 10% HCl solution 
with vigorous shaking, followed by drying over Na2SO4 and concentration under 
reduced pressure. Purification by flash chromatography (25-30% EtOAc/hexanes) 
gave 286.5 mg (89%) of the desired alcohol 289 as a light yellow oil: 1H (500 MHz, 
CDCl3) δ 7.28 (d, J = 8.5 Hz, 2H), 6.81 (d, J = 8.5 Hz, 2H), 5.25 (d, J = 4.5 Hz, 1H), 
4.82 (s, 1H), 4.79 (s, 1H), 4.56 (AB, JAB = 11.0 Hz, ∆νAB = 140.5 Hz, 2H), 4.06 (t, J = 
6.5 Hz, 1H), 3.74 (s, 3H), 3.70 (m, 1H), 3.58 (dd, J = 10.0, 5.0 Hz, 1H), 3.47 (dt, J = 
9.0, 8.5 Hz, 1H), 3.38 (s, 1H), 2.51 (d, J = 6.5 Hz, 2H), 2.31 (br, 1H), 1.98 (m, 2H), 
1.87 (m, 1H), 1.78 (s, 3H), 1.59 (s, 3H), 1.58 (m, 1H), 1.46 (s, 3H), 1.36 (s, 3H), 1.32 
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(m, 1H), 1.11 (s, 3H); 13C (100 MHz, CDCl3) δ 158.9, 142.4, 135.6, 130.9, 129.4, 
119.4, 113.5, 113.3, 99.1, 79.2, 75.2, 74.8, 69.0, 63.3, 55.1, 40.7, 40.6, 37.8, 32.5, 
30.0, 27.3, 22.7, 22.5, 19.5, 8.1; IR (film) 3444 (br), 3075, 2989, 2939, 2860, 1613, 
1515, 1380, 1250, 1043 cm-1; [α]20D = -24.4o (c 1.89, CH2Cl2); MS (ESI) calculated 
for C27H40O5 [M+Na]+: 447.3, found: 467.4. 
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Aldehyde 290. A stirring solution of oxalyl chloride (2.0 M in CH2Cl2, 1.8 mL, 3.60 
mmol, 1.2 eq) in CH2Cl2 (25 mL) was cooled to -78 oC and dimethyl sulfoxide (0.52 
mL, 7.20 mmol, 2.4 eq) was added dropwise via syringe. After stirring for 15 min at -
78 oC, alcohol 289 (1.31 g, 2.94 mmol, 1.0 eq) in CH2Cl2 (5 mL) was added slowly. 
The resulting solution was stirred for 15 min followed by dropwise addition of 
triethylamine (2.67 mL, 15.0 mmol, 5.0 eq). After stirring for another 15 min at -78 oC, 
the reaction mixture was allowed to warm to 0 oC in an ice/water bath and stirred for 
an additional 1 h. Half-saturated NH4Cl solution was then added to quench the 
reaction and the organic layer was separated. The aqueous solution was further 
extracted three times with CH2Cl2, and the combined organic layers were dried over 
Na2SO4 followed by concentration under reduced pressure. Purification by flash 
chromatography (10% EtOAc/hexanes) gave 1.30 g (99%) of the desired aldehyde 
290 as a light yellow oil: 1H (400 MHz, CDCl3) δ 9.60 (d, J = 1.2 Hz, 1H), 7.24 (d, J = 
8.4 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.26 (d, J = 4.8 Hz, 1H), 4.84 (s, 1H), 4.78 (s, 
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1H), 4.49 (AB, JAB = 11.8 Hz, ∆νAB = 168.0 Hz, 2H), 3.78 (s, 3H), 3.70 (dd, J = 7.2, 
6.4 Hz, 1H), 3.64 (dd, J = 10.0, 5.6 Hz, 1H), 3.44 (s, 1H), 2.51 (m, 4H), 2.24 (dd, J = 
19.2, 9.2 Hz, 1H), 1.93 (m, 2H), 1.76 (s, 3H), 1.48 (s, 3H), 1.38 (s, 3H), 1.36 (s, 3H), 
1.11 (s, 3H); 13C (100 MHz, CDCl3) δ 201.0, 158.9, 141.9, 134.1, 130.1, 129.6, 119.3, 
113.5, 113.3, 99.2, 78.8, 74.4, 73.3, 67.8, 54.8, 44.6, 39.3, 36.9. 36.8, 29.7, 26.9, 
21.9, 21.9, 21.7, 19.3, 8.2. 
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Homoallylic alcohol 291b. To a flask fitted with a dry ice condenser was added 
magnesium turnings (214.4 mg, 8.82 mmol, 3.0 eq), Et2O (25 mL) and a small 
crystal of iodine. Allyl bromide (0.76 mL, 8.82 mmol, 3.0 eq) was added via syringe 
at a rate to maintain a gentle reflux of the reaction mixture. After stirring an additional 
30 min at room temperature, the reaction mixture was cooled in an ice/water bath. 
Freshly prepared aldehyde 290 (1.30 g, 2.94 mmol, 1.0 eq) in Et2O (5 mL) was 
added dropwise and the reaction mixture was allowed to stir another 1 h at 0 oC. 
10% HCl solution was added at 0 oC to quench the reaction until the pH value 
became 2. The organic layer was separated and the aqueous layer was extracted 
three times with Et2O. The combined organic layers were washed with saturated 
NaHCO3 and saturated NaCl sequentially, followed by drying over MgSO4 and 
concentration under reduced pressure. Purification by flash chromatography (10% 
EtOAc/ hexanes) gave 690.1 mg (49%) of the desired alcohol 291b as a light yellow 
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oil: 1H (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 5.81 (m, 
1H), 5.32 (s, 1H), 5.15 (s, 1H), 5.22 (d, J = 5.2 Hz, 1H), 4.85 (s, 1H), 4.81 (s, 1H), 
4.57 (AB, JAB = 11.0 Hz, ∆νAB = 106.2 Hz, 2H), 4.03 (dd, J = 6.4, 6.4 Hz, 1H), 3.82 
(m, 1H), 3.76 (s, 3H), 3.66 (dd, J = 10.0, 5.2 Hz, 1H), 3.45 (s, 1H), 2.60 (dd, J = 14.0, 
5.2 Hz, 1H), 2.45 (dd, J = 14.4, 7.6 Hz, 1H), 2.41 (dd, J = 12.4, 4.8 Hz, 1H), 2.07-
1.92 (band, 5H), 1.80 (s, 3H), 1.73 (s, 3H), 1.71 (m, 1H), 1.51 (m, 1H), 1.47 (s, 3H), 
1.39 (s, 3H), 1.14 (s, 3H); 13C (100 MHz, CDCl3) δ 159.8, 142.3, 136.0, 134.8, 131.1, 
128.9, 119.9, 118.3, 113.5, 113,4. 98.7, 79.8, 75.3, 74.6, 71.1, 68.2, 55.1, 42.4, 42.0, 
41.4, 37.9, 36.3, 30.0, 27.7, 23.8, 22.8, 19.3, 7.9; IR (film) 3460 (br), 3075, 2937, 
1515, 1380, 1250 cm-1; [α]20D = -17.7o (c 2.73, CH2Cl2); MS (ESI) calculated for 
C30H44O5 [M+Na]+: 507.3, found: 507.4. 
 
Me
OPMB
O
Me
H
O
OAc
Me
 
Acetate 292b. Freshly distilled pyridine (0.35 mL, 4.34 mmol, 3.0 eq) was added to a 
stirring solution of alcohol 291b (701.0 mg, 1.44 mmol, 1.0 eq) in CH2Cl2 (15 mL). 
The reaction mixture was cooled in an ice/water bath and acetic anhydride (0.27 mL, 
2.89 mmol, 2.0 eq) was added dropwise via syringe, followed by the addition of 4-
dimethylaminopyridine (17.1 mg, 0.14 mmol, 0.1 eq). After 10 min, the reaction 
mixture was allowed to warm to room temperature and stirred an additional 5 h. Half-
saturated NH4Cl solution was added to quench the reaction and the layers were 
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separated subsequently. The aqueous layer was further extracted three times with 
CH2Cl2 and the combined organic solution was dried over Na2SO4, and concentrated 
under reduced pressure. Purification by flash chromatography (10% EtOAc/hexanes) 
gave 720.4 mg (95%) of the desired acetate 292b as a light yellow oil: 1H (400 MHz, 
CDCl3) δ 7.26 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 5.71 (dddd, J = 10.4, 7.6, 
2.8, 2.8 Hz, 1H), 5.31 (d, J = 4.0 Hz, 1H), 5.22 (m, 1H), 5.04 (d, J = 10.8 Hz, 1H), 
5.00 (d, J = 2.8 Hz, 1H), 4.86 (s, 1H), 4.83 (s, 1H), 4.58 (AB, JAB = 11.0 Hz, ∆νAB = 
114.6 Hz, 2H), 4.06 (dd, J = 6.4, 6.4 Hz, 1H), 3.76 (s, 3H), 3.63 (dd, J = 10.0, 5.6 Hz, 
1H), 3.45 (s, 1H), 2.63 (dd, J = 14.0, 5.2 Hz, 1H), 2.47 (dd, J = 14.4, 7.6 Hz, 1H), 
2.43 (dd, J = 9.2, 3.6 Hz, 1H), 2.24 (m, 1H), 2.11 (dd, J = 15.2, 10.0 Hz, 1H), 1.98 (s, 
3H), 1.97 (m, 1H), 1.91 (m, 1H), 1.85 (m, 1H), 1.84 (s, 3H), 1.72 (s, 3H), 1.65 (dddd, 
J = 16.0, 8.0, 8.0, 8.0 Hz, 1H), 1.46 (s, 3H), 1.37 (s, 3H), 1.13 (s, 3H); 13C (100 MHz, 
CDCl3) δ 170.5, 158.8, 142.2, 135.4, 133.6, 131.1, 128.7, 120.1, 117.6, 113.5, 113.4, 
98.8, 79.7, 75.6, 74.5, 73.8, 68.2, 55.1, 41.60, 41.56, 39.2, 37.9, 33.3, 30.0, 27.6, 
23.5, 22.7, 21.1, 19.3, 7.9; IR (film) 3077, 2938, 2857, 1735, 1644, 1613, 1514, 1442, 
1380, 1247, 1035 cm-1; [α]20D = -16.7o (c 1.61, CH2Cl2); MS (ESI) calculated for 
C32H46O6 [M+Na]+: 549.3, found: 549.3. 
Me
MeMe
H
O OPMB
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Bicycle 293. A solution of triene 292b (47.1 mg, 0.089 mmol, 1.0 eq) in toluene (45 
mL) was degassed by heating to reflux for 30 min. Grubbs second generation 
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catalyst [Cl2(PCy3)(IMes)Ru=CHPh] (3.8 mg, 0.0045 mmol, 0.05 eq) was added and 
the solution was stirred at reflux under an argon atmosphere. After 10 min, TLC 
indicated that all the triene 292b was consumed and the reaction mixture was 
allowed to cool to room temperature and stirred in the air for an additional 2 h. The 
reaction mixture was then directly loaded to a silica gel column, and purification by 
flash chromatography (2-10-15% EtOAc/hexanes) gave 39.9 mg (90%) of the 
desired bicycle 293 as a light brown oil: 1H (400 MHz, CDCl3) δ 7.29 (d, J = 8.4 Hz, 
2H), 6.85 (d, J = 8.4 Hz, 2H), 5.38 (m, 1H), 5.34 (s, 1H), 5.19 (dd, J = 7.6, 7.6 Hz, 
1H), 4.56 (AB, JAB = 9.4 Hz, ∆νAB = 154.2 Hz, 2H), 3.77 (s, 3H), 3.70 (m, 2H), 3.64 (d, 
J = 6.4 Hz, 1H), 2.35-2.26 (m, 4H), 2.05-1.96 (m, 3H), 2.02 (s, 3H), 1.86 (s, 3H), 
1.81 (m, 1H), 1.80 (s, 3H), 1.46 (s, 3H), 1.45 (s, 3H), 1.23 (m, 1H), 0.98 (s, 3H); 13C 
(100 MHz, CDCl3) δ 170.2, 159.2, 135.9, 131.1, 129.8, 120.4, 113.7, 98.5, 74.1, 73.5, 
73.0, 55.2, 39.9, 30.0, 27.9, 21.2, 19.1, 7.4; IR (film) 3076, 2988, 2936, 2859, 1733, 
1613, 1514, 1379, 1249, 1205, 1171, 1029 cm-1; [α]22D = +13.3o (c 2.32, CH2Cl2); MS 
(ESI) calculated for C30H42O6 [M+Na]+: 521.30, found: 521.29. 
 
Me
MeMe
H
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Alcohol 302. A stirring solution of acetate 293 (65 mg, 0.14 mmol, 1.0 eq) in CH2Cl2 
(1.5 mL) was cooled to -78 oC, into which i-Bu2AlH (1.0 M in hexanes, 0.42 mL, 0.42 
mmol, 3.0 eq) was added dropwise via syringe. After stirring for an additional 30 min 
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at -78 oC, MeOH was added to quench the reaction and the mixture was allowed to 
warm to room temperature. A saturated solution of sodium potassium tartrate (2 mL) 
was added and the resulting bi-phase mixture was stirred vigorously for 2 h. The 
organic layer was separated and the aqueous layer was extracted three more times 
with CH2Cl2. The combined organic extracts were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (15% 
EtOAc/hexanes) gave 54.0 mg (91%) of the desired alcohol as a light yellow oil: 1H 
(400 MHz, CDCl3) δ 7.29 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 5.34 (d, J = 
3.2 Hz, 1H), 5.26 (dd, J = 7.6, 6.4 Hz, 1H), 4.55 (AB, JAB = 9.4 Hz, ∆νAB = 150.2 Hz, 
2H), 4.20 (br, 1H), 3.77 (s, 3H), 3.70 (m, 2H), 3.62 (d, J = 6.4 Hz, 1H), 2.38 (dd, J = 
13.6, 8.4 Hz, 1H), 2.28-2.19 (m, 3H), 2.02-1.96 (m, 3H), 1.84 (s, 3H), 1.73 (s, 3H), 
1.71 (m, 1H), 1.47 (s, 3H), 1.45 (s, 3H), 1.34 (s, 1H), 1.24 (m, 1H), 0.98 (s, 3H); 13C 
(100 MHz, CDCl3) δ 159.1, 136.0, 131.0, 129.9, 120.4, 113.7, 98.5, 73.5, 71.4, 55.3, 
40.2, 30.0, 28.0, 19.1, 7.4 ; IR (film) 3415 (br), 3072, 2934, 2857, 1614, 1514, 1455, 
1381, 1249, 1205, 1049 cm-1; [α]22D = +12.9o (c 2.70, CH2Cl2); MS (ESI) calculated 
for C28H40O5 [M+Na]+: 479.3, found: 479.3. 
 
Me
MeMe
H
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Ketone 303. To a stirring solution of the previously prepared alcohol (29.5 mg, 0.065 
mmol, 1.0 eq) in CH2Cl2 (1 mL), was added Dess-Martin periodinane (54.8 mg, 0.13 
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mmol, 2.0 eq). The reaction mixture was allowed to stir for 4 h at room temperature, 
followed by addition of 2 mL saturated 5:1 NaHCO3:Na2S2O3 solution to quench the 
reaction. Et2O (2 mL) was subsequently added to dilute the reaction mixture, which 
was stirred vigorously for an additional 5 min. The layers were separated and the 
aqueous layer was further extracted three times with Et2O. The organic layers were 
combined, washed with saturated NaCl solution, dried over MgSO4 and 
concentrated under reduced pressure. Purification by flash chromatography (10% 
EtOAc/hexanes) gave 26.6 mg (91%) of the desired ketone 303 as a light yellow oil: 
1H (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 5.34 (s, 
1H), 5.22 (dd, J = 6.4, 6.4 Hz, 1H), 4.54 (AB, JAB = 9.6 Hz, ∆νAB = 200.8 Hz, 2H), 
3.81 (m, 1H), 3.80 (s, 3H), 3.77-3.60 (m, 2H), 3.35 (dd, J = 14.0, 6.8 Hz, 1H), 2.96 (d, 
J = 16.8 Hz, 1H), 2.89 (dd, J = 13.8, 6.6 Hz, 1H), 2.69 (d, J = 8,4 Hz, 1H), 2.31 (d, J 
= 15.2 Hz, 1H), 2.16 (dd, J = 15.2, 7.2 Hz, 1H), 2.05-1.97 (m, 3H), 1.83 (s, 3H), 1.54 
(s, 3H), 1.47 (s, 6H), 0.99 (s, 3H); 13C (100 MHz, CDCl3) δ 211.3, 159.2, 138.5, 
135.4, 130.9, 129.9, 119.3, 118.7, 113.8, 98.9, 82.3, 78.0, 73.6, 73.4, 55.3, 42.8, 
41.5, 41.1, 40.3, 40.0, 30.0, 27.9, 24.5, 22.2, 19.2, 7.6; IR (film) 3071, 2936, 1703, 
1514, 1248, 1204, 1119, 1090 cm-1; [α]21D = -93.0o (c 1.30, CH2Cl2); MS (ESI) 
calculated for C28H40O5 [M+Na]+: 477.3, found: 477.3. 
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